Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,41758,-0.159721435170286,0.00458882403623039,-0.168715530281298,-0.150727340059275,5.25427416843886e-254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,41465,-0.378130664966598,0.012723593643691,-0.403068908508233,-0.353192421424964,8.9701609700646e-188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,41905,0.353965541862508,0.0131412027723882,0.328208784428627,0.379722299296389,1.20913941590993e-155
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,39633,-0.106468795064877,0.00403167927065983,-0.11437088643537,-0.0985667036943836,4.4778538319278e-149
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,41689,-0.234386972994676,0.00910632700896337,-0.252235373932244,-0.216538572057107,1.46367591709056e-142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,39625,-0.224631333916736,0.00893762577815737,-0.242149080441924,-0.207113587391547,1.35318810109636e-135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,41786,-0.221599770419953,0.0088457497971785,-0.238937440022423,-0.204262100817484,2.39239075621416e-135
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,39655,0.142302776940191,0.00602939928571575,0.130485154340188,0.154120399540194,3.38882293466556e-120
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,39250,-0.239547219176729,0.0104363844365619,-0.260002532672391,-0.219091905681068,7.72161931350155e-114
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,41911,-0.119968454148371,0.0052889018639414,-0.130334701801696,-0.109602206495046,8.55193005153217e-112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,39308,-0.118775719610118,0.00529816260838604,-0.129160118322555,-0.108391320897682,8.13488095033736e-109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,41877,-0.146133165394383,0.00654410384732007,-0.15895960893513,-0.133306721853636,1.83321900363286e-108
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,39655,0.0596228708170663,0.00268623246001135,0.0543578551954441,0.0648878864386886,7.97555456652275e-107
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,41765,-0.144040132460322,0.00658708705690874,-0.156950823091864,-0.131129441828781,3.77924025053246e-104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,41521,-0.18604547772847,0.00852405216631529,-0.202752619974448,-0.169338335482492,9.735316424024e-104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,41703,-0.0890098043094814,0.0043715957605602,-0.0975781320001794,-0.0804414766187834,9.36152227646668e-91
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,41765,0.101965639219378,0.00502566375405221,0.0921153382614353,0.11181594017732,3.82085216914232e-90
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,41805,0.0614617518587672,0.00303509937725664,0.0555129570793442,0.0674105466381902,8.10889035976383e-90
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,41712,-0.217383018566017,0.0107981542376842,-0.238547400871878,-0.196218636260156,8.53980457209887e-89
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,41813,-0.0713869385179979,0.00355427377979864,-0.0783533151264032,-0.0644205619095926,2.07941046356072e-88
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,39581,-0.174940259498536,0.00908702801432218,-0.192750834406608,-0.157129684590465,2.96122532399301e-81
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,41802,-0.066279000648718,0.00346378551346673,-0.0730680202551127,-0.0594899810423232,1.58716210570167e-80
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,39625,-0.180906353715744,0.00951815744331307,-0.199561942304638,-0.16225076512685,2.77468289090237e-79
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,41740,-0.168114839274661,0.00890247302081329,-0.185563686395455,-0.150665992153867,1.68344435639267e-78
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,41862,-0.235832080230137,0.0126078025270338,-0.260543373183123,-0.211120787277151,4.39024637353613e-77
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,41903,0.116673829952181,0.00634843467359267,0.104230897991939,0.129116761912423,1.63259245110689e-74
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,39655,0.0892726126158148,0.00493141841378155,0.079607032524803,0.0989381927068266,3.3246470706573e-72
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,41788,-0.0954447513491972,0.00533579838016675,-0.105902916174324,-0.0849865865240704,1.0063374520828e-70
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,41877,-0.0693565247537015,0.00387880005615644,-0.0769589728637681,-0.0617540766436348,1.11740956387512e-70
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,39408,0.0575619859252627,0.00323427881087206,0.0512227994559534,0.0639011723945719,7.30657103663363e-70
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,41750,0.330961062620828,0.0186713824181982,0.29436515308116,0.367556972160497,1.7083857622301e-69
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,41411,-0.101178121151338,0.00575949319358699,-0.112466727810768,-0.0898895144919071,2.76963666337058e-68
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,41465,-0.142300338456918,0.00812816309429729,-0.15823153812174,-0.126369138792095,7.72253354106243e-68
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,41911,-0.0532574729813948,0.00307187754347052,-0.059278352966597,-0.0472365929961925,1.32825480522848e-66
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,41559,0.0984076165112856,0.00568857807751194,0.0872580034793621,0.109557229543209,2.64680434448686e-66
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,39650,0.123937371108599,0.00722758978353849,0.109771295132864,0.138103447084335,4.51995597423323e-65
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,41667,-0.126189196491831,0.00740911460468429,-0.140711061117012,-0.111667331866649,2.36451234515869e-64
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,41689,-0.0663090417057923,0.00390470875815155,-0.0739622708717693,-0.0586558125398152,5.41631517520664e-64
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,41836,0.0686298567079787,0.00405252623300179,0.0606869052912952,0.0765728081246622,1.15945106038433e-63
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,41521,-0.0962955384119014,0.00575356792405789,-0.107572531543055,-0.085018545280748,3.19839367012883e-62
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,41758,-0.0695265017228154,0.00415937444614131,-0.0776788756372523,-0.0613741278083784,4.40110439289449e-62
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,40881,-0.0726289009194014,0.0043656358497865,-0.081185547184983,-0.0640722546538199,1.78179990708785e-61
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,41740,-0.092183649855808,0.00555573948754021,-0.103072899251387,-0.0812944004602292,3.3078621610836e-61
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,41758,-0.0918695362973121,0.00559505603843169,-0.102835846132638,-0.0809032264619859,5.44850911258665e-60
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,39600,-0.12987514211167,0.0080171395904561,-0.145588735708964,-0.114161548514376,2.39406034875644e-58
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,41758,0.0458206812398037,0.00283686384894323,0.040260428095875,0.0513809343837324,3.98605198722312e-58
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,39408,-0.0478548023112381,0.00296839262562258,-0.0536728518574583,-0.0420367527650178,8.49332294116589e-58
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,39408,-0.128228130811527,0.00807140662800507,-0.144048087802417,-0.112408173820637,3.38086761201343e-56
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,41829,-0.101722784872633,0.00642608509674269,-0.114317911662249,-0.0891276580830172,6.32899449903731e-56
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,41689,-0.128428118050318,0.00819648234455882,-0.144493223445653,-0.112363012654982,7.79220964843655e-55
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,39633,0.0945558320335295,0.00604678778546235,0.0827041279740233,0.106407536093036,1.55677272202031e-54
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",41689,-0.140036783989519,0.00896919993902347,-0.157616415870005,-0.122457152109033,1.83653146072847e-54
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,39401,-0.079712793970867,0.00513944686742694,-0.0897861098310238,-0.0696394781107102,1.12357833201896e-53
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,41865,-0.236590324489843,0.015280186096241,-0.266539489238475,-0.20664115974121,1.31999516097822e-53
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,41617,-0.116970787918169,0.0075931837669684,-0.131853428101427,-0.102088147734911,4.47018716508255e-53
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,41689,-0.0906955392072661,0.00593614742317674,-0.102330388156693,-0.0790606902578397,3.00046821989602e-52
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,39633,-0.0559653899855744,0.00366801208168368,-0.0631546936656744,-0.0487760863054743,4.96381545506515e-52
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,41809,-0.0529054147551054,0.00347935344941504,-0.0597249475159588,-0.0460858819942519,8.91182294029476e-52
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),39448,0.292756856756503,0.0192497309425444,0.255027384109116,0.33048632940389,1.06073145770026e-51
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,39589,-0.0905996518654785,0.00596237567764239,-0.102285908193658,-0.0789133955372994,1.27103168765575e-51
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,39308,-0.100255703326049,0.00662255379310145,-0.113235908760528,-0.0872754978915699,3.05433507960139e-51
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,41856,-0.0501705678304939,0.00334816142721138,-0.0567329642278282,-0.0436081714331596,2.39366551674364e-50
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,39408,-0.0791149965422569,0.00527696288693381,-0.0894578438006471,-0.0687721492838666,2.62899635592359e-50
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,39655,0.0780585574530179,0.00521782827535659,0.0678316140333189,0.0882855008727168,4.14092464272243e-50
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,41534,-0.128720535342287,0.00872413785136507,-0.145819845530962,-0.111621225153611,7.17744250994261e-49
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,41925,-0.0782368537782897,0.00531703868192066,-0.0886582495948542,-0.0678154579617253,1.25451883145109e-48
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,41534,-0.0843097082285102,0.00575153836508555,-0.0955827234240779,-0.0730366930329425,2.89144820334927e-48
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,41449,-0.0911059369572094,0.0062534919863998,-0.103362781250553,-0.0788490926638658,1.06420011592497e-47
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,41802,0.0509589941965824,0.00350845899733759,0.0440824145618007,0.057835573831364,1.96378308686795e-47
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,39328,-0.126875011355875,0.00878178660424064,-0.144087313100187,-0.109662709611564,7.14925556616525e-47
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,39308,-0.0950883386210463,0.00665829885102668,-0.108138604369059,-0.082038072873034,7.55150174404359e-46
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,41877,-0.0500348888636428,0.00352898370185892,-0.0569516969192863,-0.0431180808079994,2.67255108126168e-45
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,41689,-0.0980158639778759,0.00693250118832521,-0.111603566306993,-0.0844281616487585,4.71048570197797e-45
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",39308,-0.0854743234837767,0.00608873498349876,-0.0974082440514343,-0.0735404029161192,2.25183483372392e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,41543,-0.2141487927184,0.0153547112958521,-0.24424402685827,-0.18405355857853,6.83655226513215e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,41465,-0.0963787229796571,0.00691052414021427,-0.109923350294477,-0.0828340956648372,6.87818609292412e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,41820,-0.101245273223211,0.00726793115263342,-0.115490418282373,-0.0870001281640497,8.44114532610839e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,41802,-0.035939794327681,0.00258078626026894,-0.0409981353978081,-0.0308814532575538,8.99081212130945e-44
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,41777,0.0281388991510253,0.00202690298586581,0.0241661692987283,0.0321116290033223,1.63231938315008e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,41466,-0.0772817322449631,0.00556729517394971,-0.0881936307859045,-0.0663698337040217,1.69068517788946e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,41740,-0.0578455111499218,0.00417368043615861,-0.0660259248047927,-0.0496650974950509,2.2469646919073e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,41840,-0.0712408439800151,0.00514320694871262,-0.0813215295994919,-0.0611601583605384,2.49974285561501e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,39650,-0.029598835496969,0.00213798431664672,-0.0337892847575966,-0.0254083862363414,3.16013898204054e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,39625,-0.0505333690110917,0.00366074851334735,-0.0577084360972526,-0.0433583019249309,5.47979305292203e-43
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,41689,-0.115935233484898,0.00843472390263013,-0.132467292334054,-0.0994031746357434,1.07986138507289e-42
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,41862,-0.0611361048931428,0.00445527974503391,-0.0698684531934093,-0.0524037565928763,1.46039334457544e-42
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,41455,-0.0706505138587479,0.00517962146397375,-0.0808025719281364,-0.0604984557893593,4.53732590139669e-42
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,41734,-0.0742068121093733,0.00547109847530537,-0.0849301651209718,-0.0634834590977748,1.25790119470431e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,41521,-0.0930893521049171,0.00686367648871897,-0.106542158022806,-0.0796365461870279,1.28520037835069e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,41911,-0.0437463478148987,0.00323050911202649,-0.0500781456744706,-0.0374145499553268,1.67173701998753e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,41877,-0.0401375004683265,0.00298050290516779,-0.0459792861624553,-0.0342957147741976,4.56840120325174e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,41765,-0.0883948475293048,0.00658594048720957,-0.101303290884236,-0.0754864041743741,8.36133067228427e-41
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,41802,-0.0768128512166485,0.00573488243796496,-0.0880532207950598,-0.0655724816382372,1.2077861769453e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,41877,0.0514735381629015,0.00387978319732383,0.0438691630961468,0.0590779132296562,6.44533884919841e-40
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,39625,-0.0921191561728383,0.00699888724606781,-0.105836975175131,-0.0784013371705454,2.8705647767341e-39
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,41740,0.0494293280437641,0.00376941019089669,0.0420412840696066,0.0568173720179216,4.85900220826581e-39
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",41521,-0.12678498642951,0.00967870541082414,-0.145755249034726,-0.107814723824295,5.87787744894668e-39
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,41758,-0.0388852588577835,0.00298714250630551,-0.0447400581701423,-0.0330304595454247,1.68107392469523e-38
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,41848,0.0372597236780306,0.00288037324569773,0.031614192116463,0.0429052552395981,4.80796565209542e-38
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,41703,-0.0428038776579449,0.00331584162914337,-0.0493029272510659,-0.0363048280648239,6.82364015475714e-38
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,41465,-0.081567366156406,0.00634842136696958,-0.0940102720356664,-0.0691244602771456,1.49301846396167e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,41721,-0.039157295680698,0.00306006099959297,-0.0451550152399002,-0.0331595761214958,2.87357524697697e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,41521,-0.0751960304654874,0.00588339969297182,-0.0867274938637121,-0.0636645670672626,3.513085384512e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,39625,-0.0378617133106555,0.00297943653806234,-0.0437014089252577,-0.0320220176960533,9.69783299948138e-37
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,41877,-0.045179728617409,0.00356330817762679,-0.0521638126455575,-0.0381956445892605,1.25793145827974e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,41636,-0.0405660441154022,0.00320233928902979,-0.0468426291219006,-0.0342894591089038,1.46754789969106e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,41802,-0.0300867981727806,0.0023804322445708,-0.0347524453721394,-0.0254211509734219,2.08506549102444e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,41911,-0.0440440833953455,0.00348962521002185,-0.0508837488069883,-0.0372044179837026,2.59642483144727e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",41466,-0.067313924901053,0.00534471256942969,-0.0777895615371352,-0.0568382882649708,3.69969484079994e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,41740,-0.0368943890719671,0.00293799922514897,-0.042652867553259,-0.0311359105906751,5.80451293890424e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,41758,0.0493073618120874,0.00392956990974059,0.0416054047889959,0.057009318835179,6.56228558148374e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,41821,-0.0880986532379119,0.00702911773785468,-0.101875724004107,-0.0743215824717167,7.8345411030991e-36
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,41765,0.0505306112340567,0.0040444682209746,0.0426034535209465,0.058457768947167,1.28542029267316e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,41740,-0.0695498725378678,0.00557526491608649,-0.0804773917733973,-0.0586223533023382,1.62961601494679e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,41865,-0.0320130263814204,0.00257066443151337,-0.0370515286671866,-0.0269745240956542,2.11846683716808e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,41614,-0.0681230135456933,0.00547051625442171,-0.0788452254043598,-0.0574008016870267,2.14904354122853e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,41587,-0.0646293690182138,0.00519534407771498,-0.0748122434105352,-0.0544464946258924,2.5233568925534e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,39600,-0.055378720163639,0.00446352532616032,-0.0641272298029133,-0.0466302105243648,4.11383705947335e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,41636,-0.0475315865226069,0.00383724511783506,-0.0550525869535636,-0.0400105860916502,4.8440337263885e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,41877,-0.161801580681817,0.0130652680795039,-0.187409506117645,-0.136193655245989,4.97353309129289e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,41783,-0.042064504925983,0.00340514815369699,-0.0487385953072291,-0.0353904145447369,7.29665920293354e-35
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,39589,-0.0694513215302711,0.00563110263446107,-0.0804882826938148,-0.0584143603667274,1.01400243309591e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,39334,-0.0602929668097517,0.0048984493776031,-0.0698939275898538,-0.0506920060296497,1.39277426420041e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,41865,-0.0597070083487558,0.00485624358043074,-0.0692252457664001,-0.0501887709311116,1.48771204168104e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,41740,-0.0524734856891599,0.00428749360605013,-0.0608769731570182,-0.0440699982213017,2.96519755229233e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,41884,0.048939807975839,0.00399899419067084,0.0411017793621241,0.0567778365895538,2.97691144762978e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,41689,-0.0883258877309533,0.00723519008384022,-0.10250686029528,-0.0741449151666265,4.3261238095518e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,41586,-0.052051616963867,0.00426590546054002,-0.0604127916665255,-0.0436904422612086,4.67132218532805e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,41689,-0.103942927705679,0.00852507140124566,-0.12065206765212,-0.0872337877592375,5.2031729681629e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,41758,-0.0497045747603264,0.00408305603869502,-0.0577073645961686,-0.0417017849244842,6.55612062022475e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,41689,-0.0529968160583592,0.0043642637989764,-0.0615507731043529,-0.0444428590123655,9.44889614130142e-34
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,39153,0.0539092057503543,0.00444792272551704,0.045191277208341,0.0626271342923677,1.38141098825779e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,41689,-0.107919426433875,0.00899924552983692,-0.125557947672356,-0.0902809051953951,5.82033332264617e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,39250,-0.0770648873560786,0.00642905118422116,-0.0896658276771521,-0.0644639470350051,6.76702195311255e-33
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,41721,-0.0252346664287262,0.00211711727590886,-0.0293842162895076,-0.0210851165679449,1.38204105069442e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,41715,-0.0660116108710836,0.00558390314229697,-0.0769560610299857,-0.0550671607121816,4.38336171880596e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,41689,0.0244117263040291,0.00206777141718571,0.0203588943263451,0.0284645582817131,5.29286699994143e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,39160,-0.0404180918703695,0.00342545049520766,-0.0471319748409765,-0.0337042088997625,6.23957877758515e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,41765,-0.0425001554882617,0.00360444348538381,-0.049564864719614,-0.0354354462569095,6.28317389689501e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,41765,-0.0786835678617493,0.00668747143526279,-0.0917910118748643,-0.0655761238486342,8.44866333304445e-32
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,41465,-0.104515421302998,0.0089049970779234,-0.121969215575728,-0.0870616270302686,1.19802467946757e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,41888,-0.063166327267157,0.00539952443264239,-0.0737493951551361,-0.0525832593791779,1.8503098694367e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,39408,-0.0800162518341202,0.00684578191381805,-0.0934339843852036,-0.0665985192830368,2.25595824506143e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,41758,0.0346210677706063,0.00297409993671259,0.0287918318946497,0.040450303646563,3.63074332463196e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,41877,-0.0322570815570496,0.00277222579110216,-0.0376906441076099,-0.0268235190064894,3.8378219949517e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,39625,-0.0374568554849617,0.00322389608377784,-0.0437756918091663,-0.0311380191607572,5.03068514050178e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,41877,-0.0394377983633895,0.00340913915298039,-0.046119711103231,-0.0327558856235479,8.38482670588003e-31
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,39334,-0.153091484990077,0.0132947924070515,-0.179149278107898,-0.127033691872256,1.67141320384869e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,41877,-0.0572479384965748,0.00498098115085845,-0.0670106615522574,-0.0474852154408922,1.98548058319194e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,39625,-0.0337179029049807,0.00293272899755251,-0.0394660517401836,-0.0279697540697778,2.032952923295e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,41911,-0.0546888026502335,0.00481641982439372,-0.0641289855060451,-0.0452486197944218,9.6348015582244e-30
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,41848,-0.0577446784518466,0.00511210639060405,-0.0677644069774306,-0.0477249499262627,1.87946893297292e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,41622,-0.0432586304445108,0.00383906950517486,-0.0507832066746535,-0.0357340542143681,2.58031945508384e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,41925,-0.0607381641915102,0.00539958859979633,-0.071321357847111,-0.0501549705359094,3.18401771902832e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,39490,-0.0312906607546932,0.0027862715901589,-0.0367517530714047,-0.0258295684379818,4.18321706168039e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,41376,-0.118636973525404,0.0105979398098324,-0.139408935552675,-0.0978650114981326,5.92650256388274e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,41791,-0.0381996867233246,0.00341469591005587,-0.0448924907070342,-0.0315068827396151,6.38190917307876e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,41540,-0.098809884298698,0.00883296990148867,-0.116122505305616,-0.0814972632917802,6.44500971466743e-29
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,39600,-0.131482943045388,0.0118365126935025,-0.154682507924653,-0.108283378166123,1.62154584682054e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,41636,-0.0505318101866122,0.00456107932414868,-0.0594715256619436,-0.0415920947112808,2.12585190800907e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,41765,-0.0312610858424234,0.00282757535269258,-0.0368031335337009,-0.0257190381511459,2.73714748627921e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,39598,-0.0902472306085855,0.00816249027537829,-0.106245711548327,-0.074248749668844,2.87767146060008e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,41836,-0.0500477878212305,0.0045332183150459,-0.0589328957187205,-0.0411626799237406,3.24490837233971e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,41689,-0.0429033699432348,0.00388725305269384,-0.0505223859265147,-0.0352843539599549,3.37563999405952e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,41689,-0.0826518790510125,0.00750593177413725,-0.0973635053283216,-0.0679402527737035,4.46482416343051e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,39408,-0.0322040890433768,0.00292960101020707,-0.0379461070233827,-0.026462071063371,5.82893926291059e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,41404,-0.0977118304781089,0.00891545968952669,-0.115186131469581,-0.0802375294866366,7.92472625797147e-28
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,41925,0.0386115344095061,0.00353518980031621,0.0316825624008863,0.0455405064181258,1.18437780784797e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,41466,-0.0775226717429847,0.00710134429247256,-0.091441306556231,-0.0636040369297385,1.26879964139115e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,41765,-0.0406799165889685,0.00373818772079638,-0.0480067645217294,-0.0333530686562076,1.83315270788924e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,41740,-0.037963775684232,0.00350069124930996,-0.0448251305328796,-0.0311024208355845,2.75882400631626e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,41362,-0.0237814052681604,0.00219457311362072,-0.028082768570857,-0.0194800419654638,3.03846521113203e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,41689,-0.0445910391507918,0.00414885777128232,-0.0527228003825051,-0.0364592779190784,7.85474847707168e-27
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,39385,-0.0448036701406222,0.00418219390864269,-0.0530007702015619,-0.0366065700796826,1.20458925590569e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,41813,-0.0351156752234621,0.00328413851823761,-0.0415525867192078,-0.0286787637277163,1.41715207903051e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,39408,-0.025032989582251,0.00234097603285927,-0.0296213026066551,-0.0204446765578468,1.48352941865827e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,41765,-0.0784526320409162,0.00734057570540945,-0.0928401604235187,-0.0640651036583137,1.49592836926722e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,39334,-0.0583537088516376,0.00547816323276423,-0.0690909087878554,-0.0476165089154197,2.30913600636477e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,41911,-0.0294556639209214,0.00277798552029118,-0.0349005155406922,-0.0240108123011507,3.65978553047335e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,41846,-0.077886553997041,0.00735806685925449,-0.0923083650411798,-0.0634647429529022,4.43662431436659e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,41466,-0.0572829578462635,0.0054363608870507,-0.0679382251848829,-0.0466276905076442,7.4329871330082e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,39408,0.0266174029863767,0.00252656280404467,0.0216653398904492,0.0315694660823043,7.94546650055703e-26
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,41689,-0.0390390611886845,0.00371655320577306,-0.0463235054719997,-0.0317546169053693,1.04656085638076e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,41465,-0.0716044221270276,0.00682449032118101,-0.0849804231565424,-0.0582284210975129,1.18984279413832e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,39598,-0.144478187497918,0.0138732613780091,-0.171669779798816,-0.11728659519702,2.8008906874968e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,41740,-0.0544221592628977,0.00523250812330546,-0.0646778751845764,-0.0441664433412191,3.08122160576765e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,41547,-0.0315399985910381,0.00304750386468116,-0.0375131061658132,-0.025566891016263,5.26776040554955e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",39600,-0.0696267900330661,0.00674318461523015,-0.0828434318789172,-0.056410148187215,7.01817086847291e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,39308,-0.0582873483441668,0.00565803698223382,-0.0693771008293451,-0.0471975958589885,9.03430909810344e-25
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,41466,-0.0683706358906967,0.006708444620308,-0.0815191873465004,-0.055222084434893,2.67018242120953e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,41765,-0.0827061856508504,0.00813055196336507,-0.0986420674990459,-0.0667703038026549,3.24056857279625e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",41765,0.0860515270310559,0.00846442741596773,0.0694612492957591,0.102641804766353,3.44538817861138e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,41819,-0.0196656621435873,0.00194263111494581,-0.0234732191288811,-0.0158581051582935,5.33154607667723e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,41750,-0.133198571545082,0.0131637691524293,-0.158999559083844,-0.107397584006321,5.59399729651674e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,41636,-0.0617138214516046,0.00610694760822873,-0.0736834387637329,-0.0497442041394763,6.39670553539043e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,41636,-0.0782270940914928,0.00774645132282201,-0.093410138684224,-0.0630440494987617,6.87097807083081e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,39650,0.0284589445378364,0.00281927230377347,0.0229331708224404,0.0339847182532324,7.41851913186729e-24
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,41740,-0.062773967486845,0.00624393841557726,-0.0750120867813765,-0.0505358481923136,1.07894096655677e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,39408,-0.0566483447811113,0.00563590467866898,-0.0676947179513025,-0.0456019716109201,1.15134666903304e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,39334,-0.0738542635997439,0.00735978576246148,-0.0882794436941684,-0.0594290835053194,1.36105568826192e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,41911,-0.0364049325212045,0.00365441038958872,-0.0435675768847984,-0.0292422881576107,2.69910432164749e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,41636,-0.0767382104552283,0.00771324697520073,-0.0918561745266218,-0.0616202463838349,3.08604118070799e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,41865,-0.0394728753109223,0.00397251928636789,-0.0472590131122034,-0.0316867375096413,3.4806394798967e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,41689,0.0818722876695266,0.00824028775182441,0.0657213236759508,0.0980232516631024,3.51984100423247e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,41805,-0.0812966076485459,0.00824069938529778,-0.0974483784437295,-0.0651448368533623,7.06453558269709e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,41736,-0.0837920243298083,0.00849797519188553,-0.100448055705904,-0.0671359929537127,7.43128703563172e-23
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,39633,0.0394909962080511,0.00401771674580124,0.0316162713862807,0.0473657210298215,1.04448415656431e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,39650,0.0284034871541904,0.00289081652977969,0.0227374867558222,0.0340694875525586,1.08385711450777e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,39408,-0.0390733154068307,0.00397754194934734,-0.0468692976275515,-0.0312773331861099,1.10998287858928e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,41819,0.0302944217512582,0.00308659088957009,0.0242447036077008,0.0363441398948155,1.16148529692232e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,41877,0.048107879899978,0.0049112746727671,0.0384817815413545,0.0577339782586015,1.4052539208979e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,39589,-0.0586005841967464,0.00598114687466343,-0.0703236320710867,-0.0468775363224061,1.42695442997582e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,41720,0.0671222403865916,0.00685924977060061,0.0536781108362144,0.0805663699369688,1.54956856263206e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,39308,-0.061903333844629,0.00633024983749694,-0.074310623526123,-0.049496044163135,1.72145590201901e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,39598,-0.0401463755165196,0.00410850033111001,-0.0481990361654952,-0.032093714867544,1.84088948434808e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,41466,-0.0513996536551092,0.00526609891574832,-0.0617212075299759,-0.0410780997802425,1.99008210884194e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,39633,-0.0774506067700783,0.00798090923435098,-0.0930931888694062,-0.0618080246707504,3.53849510014015e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,41802,-0.028193122980103,0.00291573536881865,-0.0339079643029876,-0.0224782816572185,4.81759535168892e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,39408,-0.0411374284803874,0.0042549054642153,-0.0494770431902493,-0.0327978137705254,5.051340867866e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,39600,-0.0598012810472688,0.0061939175446,-0.0719413594346848,-0.0476612026598528,5.73033500467456e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,41925,-0.0590428112220469,0.00614152764889927,-0.0710802054138895,-0.0470054170302044,8.23744715910829e-22
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,39625,-0.030144127257687,0.00316078767882226,-0.0363392711081786,-0.0239489834071953,1.78068465752502e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,39625,-0.057904269103754,0.00609342317968786,-0.0698473785359423,-0.0459611596715659,2.46694067835698e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,41667,-0.0261807306993941,0.00275662849081476,-0.031583722541391,-0.0207777388573972,2.52187457615071e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,41689,-0.107092390395269,0.0112955831319058,-0.129231733333804,-0.0849530474567332,2.9493841124004e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,41802,-0.0374081373076643,0.00394631327881786,-0.0451429113341473,-0.0296733632811813,2.99196791907279e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,39612,0.0497657708658584,0.00524822935425406,0.0394792413315204,0.0600523004001964,2.99500284197298e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,41925,0.0252354536921392,0.00266570415365739,0.0200106735509707,0.0304602338333076,3.36651839720948e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,41836,0.03210788606887,0.00339328818666246,0.0254570412230116,0.0387587309147284,3.51846722811477e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,41911,-0.0754145136151517,0.00798759643188784,-0.0910702026216519,-0.0597588246086515,4.27955342409778e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,39633,-0.113593699314581,0.0120543400507057,-0.137220205813964,-0.0899671928151975,5.23396131894808e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,41744,0.0446039687880599,0.0047356382171676,0.0353221178824114,0.0538858196937084,5.31433264720356e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,41689,-0.0536824032811066,0.00570592072436477,-0.0648660079008616,-0.0424987986613517,5.87788457054e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,41745,-0.044164903739558,0.00470263884410548,-0.0533820758740047,-0.0349477316051112,6.87573172119237e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,39476,-0.0233772510708805,0.00248834781658158,-0.0282544127913804,-0.0185000893503806,6.88512379255658e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,41466,-0.0525158320473269,0.00560280546650111,-0.063497330761669,-0.0415343333329847,8.20269587647019e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,39598,-0.0383390188159599,0.00409488484158548,-0.0463649931054674,-0.0303130445264523,9.28735443362984e-21
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,41465,-0.0645405326364121,0.00691070406671438,-0.0780855126071723,-0.0509955526656519,1.12819627633744e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,39250,-0.0681100446601365,0.00729391037575325,-0.0824061089966129,-0.0538139803236601,1.17791233330068e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,41740,-0.0720153072922151,0.0077245514928857,-0.0871554282182711,-0.0568751863661591,1.31034056976761e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,41911,-0.0418198930633935,0.00448652913585458,-0.0506134901696685,-0.0330262959571185,1.3288590399455e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,39625,-0.0823425190165239,0.00888025806040659,-0.0997478248149208,-0.064937213218127,2.15588851308812e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,41689,-0.0585299148636321,0.00634355231566134,-0.0709632774023283,-0.0460965523249359,3.21442800841921e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,41862,-0.0279031288560579,0.00302860795299705,-0.0338392004439322,-0.0219670572681837,3.63584200598352e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,41740,-0.0642052969463234,0.00699840211786805,-0.0779221650973448,-0.050488428795302,5.21553611842673e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,41847,-0.0296254014498138,0.00323076566108034,-0.0359577021455312,-0.0232931007540963,5.43058900402818e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,41465,-0.0714743603258097,0.00779586009030128,-0.0867542461028002,-0.0561944745488192,5.52997452010719e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,39408,-0.0225754674835678,0.0024619240923747,-0.0274008387046222,-0.0177500962625134,5.59538161479438e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,41877,-0.062037521239416,0.00678743354461058,-0.0753408909868527,-0.0487341514919792,7.13694709437193e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",39625,-0.0737819671513473,0.00807232552469876,-0.0896037251797568,-0.0579602091229377,7.33011677435e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,41636,-0.0513084664868452,0.00562731822761276,-0.0623380102129662,-0.0402789227607241,8.78004252683432e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,41865,-0.0555767927767875,0.00609933191939675,-0.0675314833388051,-0.0436221022147699,9.23787341203461e-20
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,41534,-0.0681924367270424,0.00751554452999077,-0.0829229040058243,-0.0534619694482605,1.31706575449007e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,41740,-0.0539875447606408,0.00595324638822579,-0.0656559076815633,-0.0423191818397182,1.37477575695583e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",41465,-0.0792657266913328,0.00874567157545476,-0.0964072429792241,-0.0621242104034415,1.44508641449535e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,41832,-0.0553966863404445,0.00611925162587955,-0.0673904195271684,-0.0434029531537205,1.58528943428534e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,39250,-0.0652018810786647,0.00720122556776456,-0.0793162831914833,-0.0510874789658462,1.6145541704506e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,41911,-0.0357713553933217,0.00395468501090504,-0.0435225380146956,-0.0280201727719478,1.69663054192884e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,41836,-0.0546832013458313,0.00605296484798655,-0.0665470124478849,-0.0428193902437776,1.87972548045462e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,41877,-0.0383555399112425,0.00425696389330343,-0.0466991891421172,-0.0300118906803677,2.33723717784664e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,41765,-0.0599005585772637,0.00666176177417406,-0.0729576116546449,-0.0468435054998825,2.7631155167913e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,41740,-0.0936880252861148,0.0104194002572125,-0.114110049790251,-0.0732660007819783,2.76399126203168e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,39655,0.0257801210598459,0.00286687968964674,0.0201610368681382,0.0313992052515535,2.81261136340955e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,39408,-0.0392117695707625,0.00436214678468577,-0.0477615772687466,-0.0306619618727784,2.90760826306423e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,39598,-0.0655256858202829,0.00730540524210342,-0.0798442800948056,-0.0512070915457602,3.46144131434367e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,39308,0.0538840135069502,0.00601924646216328,0.0420862904411102,0.0656817365727903,4.0694417855125e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,39598,-0.0578835520193067,0.00649096424944629,-0.0706058419482214,-0.045161262090392,5.51968811034374e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,39633,-0.0383253238301657,0.0043017054816463,-0.0467566665741925,-0.029893981086139,5.9390542688418e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,39633,-0.0521384344611031,0.00585656544467542,-0.0636173027326669,-0.0406595661895393,6.31013155154595e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,39625,-0.068682327507099,0.00771797972360608,-0.0838095677653669,-0.0535550872488311,6.5149118549265e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,39509,-0.0285619382411516,0.00321062286857573,-0.0348547590635601,-0.0222691174187432,6.69811085792803e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,41925,0.026706425582626,0.00300418546050852,0.0208182220800293,0.0325946290852227,6.90378919585811e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,39650,-0.0650273296438109,0.00732003540900469,-0.0793745990454601,-0.0506800602421617,7.48253618311294e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,41744,-0.0532088860411065,0.005994395067446,-0.0649579003733007,-0.0414598717089123,7.78813275531962e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,41466,-0.0276688472511467,0.00312521483349438,-0.0337942683247957,-0.0215434261774978,9.58808630835765e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,41636,-0.0494892945663808,0.00559034761669975,-0.0604463758951124,-0.0385322132376493,9.64050640798118e-19
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,41765,-0.0291029200000199,0.00329552675420982,-0.0355621524382712,-0.0226436875617687,1.16695674259288e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,39625,-0.0628339588576539,0.00714635390224186,-0.076840812506048,-0.0488271052092598,1.68048049096129e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,41925,-0.0577204516568144,0.00657085988422914,-0.0705993370299035,-0.0448415662837253,1.7635634998326e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,41465,-0.0524368107457987,0.00598550181037493,-0.0641683942941335,-0.0407052271974638,2.18240261085682e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,41865,0.0430615130204954,0.00493841616833686,0.0333822173305551,0.0527408087104356,3.11801080146188e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,39650,0.0226784102870851,0.00260599976883988,0.017570650740159,0.0277861698340113,3.71050557532417e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,41832,-0.0555040486910012,0.00639912802212093,-0.0680463396143582,-0.0429617577676441,4.66681662281168e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,41836,-0.0393608207826666,0.00454077191391061,-0.0482607337339314,-0.0304609078314018,4.89112555099891e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,41465,-0.0520573679324549,0.00601594282257457,-0.0638486158647011,-0.0402661200002088,5.59598446284846e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,39250,-0.0709242041788064,0.00821647615763498,-0.0870284974477709,-0.0548199109098418,6.89077661765509e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,39589,-0.033931272106082,0.00394305980443653,-0.0416596693227776,-0.0262028748893864,8.64596329331458e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,41758,-0.0508224242143625,0.00590803093848226,-0.0624021648537877,-0.0392426835749373,8.69389909167204e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,41765,0.0285753828363831,0.00332409946820203,0.0220601478787072,0.0350906177940591,9.14401458822708e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,41836,0.0391653319158074,0.00455991467888298,0.0302278991451968,0.0481027646864181,9.74173374952469e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,41765,-0.0395066133762791,0.00460080501539713,-0.0485241912064575,-0.0304890355461007,9.93094509625494e-18
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,39408,-0.031376976396538,0.00365423556953017,-0.0385392781128171,-0.0242146746802589,1.01985874563724e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,41689,-0.0299762042791941,0.00349988628419202,-0.0368359813962105,-0.0231164271621777,1.20158248186296e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,41925,0.0219834610580281,0.00257188036394545,0.016942575544695,0.0270243465713612,1.39213325364435e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,41911,-0.0430563099894556,0.0050437338814207,-0.0529420283970402,-0.033170591581871,1.5309388234006e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,41740,-0.0680319763552086,0.00797548050546589,-0.0836639181459218,-0.0524000345644955,1.62044235143304e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,41465,-0.0617640506540045,0.00724482259676568,-0.0759639029436653,-0.0475641983643438,1.69346707236781e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,41644,-0.0650938787778233,0.00764420118924098,-0.0800765131087356,-0.050111244446911,1.83963912645118e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,39600,-0.0560803060747338,0.00658936186268394,-0.0689954553255943,-0.0431651568238732,1.95257656843939e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,41740,-0.0626469067347202,0.00736631551868961,-0.0770848851513519,-0.0482089283180886,2.01924413643437e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,41855,-0.0583511764388333,0.0068615426660012,-0.0717998000641957,-0.044902552813471,2.02474911067952e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,41740,-0.0825084182921737,0.00971378619120871,-0.101547439226943,-0.0634693973574046,2.21043085189454e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,39600,-0.0398688072209046,0.00471240406375596,-0.0491051191858663,-0.030632495255943,3.00192179225368e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,41689,-0.0293663347589161,0.00347611498865104,-0.0361795201366722,-0.0225531493811601,3.27289310455612e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,41765,-0.0410255882693573,0.00486366966602247,-0.0505583808147613,-0.0314927957239532,3.65132055193632e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,39633,-0.035313654936755,0.00419666700936175,-0.0435391222751041,-0.027088187598406,4.42517695537814e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,41765,-0.0247591278014748,0.00295258508545343,-0.0305461945689636,-0.0189720610339861,5.55755805424231e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,41744,0.0308502852122049,0.00368079769422345,0.0236359217315269,0.0380646486928828,5.75754924745188e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,41465,-0.0516810652011619,0.0061759700067663,-0.0637859664144238,-0.0395761639878999,6.45665392803588e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,41724,-0.0584376920361378,0.00700460137165867,-0.0721667107245888,-0.0447086733476868,7.97775734815076e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",41689,-0.08651437187703,0.0103711565845777,-0.106841838782802,-0.0661869049712576,8.04264833864446e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,39498,-0.0461936832556833,0.00554555533119606,-0.0570629717048275,-0.035324394806539,9.06348604322442e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,41465,-0.0587690929500437,0.00705788704279609,-0.072602551553924,-0.0449356343461633,9.1460023582541e-17
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,41689,0.0359159872767656,0.00432195550002464,0.0274449544967173,0.0443870200568139,1.04959662907737e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,41805,-0.0316215162183591,0.00380837619204352,-0.0390859335547644,-0.0241570988819538,1.11186424973473e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,41791,0.0341398061011259,0.00411379867112512,0.0260767607057207,0.0422028514965312,1.15271941897465e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,39308,-0.0748308357222433,0.00902040967740709,-0.0925108386899612,-0.0571508327545254,1.20870766288204e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,41577,-0.030935503358185,0.00373076944254084,-0.038247811465565,-0.0236231952508049,1.2226985297774e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,41865,-0.0457437322631709,0.00552130767433418,-0.0565654953048659,-0.0349219692214759,1.29427661929637e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,39530,-0.0241968131197339,0.00292073484230596,-0.0299214534106536,-0.0184721728288142,1.32456481822284e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,39474,-0.0236580237683528,0.00285712503852901,-0.0292579888438696,-0.0180580586928359,1.37185789005715e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,39621,0.0311647972553465,0.00377095115465446,0.0237737329922237,0.0385558615184692,1.56430796654916e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,41466,-0.0335215362109902,0.00406289555710697,-0.0414848115029199,-0.0255582609190606,1.72773738337139e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",41764,0.0287283458597383,0.00348802650108434,0.021891813917613,0.0355648778018636,1.94317030504431e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,41925,-0.0562902796060217,0.00684478556846635,-0.0697060593202158,-0.0428744998918277,2.15264845747187e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,41889,0.0469686631455386,0.00572520783166775,0.0357472557954698,0.0581900704956074,2.54111876544067e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,41865,-0.0301101620236911,0.00367802976113571,-0.0373191003555171,-0.0229012236918651,2.93358093376972e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",41740,-0.0870300624006936,0.010638463612486,-0.107881451081166,-0.0661786737202211,3.07992682093625e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,41740,-0.0424134538756041,0.00519506234041661,-0.0525957760628206,-0.0322311316883875,3.52939390704147e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,41706,-0.0283376684035181,0.00347641935349615,-0.0351514503363705,-0.0215238864706656,3.92231102412096e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,41865,0.0322857274769212,0.00396867010257923,0.0245071340758659,0.0400643208779765,4.47813789522489e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,41636,-0.0292119184982933,0.00359518430432428,-0.0362584797347689,-0.0221653572618178,4.86281279040981e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,41764,-0.0221080789374925,0.002722801378833,-0.0274447696400052,-0.0167713882349798,5.0905905277362e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,41617,-0.0197952891337394,0.00243923687298241,-0.0245761934047849,-0.0150143848626939,5.27589078911758e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,39600,-0.0243334823470712,0.00300061057815515,-0.0302146790802553,-0.0184522856138871,5.62179457942235e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,41689,-0.0980810880806311,0.0121066592174234,-0.121810140146781,-0.0743520360144813,5.91119703198075e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,41911,-0.033343196094115,0.0041176907621673,-0.0414138699879629,-0.0252725222002671,6.09268758908009e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,41899,-0.0447916902078945,0.00553241558820476,-0.0556352247607758,-0.0339481556550132,6.15930208866976e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,39589,-0.0612457778681866,0.00757165726797319,-0.0760862261134141,-0.0464053296229592,6.65782322630616e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,41689,-0.107842773742625,0.0133863736974633,-0.134080066189653,-0.0816054812955974,8.5511222372747e-16
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,39308,-0.0439949940469689,0.00547976393027182,-0.0547353313503017,-0.0332546567436361,1.08890260758028e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,41911,-0.0360460223526603,0.00452272135829994,-0.0449105562149282,-0.0271814884903924,1.71550559591935e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,41786,0.0375213730597769,0.00472509161481518,0.0282601934947391,0.0467825526248146,2.16937115701942e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,41758,-0.0533440950843683,0.00673558440754797,-0.0665458405231623,-0.0401423496455743,2.57019831435819e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,41877,-0.0206223085491103,0.00260627756148898,-0.0257306125696287,-0.0155140045285919,2.72051889678234e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,41802,-0.0470661865876675,0.00594894763448939,-0.0587261239512667,-0.0354062492240683,2.74068825555264e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,41740,-0.0895338808592424,0.0113181477075563,-0.111717450366053,-0.0673503113524322,2.76445368491913e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,41739,0.0405551690428179,0.00512716485929271,0.0305059259186042,0.0506044121670316,2.78188184987432e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,39622,0.0124966057701585,0.00157970347506757,0.00940038695902604,0.0155928245812909,2.8034941840354e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,39408,-0.0390883158355499,0.00494178365565306,-0.0487742118006299,-0.0294024198704699,2.83039420890722e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,39625,-0.0766926728153637,0.00970556617818487,-0.095715582524606,-0.0576697631061213,3.00751885574471e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,39413,-0.0386826569193149,0.00490013949362578,-0.0482869303268214,-0.0290783835118084,3.20447955587753e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,41758,-0.0194616050679245,0.00246754661905699,-0.0242979964412762,-0.0146252136945728,3.33785457572464e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,41740,-0.0502172952343291,0.00636971292418695,-0.0627019325657355,-0.0377326579029226,3.42621811347306e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,39534,-0.020740735289708,0.00263286626730045,-0.0259011531736168,-0.0155803174057991,3.6527603212776e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,39625,-0.0272578293290742,0.00346167505181702,-0.0340427124306356,-0.0204729462275129,3.75166934718551e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,39633,-0.0234646296538927,0.00298082109166436,-0.0293070389935548,-0.0176222203142306,3.82083255607772e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,39334,-0.0270488905917878,0.00343978179601131,-0.03379086291197,-0.0203069182716056,4.09206700978531e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,39600,-0.025165145749061,0.00320403067282405,-0.0314450458677961,-0.0188852456303258,4.39703319181814e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,39250,-0.0467239105092928,0.005954237572748,-0.0583942161518789,-0.0350536048667067,4.66320129906584e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,39250,-0.032907022228705,0.00419369203465866,-0.041126658616636,-0.024687385840774,4.6772273491895e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,41466,-0.0282502132937473,0.00360349877171957,-0.0353130708863177,-0.021187355701177,4.87203440765459e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,39655,-0.0611034454874181,0.00779777701859519,-0.0763870884438647,-0.0458198025309716,5.07725048775371e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,39598,-0.0517908521640439,0.00661518691539832,-0.0647566185182246,-0.0388250858098632,5.36561755504143e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,41750,-0.0316857729314427,0.00404984251080289,-0.0396234642526163,-0.023748081610269,5.50849114343661e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,41925,-0.0361299288375018,0.00461943754114125,-0.0451840264181387,-0.027075831256865,5.62061594021075e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,39598,-0.0546564506927547,0.00699723882897242,-0.0683710387975407,-0.0409418625879688,6.18252165570666e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,39625,-0.0494020344393548,0.00633106285402096,-0.0618109176332358,-0.0369931512454737,6.58521852041471e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,39625,-0.0447560433457704,0.00574974935389746,-0.0560255520794095,-0.0334865346121314,7.65520485989658e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,41636,-0.055034931537298,0.00707316478086527,-0.068898334507794,-0.0411715285668021,7.74720408639902e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,39427,-0.0472433328310273,0.00607173395239299,-0.0591439313777176,-0.035342734284337,7.8585453882867e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",39600,-0.0336401524925485,0.00432437890759555,-0.0421159351514358,-0.0251643698336612,7.95193653861031e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,41614,-0.0305476922976727,0.00392947169609367,-0.0382494568220163,-0.0228459277733291,8.17464463602328e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,41764,-0.0512757626863402,0.00660906180933396,-0.0642295238326348,-0.0383220015400456,9.23215380595512e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,39427,-0.0445590895647505,0.00574253928011989,-0.0558144665537855,-0.0333037125757155,9.29545306128267e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,41866,-0.0415673277797498,0.00536010799949706,-0.0520731394587641,-0.0310615161007356,9.48109548728213e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,41465,-0.0406757236370294,0.00524764376125723,-0.0509611054090936,-0.0303903418649653,9.7820159097289e-15
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,41805,-0.0243953429615808,0.00316503477632483,-0.0305988111231775,-0.0181918747999842,1.37166737370271e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,39308,-0.0423198550671771,0.00549670455685668,-0.0530933959986162,-0.031546314135738,1.49068465214952e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,41758,-0.0195747047548884,0.00254641854362956,-0.0245656851004024,-0.0145837244093745,1.61093184690993e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,41865,-0.0511424396857159,0.00666779572099976,-0.0642113192988754,-0.0380735600725564,1.83861408655499e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,41823,0.026083685402749,0.00340336560734027,0.0194130888123621,0.0327542819931359,1.92636271244114e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,41865,0.0172738973193676,0.00225452765776931,0.0128550231101398,0.0216927715285955,1.95933523848898e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,39598,-0.0276890149122387,0.00361541591943541,-0.0347752301143321,-0.0206027997101453,2.03745724328352e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,41855,-0.0289956592260637,0.00378800533726386,-0.0364201496871008,-0.0215711687650265,2.07303215346669e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,41636,-0.0425189574443621,0.005577588630119,-0.0534510311593953,-0.0315868837293288,2.64595659619709e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,41689,-0.0227092520154267,0.00298639208100332,-0.0285625804941932,-0.0168559235366602,3.06086133752549e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,41465,-0.0395512355361858,0.00520270378599492,-0.0497485349567358,-0.0293539361156357,3.11642914089581e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,41865,-0.0549769132839419,0.00723310422163011,-0.0691537975583369,-0.0408000290095469,3.14187811589777e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,39598,-0.0390795907033976,0.00515275013996358,-0.0491789809777262,-0.028980200429069,3.61460416277679e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,41466,-0.047312775496703,0.00624097543358311,-0.0595450873465259,-0.0350804636468801,3.6639711596836e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,41465,-0.0512023135980648,0.00677156423806963,-0.0644745795046813,-0.0379300476914483,4.25854842415519e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,41522,-0.0448665574186817,0.00595205284272141,-0.0565325809904157,-0.0332005338469477,5.09020045454346e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,39600,-0.0481079047421943,0.00638152246945232,-0.0606156887823209,-0.0356001207020678,5.1230658357011e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,41740,-0.0711010047126301,0.0094772495593713,-0.0896764138489978,-0.0525255955762623,6.67421932569658e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,41534,-0.0375949512021952,0.00501398513432892,-0.0474223620654799,-0.0277675403389105,6.90077778724796e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,41744,-0.0217700089962502,0.00290710862727386,-0.027467941905707,-0.0160720760867935,7.40786068632009e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,41689,-0.0425825750443957,0.00568645466509772,-0.0537280261879872,-0.0314371239008041,7.4165737155583e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,41740,0.0354234719963521,0.0047316678485202,0.0261494030132525,0.0446975409794517,7.52562058291068e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,41521,-0.0447722434166783,0.00598734414156402,-0.0565074379341438,-0.0330370488992128,8.04403833065127e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,39576,-0.0258830692885498,0.0034606865200897,-0.0326660148679256,-0.019100123709174,8.05008258926684e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,41465,-0.0379274944372283,0.00507236395768821,-0.0478693277942971,-0.0279856610801594,8.07869659023217e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,41805,-0.0310518214867631,0.00415505078482854,-0.039195721025027,-0.0229079219484992,8.31440965566192e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,41744,0.045659709480609,0.00611077708481887,0.033682586394364,0.057636832566854,8.39735096450642e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,41761,-0.0312273514161108,0.00418968443141861,-0.0394391329016913,-0.0230155699305304,9.66502782644323e-14
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,41636,-0.0694889348717608,0.00933810053905937,-0.0877916119283172,-0.0511862578152044,1.05829030733796e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,41764,-0.0233425116236138,0.00313795925906201,-0.0294929117713753,-0.0171921114758522,1.07930642100985e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,39598,-0.0374733459417093,0.005043899531521,-0.0473593890234904,-0.0275873028599281,1.17142992556522e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,39328,-0.0361136504011615,0.00486237153980755,-0.0456438986191843,-0.0265834021831387,1.19374923757181e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,41765,-0.0537193095895474,0.00723903417583415,-0.0679078165741823,-0.0395308026049124,1.23566341241484e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,41718,-0.0655581267202603,0.00884280944814926,-0.0828900332386328,-0.0482262202018877,1.30330452277343e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,41465,-0.0480042623069666,0.00647568019233532,-0.0606965954839438,-0.0353119291299894,1.31184834946534e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,41899,-0.0305264745701275,0.0041188369986352,-0.0385993950874524,-0.0224535540528025,1.32485732174897e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",41689,-0.0348537227190214,0.00471122548769202,-0.0440877246748977,-0.025619720763145,1.46653278511384e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,41802,-0.0316414679256834,0.00427833991701043,-0.0400270141630238,-0.0232559216883429,1.4910762034016e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,39408,-0.0548409677798968,0.00742835217833833,-0.0694005380494399,-0.0402813975103537,1.66576248631744e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,41333,-0.031367205216672,0.00427944202932862,-0.0397549115941561,-0.0229794988391879,2.44513428557534e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,39625,-0.0488009595691756,0.00665724104760029,-0.0618491520224722,-0.0357527671158791,2.45336138699148e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,39598,-0.0422363972501806,0.00577456253623019,-0.0535545398211918,-0.0309182546791694,2.76898642805671e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,39589,-0.0381341846057232,0.0052147774448419,-0.0483551483976134,-0.0279132208138331,2.80009246707143e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",39259,-0.0659659636536129,0.0090326108754801,-0.0836698809695539,-0.0482620463376719,3.01316496629096e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,39090,-0.038555838174907,0.00528368430138751,-0.0489118594056265,-0.0281998169441875,3.15193474404107e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,39308,-0.0243234223786328,0.00333539117959814,-0.0308607890906452,-0.0177860556666205,3.25692711622482e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,41636,0.0266596420303726,0.00365700716095961,0.0194919079948918,0.0338273760658534,3.27779278663703e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,41740,0.026259456449389,0.00360324841525147,0.0191970895554962,0.0333218233432819,3.33249061986042e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,39583,-0.0853618249798039,0.0117154601959054,-0.108324126963779,-0.0623995229958292,3.40550004673633e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,41521,-0.0416620900260013,0.0057311840561936,-0.0528952107761408,-0.0304289692758619,3.81938291952311e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,41466,-0.051328607532034,0.00706643675187493,-0.0651788235657089,-0.0374783914983592,3.9827163573295e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,39408,0.0323902143771521,0.00445915699677318,0.0236502666634766,0.0411301620908275,4.0242371465039e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,39633,0.0311326646981126,0.00429240439850305,0.0227195520770466,0.0395457773191786,4.35066625776254e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,41740,-0.0329336565600433,0.00454910437058811,-0.041849901126396,-0.0240174119936906,4.75056043280764e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,41689,-0.0410621763887978,0.00568579849399263,-0.0522063414370233,-0.0299180113405722,5.41057223840292e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,39625,-0.0355384469837427,0.0049394309454652,-0.0452197316368545,-0.0258571623306309,6.65904686607634e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,39578,-0.0599770496578447,0.00834418371696099,-0.0763316497430882,-0.0436224495726011,7.00754029548301e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,39308,-0.0475357661034513,0.00661931322448768,-0.0605096200234472,-0.0345619121834555,7.35959569285527e-13
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,41805,0.0310733599004765,0.00435860915561646,0.0225304859554683,0.0396162338454848,1.06209198208105e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,39589,-0.0278678228685944,0.00390997600711741,-0.0355313758425445,-0.0202042698946443,1.08724082607104e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,39408,-0.0895418093306602,0.0125776101083685,-0.114193925143062,-0.0648896935182579,1.15494287190925e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,41802,-0.0628396029258461,0.00883813636090262,-0.0801623501932152,-0.045516855658477,1.21967436457221e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,41736,-0.0697354628515448,0.00980825669050811,-0.0889596459649407,-0.0505112797381489,1.22154899214692e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,39334,-0.0371379549324692,0.0052284740905275,-0.0473857641499031,-0.0268901457150353,1.29792531705608e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,41466,-0.0272851347803815,0.00385024852839224,-0.0348316218960302,-0.0197386476647327,1.44620872593767e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,39616,0.0550476838401251,0.00777834396610326,0.0398021296665627,0.0702932380136875,1.56212136095016e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,39259,-0.0305656568025402,0.00432637549221968,-0.0390453527672907,-0.0220859608377896,1.70697582638579e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,39250,-0.0367614546182773,0.00521596915806863,-0.0469847541680918,-0.0265381550684628,1.92925170771236e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",41675,-0.078942286101802,0.0112102259296087,-0.100914328923835,-0.056970243279769,1.98988201769532e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,39630,-0.021819575651369,0.00309809127771154,-0.0278918345556836,-0.0157473167470544,1.99474088214701e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,41819,0.0211484291615023,0.0030055588711273,0.0152575337740928,0.0270393245489118,2.06933740093513e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,39489,-0.0451603483963206,0.00641767717249092,-0.0577389956544029,-0.0325817011382384,2.08427031476552e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,41836,0.0360349732365979,0.00512340751887995,0.0259930944995932,0.0460768519736026,2.1146229614803e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,39598,-0.0515798987729112,0.00733397769683904,-0.0659544950587157,-0.0372053024871066,2.14132975316464e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,41805,0.0152005135845066,0.00216390860890201,0.0109592527110587,0.0194417744579545,2.25257227846615e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,39598,0.0275110370639479,0.00392678142156177,0.0198145454776868,0.035207528650209,2.59559632351297e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,41758,-0.019523810938805,0.00280233330510261,-0.0250163842168061,-0.0140312376608039,3.39213291916433e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,41455,-0.0288188386901913,0.00414213785862163,-0.0369374288930897,-0.0207002484872929,3.63200363253327e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,41758,-0.0330266853768607,0.00476211805018477,-0.0423604367552229,-0.0236929339984986,4.24316407471522e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,39600,-0.0570865305645762,0.00826465067512793,-0.0732852458878269,-0.0408878152413255,5.2118307902292e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,39650,-0.0142158386004679,0.00206146200230454,-0.0182563041249848,-0.010175373075951,5.64073518525461e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,39192,-0.0390797548576756,0.00567285293510583,-0.050198546610483,-0.0279609631048681,5.94143696506254e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,41636,-0.0314204500378007,0.00456217487105973,-0.0403623127850778,-0.0224785872905236,5.95256265381856e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,41465,-0.0418078305911506,0.00607098548351571,-0.0537069621388414,-0.0299086990434598,5.98396174335636e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,41765,-0.0271223624128705,0.003941062166203,-0.0348468442586284,-0.0193978805671126,6.16927052795837e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,41871,-0.0178580532396583,0.00259588470198743,-0.0229459872555537,-0.012770119223763,6.28126942767234e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,41465,-0.0815379109132515,0.0118637823764046,-0.104790924371005,-0.0582848974554984,6.58362038547498e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,39530,0.0305166377066981,0.00444043096700657,0.0218133930113652,0.039219882402031,6.65445549043588e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,39598,-0.0510499514287161,0.00744654264111379,-0.0656451750052991,-0.036454727852133,7.48575196065051e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,41740,-0.0758453748377991,0.0110762206158873,-0.0975547672449382,-0.0541359824306599,7.84454021894108e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,41521,-0.0273764366063518,0.00399984572427916,-0.0352161342259389,-0.0195367389867647,8.02787157249207e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,39625,-0.0185579296421198,0.00271482338896163,-0.0238789834844846,-0.013236875799755,8.58689549323521e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,41521,-0.0413583509008015,0.00605599549126778,-0.0532281020636864,-0.0294885997379167,8.91334974771928e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",41534,-0.0447579858991636,0.00656640809366232,-0.0576281457627418,-0.0318878260355855,9.76228673978897e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,39600,-0.0404562783280767,0.00593567540624298,-0.052090202124313,-0.0288223545318405,9.86564511841198e-12
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,39334,-0.0271420031881972,0.0039851226848406,-0.0349528436504848,-0.0193311627259096,1.02225997561776e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,41614,-0.0648978713174737,0.00953492512593466,-0.0835863245643056,-0.0462094180706418,1.04505591616339e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,41740,-0.0526399795461425,0.00774461948709265,-0.0678194337408441,-0.0374605253514409,1.11449969101589e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,41865,-0.0412981141844145,0.006085202832388,-0.053225111735895,-0.0293711166329341,1.19646631280089e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,39608,0.0137272569430095,0.0020232881960916,0.00976161207866996,0.017692901807349,1.22360250963403e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,39598,-0.0638625803926321,0.00942207810552385,-0.0823298534794588,-0.0453953073058054,1.28111406329763e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,41891,-0.0489132710272264,0.00722520539073354,-0.0630746735930641,-0.0347518684613886,1.34364606315597e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,41783,-0.0357016381526079,0.00527517064919872,-0.0460409726250374,-0.0253623036801785,1.3622353766212e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,39600,-0.0784736821065338,0.011603163431676,-0.101215882432619,-0.0557314817804489,1.41892604682625e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,39336,-0.0197266565942873,0.00291787490784729,-0.025445691413668,-0.0140076217749067,1.44531244897714e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,41740,-0.0694227633885742,0.0102720566670774,-0.0895559944560459,-0.0492895323211026,1.45400581769208e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,41689,-0.0484501151329839,0.00717318848230144,-0.0625095645582947,-0.034390665707673,1.49555096602149e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,39308,-0.0177219268138767,0.00262462270378569,-0.0228661873132966,-0.0125776663144567,1.53182495236718e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,41877,-0.0391999912713077,0.00581907724661296,-0.0506053826746691,-0.0277945998679463,1.68977090328372e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,41925,-0.0288042708539981,0.00428133446984756,-0.0371956864148993,-0.0204128552930969,1.79194067119201e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,41740,0.0282748620238624,0.00420418687893423,0.0200346557411513,0.0365150683065735,1.82347999531826e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,41740,-0.0618915351638244,0.00924703394848338,-0.0800157217028518,-0.043767348624797,2.27323098986778e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,39250,-0.0257068856891326,0.00384081338450171,-0.033234879922756,-0.0181788914555093,2.29502606119674e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,41829,-0.0727532600918257,0.0108877250380218,-0.0940932011663484,-0.051413319017303,2.44913470548412e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,41465,-0.0196981207242688,0.00295481048431415,-0.0254895492735245,-0.013906692175013,2.72744707031378e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,39600,-0.036616454734861,0.00549214404043529,-0.0473810570541141,-0.0258518524156078,2.73476891466501e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,41636,-0.039637591757938,0.00594651715311388,-0.0512927653780412,-0.0279824181378348,2.74042069454527e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,41740,-0.0570358224250927,0.00859427044909919,-0.0738805925053271,-0.0401910523448583,3.33834730426847e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,39408,-0.0370738138515734,0.00558896353239936,-0.0480281823750762,-0.0261194453280707,3.43723018668402e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,41740,0.0370346900531498,0.00558478216756653,0.0260885170047194,0.0479808631015803,3.45620866022453e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,41758,-0.0409030209641145,0.00617114393686656,-0.052998463080373,-0.0288075788478561,3.53265517171649e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,41465,-0.0374865849246962,0.00565869294614421,-0.0485776230991388,-0.0263955467502536,3.62043892144525e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,39334,-0.0592111147564067,0.00894264667658328,-0.0767387022425099,-0.0416835272703035,3.73295718263505e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,39308,-0.0312039902816125,0.00471746652671398,-0.0404502246739719,-0.0219577558892531,3.90417707565162e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,39308,-0.0513154925851355,0.00776819052947039,-0.0665411460228974,-0.0360898391473735,4.13997199574531e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,39589,-0.0559156039849842,0.00846628304813197,-0.0725095187593228,-0.0393216892106455,4.17262878917088e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,41805,-0.0295672066418528,0.00447761427852396,-0.0383433306277598,-0.0207910826559459,4.17379619514368e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,41877,-0.0261480510731761,0.00396088649361786,-0.0339113886006671,-0.0183847135456851,4.22303457920717e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,39598,-0.0217531784528633,0.00329768346856055,-0.028216638051242,-0.0152897188544847,4.40294116856656e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,39600,0.0342842028299216,0.00519907472566153,0.024094016367625,0.0444743892922182,4.46883106807128e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,39589,-0.0703892605561017,0.0107059418778067,-0.0913729066366029,-0.0494056144756004,5.09329286349786e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,41750,-0.0533678798990415,0.0081239933522784,-0.0692909068695071,-0.0374448529285758,5.25015443402475e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,41679,-0.0387047587262934,0.00589756307004887,-0.0502639823435892,-0.0271455351089976,5.47831749989726e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,39655,-0.0203339027573844,0.00309883367194919,-0.0264076167544048,-0.014260188760364,5.55419394114482e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,41888,-0.0136413680234442,0.00208302713983253,-0.017724101217516,-0.00955863482937249,6.01271682702258e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,39625,-0.0268041210012781,0.00409323163071367,-0.0348268549974769,-0.0187813870050793,6.07427900398403e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,41689,-0.0403296776354848,0.0061647511453662,-0.0524125898804026,-0.0282467653905671,6.29680528456965e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,41604,0.019023918231587,0.00290915130273068,0.0133219816782348,0.0247258547849391,6.410269398787e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,41617,-0.0480652546994566,0.00735935483184655,-0.0624895901698758,-0.0336409192290373,6.7679554166261e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',39598,-0.0307801663429715,0.00473071748927869,-0.0400523726219578,-0.0215079600639853,8.02923112028792e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,41702,-0.029199276284483,0.00449006000894007,-0.0379997939020055,-0.0203987586669605,8.15408423221379e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,41925,-0.0315892010408486,0.00486202272013498,-0.0411187655723131,-0.022059636509384,8.47757470640683e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,39334,-0.055829166406584,0.00859175674255139,-0.0726690096219847,-0.0389893231911832,8.50061145497827e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,41534,-0.0375284125805045,0.00578378766425329,-0.0488646364024409,-0.026192188758568,8.98230797524885e-11
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,41689,-0.0366199669615842,0.00566114675797298,-0.0477158146072112,-0.0255241193159571,1.02400609393067e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,41810,0.0205537318198733,0.0031822012651727,0.0143166173401348,0.0267908462996118,1.09113055742772e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,41679,-0.032414296076864,0.00502644962566857,-0.0422661373431744,-0.0225624548105536,1.16745145217721e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,41911,-0.024052498838064,0.0037332606606981,-0.0313696897330322,-0.0167353079430957,1.21358307044966e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,41802,-0.017065157666061,0.00265497378373444,-0.0222689062821805,-0.0118614090499415,1.34075021886374e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,41584,-0.03263233900063,0.00508459358034088,-0.0425981424180981,-0.0226665355831619,1.429826704489e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,41466,0.0506081203709284,0.00791142147057982,0.035101734288592,0.0661145064532648,1.64114535684514e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,41805,-0.0168935063838703,0.00264112121906546,-0.0220701039732386,-0.011716908794502,1.64511693547405e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,39338,-0.0268433054915338,0.00420034367763171,-0.035075979099692,-0.0186106318833757,1.71927567224453e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,41925,-0.0450401456218973,0.007050507620623,-0.0588591405583184,-0.0312211506854762,1.73413400217976e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,39600,-0.0646451874808713,0.0101329509706264,-0.084505771383299,-0.0447846035784437,1.84562669423338e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,41706,-0.0130780036290898,0.00205673840503698,-0.0171092109029623,-0.00904679635521736,2.10338855256712e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,39625,-0.0232082162839102,0.0036501366684709,-0.0303624841541131,-0.0160539484137072,2.12234517319915e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,39271,-0.0346165913568449,0.00546922288850681,-0.0453362682183183,-0.0238969144953716,2.56089733776723e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,41836,0.0392890354470429,0.00620904962088815,0.0271192981901021,0.0514587727039836,2.56852091443416e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,39308,-0.0155898240054818,0.00246385574115557,-0.0204189812581467,-0.0107606667528169,2.5927215901604e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,39572,-0.0306095161254056,0.00484083863845142,-0.0400975598567703,-0.0211214723940408,2.66187240743061e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,41758,0.0210369669613146,0.00333571339670602,0.0144989687037708,0.0275749652188584,2.9438076269831e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,41534,0.026435381542613,0.00419440575737442,0.0182143462581591,0.0346564168270668,3.02327223226078e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,39308,-0.0313741470721798,0.00497807595149667,-0.0411311759371133,-0.0216171182072463,3.04471577849975e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,39334,-0.0583639473336098,0.00926670512704561,-0.0765266893826193,-0.0402012052846005,3.12820740954115e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,41925,0.0181029123742349,0.00287992638598813,0.0124582566576982,0.0237475680907716,3.36134085836592e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,39589,-0.0148712490281927,0.00236624584727062,-0.0195090908888431,-0.0102334071675423,3.40835043776451e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",41765,-0.04905213275184,0.00781405019455461,-0.064367671133167,-0.0337365943705129,3.55026204815102e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,41903,0.0292864822540886,0.0046715732986983,0.0201301985886399,0.0384427659195372,3.74401059094618e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,41466,-0.0527421264606449,0.0084144264518769,-0.0692344023063236,-0.0362498506149661,3.772515545793e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,41466,-0.0286489521397603,0.00457472764226814,-0.0376154183186059,-0.0196824859609148,3.91065111040186e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,41689,-0.0213698671301748,0.00341325674030551,-0.0280598503411736,-0.014679883919176,3.94864182562697e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,41802,-0.0356937459279646,0.00571134537400622,-0.0468879828610168,-0.0244995089949124,4.24103438708411e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,39589,-0.0759459976872258,0.0121570280612365,-0.0997737726872494,-0.0521182226872022,4.33649251234311e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,41786,0.0521288884215663,0.00834904083051556,0.0357647683937558,0.0684930084493768,4.40455295183489e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",41786,-0.0562824379740526,0.00901470460821205,-0.0739512590061482,-0.038613616941957,4.41283053208038e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,41925,0.0211487680214002,0.0033930829427488,0.0144983254536126,0.0277992105891879,4.71663136097658e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",41925,-0.0332728365506634,0.00534228410176593,-0.0437437133901246,-0.0228019597112022,4.85992942073475e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,41383,-0.0715812642517703,0.0114981356996403,-0.0941176102230654,-0.0490449182804752,4.95148750690439e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,41601,0.0377910860123636,0.00607064108538065,0.0258926294850175,0.0496895425397097,4.95666405246573e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,39633,-0.0155822231051344,0.00250362882201276,-0.0204893355962794,-0.0106751106139894,5.02692590829423e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,39308,-0.0491830452012441,0.00791405121484993,-0.06469458558235,-0.0336715048201382,5.33531775454238e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,39598,-0.0551735271442319,0.00887832450078984,-0.07257504316578,-0.0377720111226838,5.338343095418e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",39334,-0.0247972294795053,0.00399074173196723,-0.0326190832741611,-0.0169753756848495,5.36740547037768e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,41803,-0.018913344669325,0.00304710531535423,-0.0248856710874193,-0.0129410182512307,5.56264735957828e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,39600,-0.0693675771274008,0.0111885192469834,-0.0912970748514883,-0.0474380794033133,5.85289415214533e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,39600,-0.0675982824137435,0.0109046701073161,-0.088971435824083,-0.046225129003404,5.88513425733099e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,41534,-0.0391860534878549,0.00632345165869468,-0.0515800187388965,-0.0267920882368133,5.9319512901779e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,41765,-0.0232150304786878,0.00374898650881802,-0.0305630440359711,-0.0158670169214045,6.10371657941134e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,41636,-0.0304180182485556,0.00491225855728805,-0.0400460450208402,-0.0207899914762711,6.10861444790222e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,39598,-0.042177124991116,0.0068180802410209,-0.055540562263517,-0.0288136877187151,6.38749947368483e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,41802,-0.0601331462625248,0.00973098058437617,-0.0792058682079021,-0.0410604243171475,6.61726115975634e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,41750,-0.0199723790840861,0.00323257681727677,-0.0263082296459485,-0.0136365285222236,6.66358783541857e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",41667,-0.0496903249422795,0.00804346886616062,-0.0654555239199544,-0.0339251259646047,6.69631591884293e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",39650,-0.0109839029231979,0.00177857209794039,-0.0144699042351611,-0.00749790161123476,6.81917621143827e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,39250,-0.0493054116841716,0.00798964366024198,-0.0649651132582459,-0.0336457101100973,7.02543725731284e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,41465,-0.0339627432344683,0.00552346303825183,-0.0447887307894419,-0.0231367556794947,8.03758362925036e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,39625,-0.0505136440616917,0.00822363741088669,-0.0666319733870296,-0.0343953147363538,8.40365221774792e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,39650,-0.0133322251081861,0.00217761842370792,-0.0176003572186537,-0.00906409299771862,9.53131888687726e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,41740,-0.0601355674044062,0.00982376623147671,-0.0793901492181006,-0.0408809855907119,9.53753162798827e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,41877,-0.0254240661282728,0.00415422335251028,-0.0335663438991929,-0.0172817883573526,9.61774576164249e-10
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,41689,-0.0543763910953993,0.00890064132539215,-0.0718216480931679,-0.0369311340976307,1.02928424844828e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,41840,-0.0380273076403746,0.00623000496515692,-0.0502381173720822,-0.0258164979086671,1.06404676440084e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,41805,-0.0428182655499193,0.00702208074266359,-0.0565815438055399,-0.0290549872942987,1.10634459661404e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,41447,-0.047392899109145,0.00777746735312757,-0.062636735121275,-0.032149063097015,1.1354632139846e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,39589,-0.0463109712307252,0.00760276836778585,-0.0612123972315854,-0.0314095452298649,1.15723702768049e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,41521,-0.0272322841012681,0.00447708733227993,-0.0360073752725367,-0.0184571929299994,1.21596417400615e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,41865,-0.0418054289052163,0.00687512182236526,-0.0552806676770522,-0.0283301901333804,1.22959248971451e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,41466,-0.0396478437403684,0.00653667258756443,-0.0524597220119947,-0.0268359654687422,1.35277496580506e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,41810,-0.0292301256481569,0.0048251457711095,-0.0386874113595315,-0.0197728399367823,1.41680458730818e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,41758,0.0255612522963601,0.00422053559402049,0.01728900253208,0.0338335020606403,1.42995652949609e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,39328,-0.0452140318157536,0.00746643017352963,-0.0598482349558717,-0.0305798286756356,1.44543867806646e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,39600,-0.0500696431809694,0.00828246519332084,-0.0663032749598782,-0.0338360114020605,1.54009899986234e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,41466,-0.0330036889217193,0.00546764724566931,-0.0437202775232312,-0.0222871003202075,1.62150088086682e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,39633,-0.0182274494029254,0.00302005794625081,-0.024146762977577,-0.0123081358282738,1.63600872151876e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,41877,0.0381463779494996,0.00632746667832182,0.0257445432599889,0.0505482126390104,1.69671334750626e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,41925,0.0198525193819817,0.00329327917933639,0.0133976921904824,0.026307346573481,1.70184462090062e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,41740,-0.0390793559535275,0.00648438270152492,-0.0517887460485164,-0.0263699658585387,1.71832879135725e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,41740,-0.0468510732292313,0.00777901547534822,-0.0620979435609138,-0.0316042028975488,1.76055712862632e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,39427,-0.0348244812493414,0.00578783512296514,-0.0461686380903531,-0.0234803244083297,1.83609071562892e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,39655,-0.0423779341542928,0.00705168792460356,-0.0561992424865157,-0.0285566258220698,1.91827365463018e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,41454,-0.025350220623483,0.00422516666977228,-0.0336315472962367,-0.0170688939507294,2.02854460555778e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,39427,-0.0731948708345511,0.0122042071139622,-0.0971151167779169,-0.0492746248911852,2.06765757400862e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,41765,-0.0183181324601099,0.00305664111283004,-0.0243091490412568,-0.012327115878963,2.11523420765916e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",41758,0.0153023389189099,0.00255629632933723,0.010291998113409,0.0203126797244109,2.2047743018157e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,39598,-0.026387840620548,0.00441535304861425,-0.035041932595832,-0.0177337486452641,2.35221151227963e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,41721,-0.0154894366343045,0.00259862095818203,-0.0205827337123412,-0.0103961395562677,2.57705742338973e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,39408,-0.0430520974727759,0.00723450131020723,-0.057231720040782,-0.0288724749047697,2.7487758174689e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,41689,-0.0131318986695394,0.00220861352729355,-0.0174607811830348,-0.00880301615604407,2.82178705667804e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,39308,-0.0469584423088441,0.00789757433875673,-0.0624376880128073,-0.0314791966048809,2.83470950986917e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,41855,-0.0127434302593575,0.00214669535093542,-0.0169509531471909,-0.00853590737152404,2.9881210338918e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,41637,-0.0318154318250455,0.00536267883230702,-0.0423262823363672,-0.0213045813137237,3.05458284029753e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,39598,-0.0395903073160614,0.0067027993696662,-0.0527277940806071,-0.0264528205515156,3.59724604091765e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",41689,-0.0382132080218492,0.00647932888524248,-0.0509126926369244,-0.0255137234067739,3.7767517629071e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,41911,-0.0593478456563044,0.0100668811937847,-0.0790789327961225,-0.0396167585164863,3.82932002120184e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,39408,-0.0341409855288839,0.00579486398863221,-0.0454989189466031,-0.0227830521111648,3.93897942065778e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,41758,-0.0155316490551824,0.00263836596013703,-0.020702846337051,-0.0103604517733139,4.03232774745111e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,41422,-0.0440505877616998,0.00748608550241237,-0.058723315346428,-0.0293778601769715,4.09654045579303e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,41534,-0.0436410554071144,0.00743955932685511,-0.0582225916877504,-0.0290595191264784,4.57128490685974e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,39650,0.0144927169357276,0.00247075623085498,0.00965003472325181,0.0193353991482033,4.60060394147715e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,41865,-0.0141571324365221,0.00241485750351491,-0.0188902531434113,-0.00942401172963288,4.66757107992166e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,39476,-0.0351650810444026,0.00599969604455812,-0.0469244852917365,-0.0234056767970687,4.73040013451262e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,39408,-0.0482027409279976,0.00823277090975588,-0.0643389719111191,-0.0320665099448761,4.90941434914293e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",41466,-0.0330790840943398,0.00567605390370662,-0.0442041497456048,-0.0219540184430749,5.74977318612791e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,41740,0.035245339896267,0.00605490590296213,0.0233777243264612,0.0471129554660728,5.98780892746915e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,39308,-0.0224172918761766,0.00385533980349112,-0.0299737578910192,-0.014860825861334,6.25135283008615e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,41689,-0.0279890477812964,0.00481734585095586,-0.0374310456491699,-0.0185470499134229,6.39050922548959e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,41636,-0.0252113622286313,0.004342320748489,-0.0337223108956698,-0.0167004135615929,6.54872801562772e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,39308,-0.0542128628762609,0.0093367721717593,-0.0725129363329091,-0.0359127894196127,6.56523179408662e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,39406,-0.0410289540884229,0.00706670922890698,-0.0548797041770806,-0.0271782039997653,6.5804839758881e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,39600,-0.0310258996214704,0.00534567237196303,-0.041503417470518,-0.0205483817724229,6.65682527312895e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,41465,-0.0279307996371823,0.00481522728645678,-0.0373686451186376,-0.018492954155727,6.76665783238256e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",39633,-0.026700041244692,0.00460668908009665,-0.0357291518416814,-0.0176709306477026,6.98050564896125e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,39589,-0.0274975195819559,0.004755751788826,-0.0368187930880548,-0.0181762460758569,7.58509612584624e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,39580,-0.0355210530445383,0.00614364311896813,-0.0475625935577158,-0.0234795125313608,7.59394015338869e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,39574,-0.0449054343951905,0.00776997617689742,-0.0601345877019095,-0.0296762810884716,7.7030339558441e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,39165,-0.0435684914285173,0.00754199086168029,-0.0583507935174106,-0.0287861893396239,7.82902270499772e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,41786,-0.035817018427496,0.00620388253942139,-0.0479766282047619,-0.02365740865023,7.94739139159e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,39554,0.0167608215304019,0.00290428794783336,0.0110684171526485,0.0224532259081553,8.09109542901873e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,41383,-0.046117342702671,0.0079933850850509,-0.0617843774693707,-0.0304503079359712,8.13798592316861e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,41925,0.00977820870024027,0.00169646434665222,0.00645313858080191,0.0131032788196786,8.40246384094208e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,41877,0.0205738715262502,0.00357061958307187,0.0135754571434293,0.0275722859090711,8.49735252106389e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,39625,-0.0460415847999931,0.00799332640862795,-0.0617085045609039,-0.0303746650390824,8.6362072599834e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,41925,-0.0190543655535353,0.00330985313582361,-0.0255416776997495,-0.012567053407321,8.75808351735555e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",39598,-0.0255345681073294,0.00443662119901371,-0.0342303456573963,-0.0168387905572625,8.87426415187731e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,39615,-0.0271033234177658,0.00470978264436054,-0.0363344974007125,-0.0178721494348191,8.91179692931784e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,41865,-0.0145005791363893,0.00252159237108852,-0.0194429001837228,-0.00955825808905579,9.09068599682093e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",41758,-0.0282888634196626,0.00492152674658893,-0.0379350558429769,-0.0186426709963483,9.23168374796463e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,41465,-0.0598220973821239,0.010408257163993,-0.0802222814235501,-0.0394219133406976,9.25940845936276e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,41802,-0.0209534246314532,0.00364968072320369,-0.0281067988489325,-0.013800050413974,9.60960502699524e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,39598,-0.0417773937517667,0.00727746266369446,-0.0560412205726078,-0.0275135669309255,9.68071797239839e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,39308,-0.0321800901527803,0.00560760846168053,-0.0431710027376741,-0.0211891775678864,9.8026235453647e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,39655,-0.0132610112542758,0.00231131087615545,-0.0177911805715405,-0.00873084193701116,9.86418023385676e-09
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,39625,-0.044499466208149,0.00776158053997696,-0.0597121640665038,-0.0292867683497942,1.01082085754467e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,39589,-0.0441349090562002,0.00770246465937957,-0.0592317397885841,-0.0290380783238162,1.03087623813731e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",39576,-0.0673467025729706,0.0117563543071117,-0.0903891570149095,-0.0443042481310317,1.03964457795846e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,39334,0.0197698146441628,0.00346497770014278,0.0129784583518829,0.0265611709364426,1.18995376003522e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,41765,0.0428396790926666,0.00751014191542031,0.0281198009384428,0.0575595572468904,1.19375640082839e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,41740,-0.0518295221693698,0.00908647287300464,-0.0696390090004589,-0.0340200353382807,1.19529247924595e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,41740,-0.0243449326140201,0.00427008697233411,-0.032714303079795,-0.0159755621482453,1.21474540416413e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",39308,-0.0228935176628896,0.00401905959589978,-0.0307708744708532,-0.015016160854926,1.25709638696038e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,39427,-0.0269463861482904,0.0047414404365198,-0.0362396094038692,-0.0176531628927116,1.35641481749024e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,41655,-0.0409518187174592,0.00720796060630247,-0.0550794215058121,-0.0268242159291064,1.36394254039391e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,41740,-0.0230141299283683,0.00405389864300417,-0.0309597712686565,-0.0150684885880802,1.39948332084186e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,41740,-0.0486036193858416,0.00856401369279495,-0.0653890862237197,-0.0318181525479635,1.41345625759508e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,41765,-0.0329808609922207,0.00581437874748897,-0.044377043337299,-0.0215846786471423,1.43864549036084e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,41899,-0.0125725980235648,0.00221816402027799,-0.0169201995033097,-0.00822499654381994,1.4745821269238e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,39633,-0.0287042548014089,0.00506360473983651,-0.0386289200914884,-0.0187795895113293,1.47462701179934e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,39308,-0.0311260087910488,0.00549273372630047,-0.0418917668945977,-0.0203602506874999,1.49281570219877e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,41466,-0.0331066275114593,0.00585750418408463,-0.0445873357122652,-0.0216259193106535,1.6195838062087e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,39600,-0.065265535378085,0.0115465522152628,-0.0878967777200001,-0.0426342930361698,1.62177252325792e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,41774,-0.0196166244261199,0.00347568405270925,-0.0264289651694301,-0.0128042836828098,1.69609781146475e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,39600,-0.0294991209918411,0.00523042975638686,-0.0397507633143593,-0.0192474786693228,1.74343629304751e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,41802,0.0166274976159426,0.00294970322248783,0.0108460792998664,0.0224089159320187,1.76575405211307e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,39408,-0.0230247442356049,0.00409257882397113,-0.0310461987305883,-0.0150032897406215,1.89052299547451e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,41521,-0.0319792842587696,0.00568897889673997,-0.0431296828963799,-0.0208288856211593,1.93483926127763e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,41802,0.0227787375606523,0.00405238743785102,0.0148360581824643,0.0307214169388403,1.9362716733567e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,39427,-0.0313077663829649,0.00557739433929496,-0.0422394592879831,-0.0203760734779468,2.03352222352468e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,39328,-0.0290782198855288,0.00520261921842083,-0.0392753535536336,-0.0188810862174239,2.33757116933172e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,41636,-0.0330999259934874,0.00592401281645624,-0.0447109911137417,-0.0214888608732332,2.35091505034119e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",41755,0.0316069512095682,0.00565775857805388,0.0205177443965826,0.0426961580225538,2.36317525289683e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,41617,-0.0373548665275515,0.006687161101787,-0.050461702287054,-0.0242480307680489,2.36939789840546e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,39600,0.0225037853433007,0.00403643539293054,0.0145923719731568,0.0304151987134445,2.53130090321451e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",41689,-0.0616911232509255,0.0110757535522483,-0.0833996002133321,-0.039982646288519,2.59872471704685e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,41765,-0.0363670525057252,0.00654184945229407,-0.0491890774322215,-0.0235450275792288,2.76381844968768e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",41689,0.0251337641323974,0.00452292512707935,0.0162688308833219,0.0339986973814729,2.79858794118843e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,41865,-0.0273774325206892,0.00493032845077555,-0.0370408762842093,-0.0177139887571692,2.86431384741993e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,41765,0.0300057776676598,0.00540794405846754,0.0194062073130634,0.0406053480222562,2.93755701685887e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,39625,-0.0270424359799004,0.00488795451580135,-0.0366228268308711,-0.0174620451289298,3.22970698701901e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,41758,0.0347442877481321,0.00628338614509608,0.0224288509037438,0.0470597245925204,3.27175592803652e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,41521,-0.020957996630471,0.0037905105911437,-0.0283873973891126,-0.0135285958718293,3.28181157929084e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,41636,0.0196015223922094,0.00354696342876192,0.012649474071836,0.0265535707125827,3.3336564954759e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,39600,-0.0234711180112771,0.00425047971223084,-0.0318020582472496,-0.0151401777753047,3.42789175401978e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,41636,0.0153048590182893,0.00277329400192819,0.00986920277451003,0.0207405152620685,3.48121567640555e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",41716,-0.0400022780107918,0.00725323101691009,-0.0542186108039355,-0.025785945217648,3.55183794630687e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,41888,-0.0194592756232798,0.00353729158241209,-0.0263923671248075,-0.0125261841217521,3.84236929086908e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,41728,-0.0372981319278328,0.00678216398051566,-0.0505911733296435,-0.0240050905260221,3.88115009050775e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,39600,-0.0506352067144445,0.00920690670765149,-0.0686807438614414,-0.0325896695674475,3.88947197266293e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,41693,-0.025858585105853,0.00470392541791491,-0.0350782789249662,-0.0166388912867398,3.93014146999238e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,41465,-0.0312570703528268,0.00569906034751381,-0.0424272286339539,-0.0200869120716997,4.22230352396551e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,41740,-0.0338208245567149,0.00617231799871083,-0.0459185678341881,-0.0217230812792417,4.34541439381525e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,41465,-0.055831579544206,0.0102208086192943,-0.0758643644380228,-0.0357987946503891,4.78094140952999e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,39589,-0.0360229426898137,0.0065991423449967,-0.0489572616860072,-0.0230886236936201,4.89971452727553e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,41689,0.0174401027982828,0.00319632501074649,0.0111753057772197,0.023704899819346,4.95004979554216e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,41911,-0.0231455913472827,0.00424881362751337,-0.0314732660572089,-0.0148179166373565,5.19781418446239e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,41636,-0.0138608161914246,0.00254444736792297,-0.0188479330325536,-0.00887369935029554,5.20166983299671e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,39627,-0.0217033546290313,0.00398671207797501,-0.0295173103018623,-0.0138893989562003,5.323648219074e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,41877,0.00960274262594736,0.00176684312045077,0.00613973010986385,0.0130657551420309,5.57727113914134e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,39328,-0.0194070502602174,0.00357219167835866,-0.0264085459498004,-0.0124055545706344,5.66847973160657e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,41465,-0.0332172871563661,0.00611877409939932,-0.0452100843911887,-0.0212244899215434,5.7780198802754e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,41521,0.0127367774841311,0.00234866913944486,0.00813338597081918,0.017340168997443,5.96691840323486e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,41452,-0.0339842979229594,0.00627037775447651,-0.0462742383217334,-0.0216943575241855,6.07368141470032e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,39580,-0.0374154149031163,0.00690423434576778,-0.0509477142208211,-0.0238831155854115,6.11324912051038e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,39589,-0.0359590650744028,0.00663835471052682,-0.0489702403070354,-0.0229478898417703,6.19324285008883e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,39408,-0.047964797075026,0.00886336545992526,-0.0653369933764795,-0.0305926007735724,6.38061327287046e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,39250,-0.0247094122233718,0.00456749607498251,-0.0336617045303376,-0.0157571199164061,6.44478970283066e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,41758,0.0184100800621514,0.00340695640507719,0.0117324455082001,0.0250877146161026,6.64270353906679e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,41465,-0.0225692236135656,0.00417664915415472,-0.0307554559557088,-0.0143829912714223,6.64553206378397e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,39328,-0.0381050562311303,0.00705745844606451,-0.0519376747854167,-0.0242724376768439,6.83435849042923e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,39650,-0.0186497781304776,0.00346197431818461,-0.0254352477941194,-0.0118643084668358,7.30992991713813e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,39598,-0.0365775160020979,0.00679058703604431,-0.0498870665927448,-0.0232679654114511,7.33225934280914e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,39573,-0.0260144206387348,0.00483198697771725,-0.0354851151150606,-0.016543726162409,7.44358679873184e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,41829,-0.0188949675710718,0.00351310375732444,-0.0257806509354277,-0.0120092842067159,7.64181919361438e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",39617,-0.0224985327196467,0.00418984858734846,-0.0307106359508497,-0.0142864294884437,8.04386428032413e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,41621,0.0156234379938559,0.00291266020499745,0.0099146239920609,0.0213322519956509,8.28024046918869e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,41758,-0.0172266184714472,0.00321345482415338,-0.0235249899267878,-0.0109282470161066,8.42634321310844e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,41758,0.029652470814345,0.00553231253107497,0.018809138253438,0.0404958033752519,8.46876280683831e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,41758,-0.0283376046669438,0.00528799204172753,-0.0387020690687297,-0.0179731402651578,8.51612798235594e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,41812,-0.013431648905313,0.00251123108748484,-0.0183536618367833,-0.00850963597384271,9.00990697952499e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,39308,-0.0222817770835089,0.00416711019884031,-0.0304493130732359,-0.0141142410937819,9.12350218753558e-08
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,39600,-0.0280048425436605,0.00526246810139974,-0.038319280022404,-0.017690405064917,1.0487007899601e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,39600,-0.0566817309483397,0.0106517944554855,-0.0775592480810913,-0.0358042138155881,1.05034621067787e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,39633,0.0289513291908079,0.00544653724133355,0.0182761161977941,0.0396265421838216,1.08411362192681e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,39643,-0.0315331593316703,0.00593959397474949,-0.0431747635221793,-0.0198915551411613,1.12381437217479e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,39565,-0.0256764133150402,0.00483936340118485,-0.0351615655813625,-0.0161912610487179,1.14402615820251e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,39598,-0.0491414320148371,0.00926737852712869,-0.0673054939280093,-0.0309773701016649,1.16362188932477e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,39035,-0.0699543949178006,0.0132061384761039,-0.0958384263309643,-0.0440703635046369,1.20043555070974e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,41636,-0.03412705222234,0.00644780828468998,-0.0467647564603324,-0.0214893479843477,1.22401514835501e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,41758,0.0151123522950127,0.00285729169177425,0.00951206057913516,0.0207126440108902,1.24924670497031e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,41689,-0.0534101080613847,0.0100989433574667,-0.0732040370420194,-0.03361617908075,1.25184099963197e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,39334,-0.0251958258699203,0.0047637576609471,-0.0345327908853766,-0.015858860854464,1.25361057436107e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",39297,-0.0445902501631381,0.00843393231478062,-0.0611207575001081,-0.0280597428261681,1.26784916505522e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,41465,-0.0422191407673611,0.0079940497090385,-0.0578874781970766,-0.0265508033376457,1.30345912892482e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,41750,-0.0266916111142084,0.00505475703974765,-0.0365989349121138,-0.016784287316303,1.30888885265861e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,41740,-0.0486551888631632,0.00921814153202333,-0.0667227462659289,-0.0305876314603975,1.32535816158262e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,41740,-0.0370535158073472,0.00702770866212795,-0.050827824785118,-0.0232792068295764,1.36718987401369e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,41657,-0.0161176992791207,0.00305845452142957,-0.0221122701411226,-0.0101231284171187,1.38683457494399e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,41740,-0.0329254508215814,0.00626729489910901,-0.045209348823835,-0.0206415528193277,1.51539381821759e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,41534,-0.02450271491483,0.00466589400995621,-0.0336478671743442,-0.0153575626553158,1.53297897917209e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,41769,-0.0347014061930967,0.00661324708563395,-0.0476633704809393,-0.0217394419052542,1.56776674199434e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,39407,0.0173228959423667,0.0033014367257087,0.0108520799599776,0.0237937119247557,1.57456788559153e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,41408,-0.0183860116400187,0.00351284963808068,-0.0252711969306568,-0.0115008263493806,1.6856517450223e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,41810,-0.0190523254913627,0.00364091167967471,-0.0261885123835251,-0.0119161385992002,1.69476070937343e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,39650,-0.0173615633148982,0.00332208979374195,-0.0238728593106324,-0.010850267319164,1.76281692359719e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,39167,-0.0170159701968763,0.00325698479353345,-0.0233996603922019,-0.0106322800015508,1.77995691078045e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,39328,-0.0261907860125652,0.00501323610265305,-0.0360167287737651,-0.0163648432513652,1.78067862877718e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,41251,-0.0211205944319547,0.00404840126365931,-0.029055460908727,-0.0131857279551825,1.84696586023458e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,39589,-0.0223938768708453,0.00430196833119034,-0.0308257347999784,-0.0139620189417123,1.96972283693948e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,41869,-0.0312198450611213,0.00601278978007882,-0.0430049130300758,-0.0194347770921668,2.10851151863874e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,39655,0.035732082192584,0.00688391221862494,0.0222396142440791,0.0492245501410889,2.13262690934033e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,39600,0.0246775335237042,0.00475694920169803,0.015353913088376,0.0340011539590323,2.16718233914923e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,39650,-0.0187992322384581,0.00362774766435273,-0.0259096176605895,-0.0116888468163268,2.23310747459235e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,41465,-0.0540833958625492,0.0104728687872827,-0.0746102186856233,-0.033556573039475,2.45149308514873e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,41865,-0.0167765380971629,0.0032506226917066,-0.0231477585729079,-0.010405317621418,2.49152000208838e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,39408,-0.0296808997652946,0.00575473067320553,-0.0409601718847774,-0.0184016276458117,2.54493574052648e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,41876,-0.0147055206587588,0.00285177289966796,-0.020294995542108,-0.00911604577540958,2.55059090805681e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,41819,-0.0175863898098476,0.00341795947266476,-0.0242855903762705,-0.0108871892434246,2.70935359222277e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,41925,-0.0196329215204817,0.00381733463028803,-0.0271148973958463,-0.0121509456451172,2.74080199903823e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,39600,-0.0315432236175515,0.00614710694407674,-0.0435915532279419,-0.0194948940071611,2.9251009462476e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,39334,-0.0189983437666968,0.00370478806224422,-0.0262597283686955,-0.0117369591646981,2.9786085546512e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,41862,-0.0303052039914437,0.00592559371501465,-0.0419193676728724,-0.018691040310015,3.19315562351364e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,39308,-0.0174056174811483,0.00340705484635661,-0.0240834449800072,-0.0107277899822893,3.2997161580016e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,41751,-0.0313788826348411,0.00614608135630398,-0.0434252020931969,-0.0193325631764854,3.34511984732408e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,39600,-0.0360414124193178,0.00706196303273392,-0.0498828599634763,-0.0221999648751593,3.38822431607781e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,39600,-0.0221306528198452,0.00434462767850542,-0.0306461230697158,-0.0136151825699745,3.5677856558652e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,39485,-0.0598540667707191,0.0117808306675833,-0.0829444948791824,-0.0367636386622559,3.82418766141199e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,39600,-0.0759414460240259,0.0149556902449902,-0.105254598904207,-0.0466282931438452,3.88157581842537e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",39308,-0.0522888044491716,0.0103093318562489,-0.0724950948874194,-0.0320825140109237,4.00274643535358e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],41509,-0.0254928578149032,0.00502754040599823,-0.0353468370106598,-0.0156388786191467,4.01971403490342e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,39625,-0.0146267992198999,0.00288695142309013,-0.0202852240091566,-0.00896837443064326,4.1171364714641e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,41465,-0.0340853450623842,0.00672895041241897,-0.0472740878707254,-0.0208966022540431,4.13022203120216e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,39600,-0.0407938926505072,0.00806038777602627,-0.0565922526915187,-0.0249955326094957,4.23729590660321e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,41765,-0.0466876385325017,0.0092352793839041,-0.0647887861249537,-0.0285864909400497,4.35355419490399e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,39328,-0.0664038486437865,0.013148248603262,-0.0921744159061801,-0.0406332813813929,4.48145918171613e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,39250,-0.0194563514285384,0.00385797176154583,-0.0270179760811682,-0.0118947267759086,4.65458459348392e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,41689,-0.0548261284054523,0.0108793217429756,-0.0761495990216845,-0.0335026577892201,4.73027431827373e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,41466,-0.0456672462759865,0.00906522021487007,-0.0634350778971318,-0.0278994146548411,4.77716632147162e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,41802,0.0153075748530154,0.00304011696599687,0.00934894559966153,0.0212662041063693,4.83663656378698e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,39625,-0.0146344122469117,0.00290818928107529,-0.0203344632378192,-0.00893436125600412,4.92687307238285e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,41877,-0.0168811326859368,0.00337178968855228,-0.0234898404754993,-0.0102724248963743,5.6116461318225e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",41689,-0.0183978041163271,0.00367513880752435,-0.0256010761790748,-0.0111945320535794,5.62908010292265e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,41689,-0.0412260095438614,0.00824907270955036,-0.0573941920545801,-0.0250578270331427,5.87819143236678e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,41875,-0.0432280974234178,0.00865337436608199,-0.0601887111809385,-0.0262674836658971,5.94239893517895e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,41689,-0.0727091195599127,0.0145565246137676,-0.101239907802897,-0.0441783313169282,5.96097171487998e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,39334,-0.0237793792014491,0.00476402469129952,-0.0331168675963962,-0.0144418908065021,6.08692533251247e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,39408,-0.039783688702008,0.0079731342102697,-0.0554110317541366,-0.0241563456498793,6.14090427090932e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,39600,-0.027478647037609,0.00550724552394382,-0.0382728482645388,-0.0166844458106791,6.14474200965331e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,39583,-0.0213769384286701,0.00428494600620238,-0.0297754326008267,-0.0129784442565134,6.16707498466711e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,39598,-0.0161998707239461,0.00325328952712471,-0.0225763181971105,-0.00982342325078167,6.47044542599285e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,41465,-0.0230330579663987,0.00462909788261987,-0.0321060898163337,-0.0139600261164638,6.58484866144271e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,41614,-0.0170727058814102,0.00343731569122243,-0.0238098446362062,-0.0103355671266143,6.89049522577081e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,41750,-0.0163574707463983,0.00329607759630435,-0.0228177828351548,-0.00989715865764177,7.038713230286e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,39542,-0.0330765014451913,0.00668742376258385,-0.0461838520198556,-0.0199691508705269,7.68501152110804e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,41773,0.0265302059401687,0.00536761719495127,0.0160096762380642,0.0370507356422732,7.80191900580518e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,39373,-0.0285694285917394,0.00579317807766619,-0.0399240576239652,-0.0172147995595137,8.2791369274203e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,41689,-0.0403006584542027,0.00818759868485343,-0.0563483518765154,-0.02425296503189,8.66375114643474e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,39598,-0.0175253031721962,0.00356267184448242,-0.0245081399873818,-0.0105424663570107,8.81809169977952e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,41765,-0.0570149856326542,0.0115929595741421,-0.0797371863979726,-0.0342927848673357,8.84568019481562e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,41614,-0.0262435189763083,0.00535039146332711,-0.0367302862444295,-0.0157567517081872,9.45702207251852e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,41765,0.0246540068183322,0.00502956031938904,0.0147960685923296,0.0345119450443347,9.60837616287072e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,39308,-0.0164691086901964,0.00335954325000677,-0.0230538134602096,-0.0098844039201831,9.61662768882569e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,41862,-0.0267866717791149,0.00546718683892057,-0.0375023579833992,-0.0160709855748306,9.71983137692907e-07
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,39334,-0.0506419958954045,0.0103679577889976,-0.0709631931618399,-0.0303207986289692,1.05203400273325e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,41287,0.0163088964287608,0.00334109565591666,0.00976034894316416,0.0228574439143575,1.06670370980697e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,39600,-0.0344503252265127,0.00706108565364626,-0.0482900531076594,-0.020610597345366,1.08175237677629e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,39600,-0.0454382469237351,0.00931717143010149,-0.0636999029267341,-0.0271765909207362,1.0931407780706e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,39308,-0.0223862499757629,0.0045927361664281,-0.031388012861962,-0.0133844870895638,1.10777247340006e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,41556,-0.0236395371769988,0.00485262273698635,-0.033150677741492,-0.0141283966125055,1.12065411742642e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,41465,-0.0200382615092143,0.00411380011035624,-0.0281013097255126,-0.0119752132929161,1.12364640564595e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,39328,-0.0346823164309638,0.00712976990540134,-0.0486566654455504,-0.0207079674163771,1.1641452964173e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,39094,-0.0121572014546432,0.00249943059900639,-0.0170560854286957,-0.00725831748059065,1.16714895475415e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,39334,-0.0289762199249375,0.00595797491495479,-0.0406538507582489,-0.0172985890916261,1.1700381706893e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,41911,-0.0283598372650418,0.00583231469181376,-0.0397911740609967,-0.0169285004690868,1.17215706620103e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,39625,-0.0148826624162832,0.0030655148914815,-0.020891071603587,-0.00887425322897946,1.22121733142678e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,41911,-0.0504031986718623,0.0103878151141329,-0.0707633162955628,-0.0300430810481618,1.23516406661002e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,41758,-0.0287381842363517,0.00592322495722167,-0.0403477051525062,-0.0171286633201972,1.2376060389937e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,39600,-0.0151526851600642,0.00312924069944453,-0.0212859969309755,-0.00901937338915294,1.30100269731336e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,39596,0.024711704439103,0.00511131587407561,0.0146935253259148,0.0347298835522912,1.35148687172033e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,39598,0.036430743508364,0.00754139820428483,0.0216496030279658,0.0512118839887623,1.37842960353004e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,39308,-0.0265577727474834,0.0054998726888961,-0.0373375232177198,-0.0157780222772471,1.39260972657715e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,41911,0.0143078290527059,0.00296482749484453,0.00849676716281063,0.0201188909426012,1.4095037146252e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,39600,-0.0367750056898638,0.00762812314251981,-0.0517261270492026,-0.021823884330525,1.44769293066113e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,41764,0.0121833741523462,0.00253359552544089,0.00721752692248206,0.0171492213822104,1.53574032483976e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,41877,-0.0207400553967737,0.00431775897699388,-0.0292028629916817,-0.0122772478018657,1.5767413091496e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,39328,-0.0332719582443978,0.00692752178375333,-0.0468499009405543,-0.0196940155482413,1.58526825934674e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,39600,-0.0391078132456333,0.00814660882835237,-0.0550751665492039,-0.0231404599420627,1.60352404720353e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,39308,-0.0150035985277807,0.00313033494593273,-0.0211390550218089,-0.00886814203375257,1.66540811483143e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,39373,-0.0332744602018421,0.00695313660219,-0.0469026079421345,-0.0196463124615497,1.72800409665216e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,41467,-0.0227738072062036,0.00476494549216248,-0.032113100370842,-0.0134345140415651,1.77721553167918e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,41465,-0.0428537512510104,0.00897643959921891,-0.0604475728654795,-0.0252599296365414,1.82568276704594e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,41802,-0.0139108816298017,0.00291619266982629,-0.0196266192626612,-0.00819514399694219,1.85993161805303e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,41802,-0.0112246461637524,0.00235393681647048,-0.0158383623240345,-0.00661093000347026,1.87625551174482e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,41769,-0.0235259315168542,0.00494712651326657,-0.0332222994828567,-0.0138295635508517,2.00079412294814e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,41865,0.0146763389268315,0.00308779734234004,0.00862425613584501,0.020728421717818,2.02512241357228e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,41689,0.0121456018590943,0.00255896837415578,0.00713002384574896,0.0171611798724396,2.09375910718822e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,41899,-0.0260969708450225,0.00550332152647071,-0.0368834810369051,-0.0153104606531399,2.13772864092793e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",39308,-0.0347503432690043,0.00733350030035723,-0.0491240038577045,-0.0203766826803041,2.1799541615242e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,39589,-0.0423681844255851,0.00895424972123117,-0.0599185138791982,-0.024817854971972,2.25502029985182e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,41865,-0.0480030063914187,0.0101543044166119,-0.067905443047978,-0.0281005697348594,2.2980171900089e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,39408,-0.0335453817708867,0.00709941076755859,-0.0474602268753015,-0.0196305366664718,2.32909127583329e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,39600,-0.041792825876897,0.00892129643232837,-0.0592785668842606,-0.0243070848695334,2.83849585557913e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,41728,-0.0170758231272936,0.00364593406613944,-0.0242218538969269,-0.00992979235766029,2.84809577294289e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,39250,0.018439290624572,0.0039401375159323,0.0107166210933447,0.0261619601557993,2.90610827056266e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,39308,-0.0157155481321675,0.00335829918888197,-0.0222978145423762,-0.00913328172195885,2.90937452195548e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,41740,-0.0388377075499746,0.0083073178842104,-0.055120050603027,-0.0225553644969222,2.9670357943421e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,41740,-0.0305486591229413,0.00653767666090481,-0.0433625053783148,-0.0177348128675679,3.00203475015443e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,39250,-0.0313075930473227,0.00671031078242213,-0.0444598021808701,-0.0181553839137754,3.11474858924241e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,41466,-0.0353986130715946,0.00759952509704854,-0.0502936822618097,-0.0205035438813794,3.22488864039667e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,39308,-0.0510077277941272,0.0109664838240739,-0.072502036089312,-0.0295134194989424,3.33899439304872e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,39600,-0.0509732681263828,0.01096340388056,-0.0724615397322804,-0.0294849965204851,3.36773892834781e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,41925,-0.0135807266423201,0.00292163609926834,-0.019307133396886,-0.00785431988775412,3.37844177306825e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,41915,0.0218405312447405,0.00470058080208159,0.0126273928726606,0.0310536696168205,3.41101766842587e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,41504,-0.0256528208431834,0.00552243442308028,-0.0364767923124208,-0.0148288493739461,3.43101430975755e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,39650,0.0111149708030312,0.00239757655102297,0.00641572076302613,0.0158142208430362,3.59426280354653e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,41726,0.0307289787337949,0.00663732965256791,0.0177198126147618,0.043738144852828,3.6967123088725e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,41689,-0.00974688994074495,0.00211058189544854,-0.0138836304558241,-0.00561014942566582,3.90947254461274e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,41765,-0.0398178155909614,0.00863504510014229,-0.0567425039872403,-0.0228931271946825,4.04143362216728e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,39408,0.0230470216054153,0.00499806479627452,0.0132508146047172,0.0328432286061133,4.04966742332955e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,39334,-0.0272675786075632,0.00591445557689951,-0.0388599115382863,-0.0156752456768402,4.0667684825998e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,39470,0.00400758994488404,0.00086954695974852,0.00230327790377694,0.00571190198599113,4.0956190324488e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,41636,0.0166187905669291,0.00361053494174237,0.00954214208111411,0.0236954390527442,4.2066070562529e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,39317,-0.0131274121256099,0.0028608529402855,-0.0187346838885695,-0.00752014036265036,4.51219040886421e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,39600,-0.0177036794435945,0.00386369411384986,-0.0252765199067402,-0.0101308389804487,4.65482865621822e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,39600,-0.0356701617853593,0.00779826938631277,-0.0509547697825324,-0.0203855537881863,4.8346963480194e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,41465,-0.0375816252700015,0.00822312259050774,-0.0536989455473967,-0.0214643049926063,4.91706244775445e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,39625,-0.0524529809745762,0.0114841529498427,-0.074961920756268,-0.0299440411928845,4.99111582439917e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,41689,-0.0269358674550545,0.00590755721962608,-0.0385146796055216,-0.0153570553045874,5.17254544544687e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,41636,0.0176148782829639,0.00387005643741864,0.0100295676656233,0.0252001889003044,5.37255868023331e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,41689,0.021946321637238,0.00482383613482025,0.0124916028129903,0.0314010404614857,5.42420882870117e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,41925,-0.0191266934278359,0.00420664848586677,-0.0273717244601347,-0.010881662395537,5.49535431862768e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,39633,0.0106059018941202,0.00233451580184027,0.00603025092251324,0.0151815528657271,5.60255496064198e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,41765,-0.0181254386193179,0.00399023358436531,-0.0259462964446739,-0.0103045807939619,5.60981066732598e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,41758,0.0215627106276433,0.00475316172190567,0.0122465136527081,0.0308789076025784,5.77018346914004e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,41737,-0.0194945222708818,0.00429810106372655,-0.0279188003557858,-0.0110702441859777,5.79449426861016e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,39600,-0.0317935282328147,0.00701048347689978,-0.0455340758475382,-0.0180529806180911,5.81739024580316e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,41740,-0.0115619733294151,0.00255541333339334,-0.0165705834628661,-0.0065533631959642,6.10685990464241e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,41877,-0.0161000294156051,0.00356509137198747,-0.0230876085047006,-0.00911245032650968,6.35550931347432e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,41750,0.0187614538654443,0.00415927720617065,0.0106092705413498,0.0269136371895388,6.51586249774352e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,41911,-0.0280611972389225,0.00622441596551775,-0.0402610525313373,-0.0158613419465077,6.59237794088191e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,41636,0.0537345190798082,0.0119278915886664,0.0303558515660221,0.0771131865935943,6.69665892522742e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,39600,-0.0318472135388451,0.00708768901976654,-0.0457390840175875,-0.0179553430601027,7.08388520042042e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,39488,-0.0158282816699408,0.00353336473216375,-0.0227536765449817,-0.00890288679489982,7.55230305295828e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,39600,-0.0227693419944891,0.00509554544516459,-0.0327566110670117,-0.0127820729219665,7.95644696959353e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,41521,-0.0166742097047705,0.00373450828999343,-0.0239938459531576,-0.00935457345638339,8.0784634372467e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,39334,-0.0154221733069483,0.00345381746949976,-0.0221916555471679,-0.00865269106672882,8.07902909176348e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,41534,-0.0205308033458825,0.00460170556635909,-0.0295501462559463,-0.0115114604358186,8.20505164414193e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,39534,-0.013827880803148,0.0031073158135557,-0.0199182197977172,-0.00773754180857879,8.66775500343331e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,39328,-0.0377206254799143,0.00848016656115021,-0.0543417519397687,-0.0210994990200599,8.75054599541303e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,41774,-0.0190979943736585,0.00429698345867961,-0.0275200819526705,-0.0106759067946464,8.88110003119726e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,41521,-0.0241047263605674,0.00542528563728046,-0.0347382862096371,-0.0134711665114977,8.94369502597755e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,41689,-0.0278224282951487,0.0062769883155713,-0.0401253253936684,-0.0155195311966289,9.39267746364743e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,39308,-0.0200127259096679,0.00451629815659943,-0.0288646702966028,-0.011160781522733,9.46312862011491e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,41911,-0.0159687557934071,0.00360469602643756,-0.0230339600052247,-0.00890355158158947,9.49910075769965e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,41836,-0.026286950892377,0.00593518970977674,-0.0379199227235394,-0.0146539790612146,9.54305890467551e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,39334,-0.0219806162908805,0.00497057458292925,-0.0317229424734218,-0.0122382901083392,9.86858594611492e-06
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,41786,-0.0245300730165797,0.00555445333602989,-0.0354168015551983,-0.0136433444779611,1.01209138396233e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,41914,-0.0158970540020553,0.0036099695061469,-0.0229725942341032,-0.00882151377000736,1.07273196196966e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,39650,0.014159877806852,0.00321661649517445,0.00785530947631006,0.0204644461373939,1.08213219734178e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,41848,0.00897908443488075,0.00204121260665502,0.00497830772583692,0.0129798611439246,1.09651634020881e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,39600,-0.0312559452745478,0.00710733367347903,-0.0451863192745667,-0.0173255712745289,1.10430399951558e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,41783,-0.0328407099634903,0.00747494869692927,-0.0474916094094717,-0.018189810517509,1.12444029651314e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,41758,0.0132127859007704,0.00301238689727009,0.00730850758212104,0.0191170642194198,1.16270415144713e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,39328,-0.0203357461508679,0.00464657272825204,-0.0294430286982419,-0.0112284636034939,1.21738496348247e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,41764,-0.0236821779055478,0.00542351657881163,-0.0343122704000186,-0.013052085411077,1.27175329993298e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,41521,-0.0441583771678156,0.0101226545499319,-0.0639987800856822,-0.0243179742499491,1.2968112421193e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,41465,-0.0207233614357304,0.00475349156863455,-0.0300402049102542,-0.0114065179612067,1.31307496923414e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,39633,0.0229800568392676,0.00528130179957641,0.0126287053120978,0.0333314083664373,1.36605673482109e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,41612,-0.0211898798903711,0.00487321188996596,-0.0307413751947044,-0.0116383845860378,1.38279714343934e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,41636,0.0192429110079169,0.00443252312487396,0.010555165683164,0.0279306563326699,1.4271078341055e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,39598,-0.0501859327535177,0.0115781584664088,-0.0728791233476789,-0.0274927421593565,1.47367395145024e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,41633,0.0226431543848318,0.00523661603237383,0.0123793869613791,0.0329069218082845,1.54360219955354e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,41789,0.0125595755985204,0.0029072598768588,0.00686134623987716,0.0182578049571637,1.57118638533375e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,39250,0.0121912127242611,0.00282238832907363,0.00665933159927678,0.0177230938492454,1.57823958105786e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",39600,-0.0373724818829433,0.00866137474795351,-0.0543487763889322,-0.0203961873769544,1.61110950940822e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,39276,-0.0191676486110281,0.00444342750914665,-0.0278767665289556,-0.0104585306931007,1.61982820535001e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,39589,-0.0265886927033929,0.00616422460975537,-0.0386705729385135,-0.0145068124682724,1.62175784139484e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",39600,-0.0218940017804325,0.00507853686276195,-0.0318479340314459,-0.011940069529419,1.63870374329657e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,39334,-0.041816599861461,0.0097061375232692,-0.0608406294070686,-0.0227925703158534,1.6600585999756e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,39600,-0.0490301674911119,0.0113925609572741,-0.0713595869673692,-0.0267007480148547,1.69421931173969e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,39308,-0.0148628521187948,0.00345451942636138,-0.0216337101944631,-0.00809199404312649,1.70429386694219e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,41765,-0.030938380562572,0.00719957319637811,-0.0450495440274731,-0.0168272170976709,1.7417067857651e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,41703,-0.0498226255232199,0.0115971541223037,-0.0725530476029351,-0.0270922034435046,1.7507620895476e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,39408,0.0239071042514971,0.00556684330420612,0.0129960913752531,0.034818117127741,1.76574334325766e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,39598,-0.013827922195494,0.00322777582455475,-0.0201543628116213,-0.00750148157936668,1.85089910291107e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,41905,-0.0266594895598232,0.00623138365767896,-0.038873001528874,-0.0144459775907725,1.89674794829004e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,39598,-0.0346933664640395,0.00810861799812425,-0.050586257740363,-0.0188004751877159,1.89681220066245e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,41689,-0.0186498683571735,0.00436066589337627,-0.027196773508191,-0.010102963206156,1.90910205108033e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,39600,-0.0283893512370205,0.00666461957836838,-0.0414520056106226,-0.0153266968634185,2.06394202696904e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,39598,-0.0178122197052411,0.00419041587184458,-0.0260254348140565,-0.00959900459642577,2.1485764241593e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,41521,-0.0429962134787741,0.0101196114269006,-0.0628306518754992,-0.0231617750820489,2.16424186952805e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,41791,0.0117758896513542,0.00277330123022238,0.00634021924011837,0.0172115600625901,2.18951574859498e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,41736,-0.0107734288976722,0.00254159897113999,-0.0157549628811066,-0.00579189491423783,2.26213744050463e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,41534,-0.0386045547129594,0.00911256890188333,-0.0564651897606507,-0.020743919665268,2.28697095548901e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,41758,0.0222033180440385,0.0052703495872303,0.0118734328530671,0.0325332032350099,2.53821832225276e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,39250,0.0188374115147265,0.00447358882158849,0.010069177424413,0.0276056456050399,2.56553932150244e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,39600,-0.0136521845551318,0.00324235304945019,-0.0200071965320541,-0.00729717257820939,2.56743522450557e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,39600,-0.0175692650820956,0.00417427024318299,-0.0257508347587342,-0.00938769540545692,2.58606724236367e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,41617,0.0204955410925555,0.00487009592899232,0.0109501530717305,0.0300409291133804,2.58856576754212e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,39600,-0.0261809536161872,0.00622187527863924,-0.0383758291623202,-0.0139860780700543,2.5981478061161e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,41465,-0.0271479079487266,0.00645233927541034,-0.0397944929285308,-0.0145013229689223,2.60017628812287e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,39600,-0.0266524797085781,0.00634080525715049,-0.039080458012593,-0.0142245014045631,2.65099015910417e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,39598,-0.0102651242549169,0.00244445868483876,-0.0150562632772009,-0.00547398523263295,2.69797531084576e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,41911,-0.0219417900132769,0.00522555602510182,-0.0321838798224765,-0.0116997002040773,2.6991273539409e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,41443,0.0203779182174851,0.00485554093188127,0.0108610579909978,0.0298947784439724,2.72488555648925e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,39308,-0.0310619877341108,0.00740213125669038,-0.0455701649972239,-0.0165538104709976,2.73431079085151e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,39650,-0.0112879817018437,0.00269806417016142,-0.0165761874753601,-0.00599977592832729,2.8897680682504e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,39600,-0.0421414219481514,0.010076812651189,-0.0618919747444819,-0.0223908691518209,2.91171948235426e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,41521,-0.0164124718188807,0.00393360316658693,-0.0241223340253911,-0.00870260961237035,3.03410911981016e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,39334,-0.0196917885325994,0.00472408157203586,-0.0289509884137897,-0.0104325886514091,3.09173447980459e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,39250,-0.0196907687482597,0.00472670071138505,-0.0289551021425744,-0.010426435353945,3.12630112302359e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,39297,-0.025261115304388,0.00606771362778177,-0.0371538340148403,-0.0133683965939357,3.16275527879329e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,41470,-0.0248371881406815,0.00596674352075574,-0.0365320054413627,-0.0131423708400002,3.16686794900917e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,39250,0.0137584210933667,0.00331376263257921,0.00726344633351144,0.0202533958532219,3.32290855971528e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,39314,-0.0254407567311108,0.00613181636938732,-0.0374591168151099,-0.0134223966471117,3.36545756289039e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,41748,-0.0128314513023279,0.00309490968020526,-0.0188974742755302,-0.00676542832912562,3.40477513155676e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,39408,-0.0254895600668215,0.00614923591313024,-0.0375420624565568,-0.0134370576770863,3.42168900552078e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,41392,0.0308741412817235,0.00745045416468393,0.0162712511189431,0.045477031444504,3.43605160313911e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,41758,0.0087581733416308,0.00211584023143534,0.00461112648801754,0.0129052201952441,3.50482788158796e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,41707,-0.00883233964780466,0.00213659002215864,-0.0130200560912356,-0.00464462320437373,3.58958545383962e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,39600,-0.0299798475720802,0.00725562286173179,-0.0442008683810745,-0.0157588267630859,3.62367404628017e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,41636,-0.0255256117582216,0.00618146871478127,-0.0376412904391929,-0.0134099330772503,3.66014920644586e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,39250,-0.0166096213644883,0.00402432643723569,-0.0244973011814703,-0.00872194154750637,3.69835545633275e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,39589,-0.0145921591078302,0.00353585518081074,-0.0215224352622193,-0.00766188295344116,3.70381632628399e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",41716,-0.029751080313907,0.0072160935568178,-0.0438946236852699,-0.0156075369425442,3.76469770950822e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,41447,-0.0209366889760902,0.0050793035659303,-0.0308921239653135,-0.0109812539868668,3.78020702707988e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,39328,-0.0301033834838075,0.00731834127175553,-0.0444473323764483,-0.0157594345911667,3.92756688039542e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,41375,0.0400679553531562,0.00976525542492061,0.0209280547203118,0.0592078559860006,4.10156307250686e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,39244,-0.0445580979881099,0.0108699119173627,-0.0658631253461408,-0.023253070630079,4.17633330607812e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,41617,-0.0485620781220975,0.0118633396123554,-0.0718142237623141,-0.0253099324818809,4.27553144048491e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,39625,-0.0211111637798939,0.00516261356257759,-0.031229886362546,-0.0109924411972418,4.35863280079805e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,41750,-0.0168313494742691,0.00411871445176185,-0.0249040297997224,-0.0087586691488159,4.4042677794593e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,41465,-0.0155308373672636,0.00380205917490212,-0.0229828733500718,-0.00807880138445545,4.43727439208314e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,39250,-0.0123110544782302,0.00301451609603584,-0.0182195060264604,-0.00640260292999995,4.46055080659992e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,41689,-0.0135019042849427,0.0033072567313462,-0.0199841274783812,-0.00701968109150411,4.48168905047364e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,41508,-0.0173087591425043,0.00424664870879562,-0.0256321906117437,-0.00898532767326489,4.61185084502335e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,39600,-0.0210088021887597,0.00515642003345508,-0.0311153854543317,-0.0109022189231878,4.64769343918222e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,39408,-0.0300035461273416,0.00736544840946086,-0.0444398250098848,-0.0155672672447983,4.66318429602708e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,41740,-0.0149811759201321,0.00368026606464505,-0.0221944974068364,-0.00776785443342775,4.71510527778118e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,39427,-0.0311160146317223,0.00764389291000079,-0.0460980447353239,-0.0161339845281208,4.72047336733042e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,39589,-0.0125853094326973,0.00309235370004938,-0.0186463226847941,-0.00652429618060054,4.73795858459776e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,39598,-0.0313101738202889,0.00769378692179015,-0.0463899961869976,-0.0162303514535802,4.7435310692062e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,39320,-0.0120881518775066,0.00297040076770903,-0.0179101373822163,-0.00626616637279695,4.74447568243776e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,41765,-0.0167493457400674,0.004119238825767,-0.0248230538385708,-0.00867563764156413,4.80791368392936e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,39334,-0.0195929236867787,0.0048193619017077,-0.0290388730141258,-0.0101469743594316,4.8279821085292e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,39600,-0.0230157534801919,0.00566277565813059,-0.0341147937701279,-0.011916713190256,4.84922783107169e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,41521,-0.0315261514194737,0.00775734796763838,-0.046730553436045,-0.0163217494029025,4.85164906721767e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,41740,-0.0167490632872463,0.00412227154475537,-0.0248287155149668,-0.00866941105952576,4.8713754779206e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,41805,-0.0542342453990632,0.0133491622134026,-0.0803986033373323,-0.0280698874607941,4.87793859614331e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,39600,-0.0460993154252331,0.0113539463225455,-0.0683530502174223,-0.0238455806330439,4.93699531962023e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,41317,-0.0389647324319582,0.00960269370566851,-0.0577860120950685,-0.0201434527688479,4.98571678583693e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,41858,-0.0393846827664403,0.00972171938295977,-0.0584392527570415,-0.0203301127758392,5.12447373931266e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,39589,-0.0208052720967929,0.0051385008160033,-0.0308767336961593,-0.0107338104974264,5.18121844645862e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,41751,-0.0244671827706732,0.00604507033346928,-0.036315520624273,-0.0126188449170734,5.20726842584778e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,39625,-0.0354844319595385,0.00879158772329996,-0.0527159438972064,-0.0182529200218706,5.46956507872845e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,39600,-0.0331813828043531,0.0082350904270291,-0.0493221600413302,-0.0170406055673761,5.63274188606858e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,39589,-0.0237335061789712,0.00589907685683839,-0.0352956968183744,-0.0121713155395679,5.77830986416661e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,41534,-0.0189376610364908,0.00471430520419895,-0.0281776992367208,-0.0096976228362609,5.92612442375584e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,39598,-0.0357529512593754,0.00890236358253022,-0.0532015838811346,-0.0183043186376161,5.95576955585782e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,41736,-0.0114684230568513,0.00285762573541919,-0.0170693694982729,-0.00586747661542974,6.02156645413517e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,41740,-0.0482807745660758,0.0120423448568916,-0.0718837704855834,-0.0246777786465683,6.12484127972777e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,41888,-0.0121853710390347,0.00303940039177229,-0.0181425958069084,-0.006228146271161,6.12741373019072e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,39589,-0.0191332132902825,0.00477781698728355,-0.0284977345853583,-0.00976869199520675,6.25331307934347e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,41765,-0.0074685797854515,0.00186555538437267,-0.0111250683388219,-0.00381209123208107,6.2778878661138e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,39328,-0.0311203467551572,0.00777783251418163,-0.0463648984829532,-0.0158757950273612,6.34564508554691e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,41560,-0.0102292484904327,0.0025573297198789,-0.0152416147413953,-0.00521688223947005,6.37016727357344e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,41598,-0.0125806309059311,0.00314662641221383,-0.0187480186738702,-0.00641324313799198,6.41969865520802e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,39385,0.0208997959789738,0.00523327048104117,0.0106425858361331,0.0311570061218145,6.54985526929037e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,39613,-0.0202518565147561,0.00507125578831406,-0.0301915178598516,-0.0103121951696605,6.55391890591694e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,41865,-0.0250133690766275,0.00626432160538751,-0.037291439423187,-0.012735298730068,6.55971799676036e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,41802,-0.0403427024303158,0.0101113220926326,-0.0601608937318757,-0.0205245111287559,6.64708633813035e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,41758,-0.0111599426299173,0.0027989911819871,-0.016645965346612,-0.00567391991322258,6.72386697773581e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,41636,-0.0401894827560961,0.0100815204547933,-0.059949262847491,-0.0204297026647012,6.74346736540689e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,39328,-0.0211243679766102,0.00531441327374813,-0.0315406179931565,-0.0107081179600638,7.08642980366959e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,39589,-0.0364612373167559,0.00918896917472512,-0.0544716168992171,-0.0184508577342946,7.29586754037896e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,39600,-0.0509803855410814,0.012853312419203,-0.0761728778827193,-0.0257878931994434,7.34526946858062e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,39408,-0.0173529699214637,0.00438011087424752,-0.0259379872349889,-0.00876795260793861,7.48756694183424e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,39308,-0.0223400708974437,0.00564517450868562,-0.0334046129344675,-0.0112755288604199,7.62672884603091e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,39334,-0.0234601994341182,0.00593529028823873,-0.0350933683990661,-0.0118270304691703,7.7781970417481e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,41925,0.0122736655454952,0.00312443117764981,0.00614978043730161,0.0183975506536889,8.59841976512897e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,41911,-0.0147305162678707,0.00375151293385272,-0.022083481618222,-0.00737755091751937,8.6606064276019e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,39598,-0.023774323058704,0.00606491970504949,-0.0356615656806011,-0.011887080436807,8.90958153245095e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,41707,-0.0131607540126004,0.00336813593870753,-0.0197623004524671,-0.00655920757273363,9.37519823832009e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,41805,-0.0432358769753618,0.0110656687258778,-0.0649245876780823,-0.0215471662726413,9.38341161895684e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",41802,-0.0252563422401023,0.00647701760882346,-0.0379512967533963,-0.0125613877268083,9.6917373523711e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,39600,-0.029082254754941,0.00746052779363527,-0.0437048892304661,-0.0144596202794159,9.75058502487897e-05
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,41465,-0.0234519346376577,0.00603633530397899,-0.0352831518334566,-0.0116207174418589,0.000102788462808566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,39259,-0.0173719581587718,0.00447124887341345,-0.0261356059506622,-0.00860831036688141,0.000102839468001889
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,41758,-0.0174127927459522,0.00448506728139472,-0.0262035246174859,-0.00862206087441856,0.000103938956535206
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,41706,-0.0791534178639331,0.0204057119428171,-0.119148613271855,-0.0391582224560115,0.000105406698099339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,39328,-0.020306078869082,0.0052408485433195,-0.0305781420139883,-0.0100340157241758,0.000107444822392843
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,41740,0.0112160482016801,0.00289641987454838,0.00553906524756531,0.0168930311557949,0.000108298384010612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,39598,-0.0450044575674479,0.0116287862270696,-0.0677968785725042,-0.0222120365623915,0.000109423388776758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,39589,-0.0144548895623799,0.00373812588078034,-0.0217816162887093,-0.00712816283605039,0.000110871365772313
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,41466,-0.0265216440664084,0.00686117679614252,-0.0399695505868477,-0.0130737375459691,0.000111422324991107
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,41466,0.0132257587370084,0.003422733995914,0.00651720010501698,0.0199343173689999,0.000112050502282836
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,41636,-0.0161631526956128,0.00418463289565408,-0.0243650331710948,-0.00796127222013078,0.000112774473619755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,41911,-0.0310320448540789,0.00804200488843125,-0.0467943744354042,-0.0152697152727536,0.000114508678712068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,41836,0.0147256768057767,0.00381894965973926,0.00724053547268772,0.0222108181388656,0.000115826915815815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,39308,-0.0201280587773607,0.00521988463488216,-0.0303590326617298,-0.00989708489299171,0.000115915401189753
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,41877,-0.016600864136724,0.00431119350302707,-0.025050803402657,-0.00815092487079089,0.000118361401022425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,39334,-0.014988483080795,0.0038962513149443,-0.0226251356580858,-0.00735183050350415,0.000120314730476736
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,39334,-0.0391419747885976,0.0101940624433871,-0.0591223371776363,-0.0191616123995589,0.000123900776852181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,39600,-0.0226137786456877,0.00590654639718847,-0.0341906095841771,-0.0110369477071982,0.000129591162439018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,39598,-0.0155193907459043,0.00406363966247913,-0.0234841244843634,-0.00755465700744523,0.000134682874273718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,41534,-0.0223032042726897,0.00584059744821769,-0.0337507752711964,-0.0108556332741831,0.000134809839817604
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,39328,0.0127545471904329,0.00334649331931347,0.00619542028457847,0.0193136740962873,0.000139001030607193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,41765,-0.046456001090826,0.0121936245463548,-0.0703555052016815,-0.0225564969799705,0.00013967782869684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,39250,-0.0270963038511675,0.0071185680088606,-0.0410486971485342,-0.0131439105538007,0.00014177942547977
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,39308,-0.030742964684718,0.00808421653227207,-0.0465880290879713,-0.0148979002814648,0.000143842431839064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,41836,-0.0129638291695684,0.00341831179231691,-0.0196637202825096,-0.00626393805662731,0.000149822104912262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,39598,-0.0363339502059304,0.00958170961047201,-0.0551141010424556,-0.0175537993694053,0.000150231505514312
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,41925,0.0122107368568176,0.00322168582435232,0.00589623264108708,0.0185252410725482,0.000151207463186815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,41805,-0.0159053261277418,0.00419929353108407,-0.0241359414486666,-0.00767471080681702,0.000152771983058884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,39600,-0.0162524346059993,0.00429416764157862,-0.0246690031834934,-0.0078358660285052,0.000154668034765707
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,39334,-0.0125625810758592,0.00332501712345627,-0.0190796146378335,-0.00604554751388493,0.000158819704198005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",39600,0.0419374509759381,0.011102702089265,0.0201761548809788,0.0636987470708974,0.000159418484093545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,41689,-0.0180360098096732,0.0047820179836028,-0.0274087650575347,-0.00866325456181168,0.000162897715459002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,41740,0.0268845640187239,0.0071484206793467,0.0128736594872044,0.0408954685502435,0.000170031189359589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,41465,-0.0178236237169567,0.00474040306117078,-0.0271148137168515,-0.00853243371706201,0.000170707667252081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,39408,-0.027027732605983,0.00719466466455553,-0.0411292753485119,-0.0129261898634542,0.000173117923734209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,41676,-0.0251603472984018,0.0067049312897263,-0.0383020126262653,-0.0120186819705382,0.000175827142044521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,41787,0.00841132637413428,0.00224330594199122,0.00401444672783148,0.0128082060204371,0.00017792882794614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,39308,-0.0161322022387443,0.00430235012460189,-0.024564808482964,-0.00769959599452461,0.000178031429531567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,41911,-0.0242803363313381,0.00648853754006656,-0.0369978699098686,-0.0115628027528077,0.000183303055078299
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,41865,0.0510733272018824,0.0136645781916345,0.0242907539462787,0.0778559004574861,0.000186532729797061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,39241,-0.0199864491528369,0.00534780650570878,-0.0304681499040261,-0.00950474840164769,0.000186967787335322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,41689,-0.0220533935212951,0.00592182589121644,-0.0336601722680794,-0.0104466147745109,0.000196846315226887
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,41765,0.0437476262252849,0.011756361302572,0.0207051580722438,0.0667900943783259,0.000199113131673095
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,41534,-0.0121396530183792,0.0032625189791544,-0.0185341902175218,-0.00574511581923657,0.000199319278652238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,41465,-0.0202780473050615,0.00545351392656449,-0.0309669346011279,-0.00958916000899512,0.000201383587964377
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,41911,-0.00919918389470631,0.00247512984108214,-0.0140504383832273,-0.0043479294061853,0.000202711224721782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,41758,-0.0199219291484397,0.00537576624519915,-0.0304584309890301,-0.00938542730784939,0.000211523965823354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,41865,-0.0245467865609359,0.00662465371786774,-0.0375311078479567,-0.0115624652739152,0.000211941048832227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,41384,0.0154283797123334,0.00416391755999996,0.00726710129473348,0.0235896581299333,0.000212067963852931
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,41765,-0.0484666541440714,0.0130914700839793,-0.0741259355086708,-0.022807372779472,0.000214648318087537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,41799,0.0191196353281135,0.00516528738830683,0.00899567204703216,0.0292435986091949,0.000215147465275926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",39427,-0.0186598709552755,0.00504724052049175,-0.0285524623754394,-0.0087672795351117,0.000219201689663792
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,41367,-0.0326321707879442,0.00884354837101828,-0.04996552559514,-0.0152988159807484,0.000225238613939663
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,41636,-0.0142724794337915,0.00388945373010624,-0.0218958087447997,-0.00664915012278325,0.000243962682549612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,41802,0.0107371421409624,0.00292920654049272,0.00499589732159669,0.0164783869603281,0.000247778905616121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,39427,-0.0113332592425265,0.00309311241347165,-0.0173957595729309,-0.00527075891212207,0.000249462401503859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,39334,-0.0177598357433021,0.00484711133304496,-0.0272601739560702,-0.00825949753053398,0.00024949871770743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,39308,-0.0238627624208679,0.00651619627066947,-0.03663450711138,-0.0110910177303557,0.000251391645554002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,41744,-0.0114727684183072,0.00313724268944466,-0.0176217640896187,-0.00532377274699564,0.000256221350794082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,39241,0.0133136229876586,0.0036517288960818,0.00615623435133831,0.020471011623979,0.000267789646751681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,39633,-0.0325376175580688,0.00893668589106412,-0.0500535219045545,-0.0150217132115831,0.000272925288416303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,41802,0.0106977943325926,0.00294163040000532,0.00493219874858214,0.016463389916603,0.000277216420223909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",39600,-0.0303599709686072,0.00834989859255528,-0.0467257722100155,-0.0139941697271988,0.00027820233641722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,39600,-0.0245445714054986,0.00675343804478403,-0.0377813099732753,-0.0113078328377219,0.000279918350161954
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,39427,-0.0499371517665434,0.0137799843620005,-0.0769459211160643,-0.0229283824170225,0.000291534311492181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,41465,-0.0349697762732057,0.00965482699674782,-0.0538932371868314,-0.0160463153595799,0.000293459658005652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",41840,-0.0263034387353025,0.00726240567709421,-0.0405377538624071,-0.0120691236081978,0.000293582198257758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,39334,-0.0196446849445729,0.00542369020415603,-0.0302751177447187,-0.0090142521444271,0.000293665920999351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,41466,-0.0160728879014793,0.00443793197040273,-0.0247712345634687,-0.00737454123948997,0.000293791388823325
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,41689,0.0107249115240763,0.00296282950249147,0.00491776569919301,0.0165320573489596,0.000295919509984356
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,41521,0.0132949119583937,0.00367422446910967,0.00609343199893874,0.0204963919178486,0.000297530608988696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,39633,0.0126605624301048,0.00350203568177061,0.0057965724938344,0.0195245523663752,0.000301452019921147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,39334,0.0165883295709019,0.00459415083637273,0.00758379393161136,0.0255928652101925,0.000306704844368455
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,41711,0.00999159909558099,0.00276801322306618,0.00456629317837128,0.0154169050127907,0.000307735973203687
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,41521,-0.0439314229101944,0.0121723380056822,-0.0677892054013316,-0.0200736404190572,0.000308399316621428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,41534,-0.0437750928458381,0.0121408134131413,-0.067571087135595,-0.0199790985560813,0.000312586773118325
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,39328,-0.0226441617344553,0.00628075571842791,-0.034954442942574,-0.0103338805263366,0.000313177319282679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,41764,-0.0121347876103815,0.00336645855137842,-0.0187330463710832,-0.00553652884967976,0.000313770151100899
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,41740,0.0237765957678796,0.00661227969683691,0.0108165275620793,0.03673666397368,0.000324551405717617
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,41740,-0.0145108563812141,0.00403868991917725,-0.0224266886228015,-0.00659502413962672,0.000328136110512383
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,41911,-0.0255551991162557,0.00711570581706462,-0.0395019825177023,-0.011608415714809,0.00033011715870617
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,41836,0.0125147053074098,0.00348545255883583,0.00568321829209161,0.0193461923227281,0.000331170191347552
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,41911,-0.0106536442520708,0.00297138950942405,-0.0164775676905419,-0.00482972081359963,0.000337756059442295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,41764,-0.0401616176299699,0.0112150832944981,-0.0621431808871861,-0.0181800543727537,0.000343467466196433
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,39334,-0.0177237832488602,0.00495130500613789,-0.0274283410608905,-0.00801922543682993,0.000345614683488941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,41740,-0.0111881868899411,0.00312852620137371,-0.0173200982446336,-0.00505627553524861,0.000349897713998098
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,41534,0.023183279129867,0.00649337843053576,0.0104562574060169,0.035910300853717,0.000357871861025815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,39259,0.0235328060439256,0.0066066660649929,0.0105837405565396,0.0364818715313117,0.000369675604534614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,41911,-0.016155316338129,0.00453786921338938,-0.0250495399963722,-0.00726109267988585,0.000371990791868209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,41740,-0.0138661166705305,0.00389651832178101,-0.0215032925812213,-0.00622894075983975,0.000374163516972873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,39600,-0.0185349665309252,0.00521490049259337,-0.0287561714964082,-0.00831376156544222,0.000380674096826343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,41805,-0.0179489012345023,0.00505486740674722,-0.0278564413517268,-0.00804136111727772,0.000385375921841309
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,39600,-0.0243364116298675,0.00685994819568374,-0.0377819100934077,-0.0108909131663274,0.000390364068612721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,39598,-0.00850739767639581,0.00240003212779126,-0.0132114606468667,-0.00380333470592494,0.000394689773319099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,39625,0.0105146227111805,0.00297196340463329,0.00468957443809921,0.0163396709842617,0.000404922840457631
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,39408,-0.0222034371523008,0.00627987429371304,-0.0345119907679783,-0.00989488353662324,0.000408475602819279
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,39600,-0.0126878470257154,0.00360669176360728,-0.0197569628823857,-0.00561873116904512,0.000436792433435825
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,39598,-0.0176038042682685,0.00501584559971033,-0.0274348616437008,-0.00777274689283627,0.000450511559811746
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,39334,-0.0165462248512987,0.00471483213870493,-0.0257872958431604,-0.00730515385943708,0.000450961907079314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",39589,0.0156266729090256,0.00445408975173071,0.0068966569956334,0.0243566888224178,0.000452634437485257
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,41750,-0.0188870301563649,0.00538663480836528,-0.0294448343807609,-0.00832922593196898,0.000455937827799622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,39250,-0.0450303524576999,0.0128517848758321,-0.0702198508143309,-0.0198408541010689,0.000460516771201637
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,41877,0.0232356558435233,0.0066319799474642,0.0102369751464935,0.0362343365405532,0.00046056410793901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,41925,-0.0212687674084965,0.00607502117567149,-0.0331758089128126,-0.0093617259041804,0.000464998004181717
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,39334,0.00976701254107032,0.00279236328650328,0.00429398049952388,0.0152400445826167,0.000471084680113371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,39408,-0.0159826918267345,0.00457847345503492,-0.024956499798603,-0.00700888385486609,0.000483436177934621
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,41614,-0.0174788225918455,0.00500827296688548,-0.0272950376069411,-0.00766260757674998,0.000484637455917777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,39650,-0.0101325562292132,0.00290339794500858,-0.01582321620143,-0.00444189625699641,0.000485092798055988
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",39625,-0.0286032386825803,0.00819835626644555,-0.0446720169648136,-0.012534460400347,0.000486907145451871
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,39308,-0.0124774663225398,0.00357809993712104,-0.019490542199297,-0.00546439044578253,0.000490107182570292
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,41466,-0.0153501539936631,0.00440537646981861,-0.0239846918745075,-0.0067156161128186,0.000494858047330979
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,41765,-0.00908554898134812,0.00260939604942948,-0.0141999652382299,-0.00397113272446634,0.00049956105090393
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,39250,-0.0245810609814384,0.00706344774452768,-0.0384254185607127,-0.0107367034021642,0.000503350890185788
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,39408,-0.0188516343547412,0.00542549914873169,-0.0294856126862553,-0.00821765602322709,0.00051355303890464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,39308,-0.0161063429694285,0.00463761220217405,-0.0251960628856896,-0.00701662305316735,0.000516743787492104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",39625,-0.0200906440194245,0.00578883881971867,-0.0314367681060731,-0.00874451993277587,0.000521318006790936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,41911,-0.0146680953498722,0.0042304388802216,-0.0229597555551065,-0.00637643514463783,0.000527423964440809
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,41766,-0.020818312063147,0.00600901163211105,-0.0325959748620847,-0.00904064926420933,0.000532879183013458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,39250,-0.0233131704541873,0.00672944078960584,-0.0365028744018147,-0.0101234665065598,0.000533596917403873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,41740,-0.0268408040734058,0.00775894933771859,-0.0420483447753343,-0.0116332633714774,0.000543228890528576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,41466,-0.0174619348676399,0.00506916182453783,-0.0273974920437341,-0.00752637769154577,0.000573435838582604
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,39600,0.0425235414967688,0.0123522789310945,0.0183130747918235,0.066734008201714,0.000578366825455777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,41865,-0.0185951983623615,0.00540947648570578,-0.0291977722743448,-0.00799262445037817,0.000588863107788452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,41877,0.0121386590000051,0.00353962492210226,0.00520099415268469,0.0190763238473256,0.000606838297817227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,41911,-0.0314618908660842,0.00919974915624101,-0.0494933992123166,-0.0134303825198518,0.000628404236084922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,41786,0.0326578649718609,0.00955424338291123,0.0139315479413549,0.0513841820023669,0.000632382686732797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,41740,0.0161152560288478,0.00472164497775427,0.00686083187244939,0.0253696801852461,0.000644316733210649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,39334,-0.0210014944683822,0.00616076518592896,-0.033076594232803,-0.00892639470396149,0.000654628135600627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,41865,-0.00991381523056656,0.00290997701987316,-0.015617370189518,-0.00421026027161517,0.000659156110356111
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",39308,0.0258781761803316,0.00760867508981879,0.0109651730042868,0.0407911793563764,0.000673504915563194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,41765,-0.0243289956875062,0.0071579178718548,-0.0383585147163416,-0.0102994766586708,0.000678598263372502
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,39600,-0.0131755115808113,0.00387659770024013,-0.020773643073282,-0.00557738008834065,0.000679395698033964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,39589,-0.0146928379595637,0.00432988210360673,-0.0231794068826329,-0.00620626903649452,0.000692852628767227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,41911,-0.00993673301375588,0.00292852852027358,-0.0156766489134921,-0.00419681711401966,0.00069312697351641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,41764,-0.0117568288356723,0.00346620317206535,-0.0185505870529204,-0.00496307061842422,0.000696276061591916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,39408,0.0131976462464387,0.00389169955287683,0.00556991512280015,0.0208253773700773,0.000698290495131735
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,41911,-0.0170081863752154,0.00501743381753664,-0.0268423566575872,-0.00717401609284353,0.000701421517032304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,39334,-0.0308834489950498,0.00911156199671035,-0.0487421105086021,-0.0130247874814975,0.000702776231076984
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,41805,-0.0233977965084604,0.00690351820120489,-0.0369286921828219,-0.00986690083409878,0.000702873069329477
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",41805,-0.0100742323274199,0.00297256797551606,-0.0159004655594314,-0.00424799909540845,0.00070335927186723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,41447,-0.0240574886288257,0.00710253173347751,-0.0379784508264417,-0.0101365264312098,0.000708292115518025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,41694,-0.0139194069815787,0.00411036341397682,-0.0219757192729732,-0.00586309469018412,0.000710197612713231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,39334,-0.02115698273839,0.00624939505156334,-0.0334057970394542,-0.00890816843732588,0.000713176507706496
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,41865,-0.0201397283543267,0.00595802622099849,-0.0318174597474838,-0.0084619969611697,0.00072623823789906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,41836,-0.0165521802136013,0.00490669655235026,-0.0261693054562078,-0.00693505497099477,0.000744627675748288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,39408,-0.0118348706615868,0.00351261665349716,-0.0187195993024412,-0.00495014202073238,0.000756375830296498
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,41865,-0.00810840086845534,0.00240737661611171,-0.0128268590360343,-0.00338994270087639,0.000758902253822775
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,41708,-0.0298527890833347,0.00887655146957044,-0.0472508299636927,-0.0124547482029766,0.000772912360269714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,39250,0.00747046082266645,0.00222365104883538,0.00311210476694911,0.0118288168783838,0.000783443624506365
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,41877,0.0189943111469736,0.00566194226693659,0.0078969043037779,0.0300917179901693,0.000796637544746442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,41458,-0.0283570725610284,0.00845330174188133,-0.0449255439751158,-0.011788601146941,0.000797223396814976
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,41805,-0.00972652948759879,0.00290005405565268,-0.015410635436678,-0.00404242353851955,0.000799015046659749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,41740,-0.030841018088367,0.009200423432254,-0.0488738480155849,-0.0128081881611492,0.000804185299456007
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,39600,-0.0211804295772493,0.0063190584356281,-0.0335657841110803,-0.00879507504341819,0.000805489090711574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,41740,0.0280459049171369,0.00837274155848219,0.0116353314625118,0.044456478371762,0.000811361185394942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,41740,0.0212995012105272,0.00636073135461437,0.00883246775548303,0.0337665346655713,0.000814512557708547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,41466,0.0162027203040357,0.00484758738085006,0.00670144903756958,0.0257039915705018,0.000832851259431593
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,41689,-0.0473523045726823,0.0141879921729922,-0.075160769231747,-0.0195438399136176,0.000847738755128934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,41502,0.0201038745671013,0.00603563411932,0.00827403169323413,0.0319337174409685,0.000868199628809317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,41836,-0.0111074078007049,0.00333895316174299,-0.0176517559977212,-0.00456305960368869,0.00088147451428355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,41846,-0.0132832589156169,0.00399612423817471,-0.0211156624224394,-0.00545085540879447,0.000889655900808845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,39655,0.018923995681423,0.00569640123827653,0.00775904925440101,0.030088942108445,0.000896335594741587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,41758,-0.014725549008961,0.00443488092063644,-0.0234179156134084,-0.00603318240451355,0.000901351998500749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,39554,-0.017220619388144,0.00519245213861011,-0.0273978255798198,-0.00704341319646814,0.000914584823484545
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,41706,-0.0282715692293433,0.00853901523653731,-0.0450080390929564,-0.0115350993657302,0.000932576954709665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,39600,-0.0306269083802107,0.00925435219983328,-0.0487654386918839,-0.0124883780685374,0.000937766011672914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,41465,-0.0137098670757478,0.00414380761397665,-0.0218317299991421,-0.00558800415235358,0.000940482273502386
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,41696,-0.00946631290905199,0.00286719475872892,-0.0150860146361607,-0.00384661118194332,0.000963943808892929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,41786,-0.0289261109907377,0.00876370157247598,-0.0461029660727906,-0.0117492559086848,0.000967093842940264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,39655,-0.0246044667052827,0.00746433423655609,-0.0392345618089326,-0.00997437160163276,0.000982863133180403
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,41581,-0.0152090703003227,0.00461778438836929,-0.0242599277015266,-0.00615821289911893,0.00099182704137456
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,41740,0.0174303144312887,0.00529337355867647,0.00705530225628278,0.0278053266062945,0.000994373282311857
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,39427,-0.0371225287635508,0.0112740321795826,-0.0592196318355326,-0.015025425691569,0.000995319241612567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,39393,-0.0203747759311941,0.00619216606445394,-0.0325114214175239,-0.0082381304448644,0.00100361697416245
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,39600,-0.0126355825718469,0.00384477024374972,-0.0201713322495964,-0.00509983289409746,0.00101782477444841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,39634,0.00900204698081443,0.00274466606531805,0.00362250149279106,0.0143815924688378,0.00104190412801798
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,41466,-0.0238409968897407,0.00726992302424928,-0.0380900460172693,-0.00959194776221212,0.00104303855236271
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,39259,0.0203438148800111,0.00620543933579146,0.00818115378185981,0.0325064759781623,0.00104737609003403
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,41740,-0.0215145350544097,0.00658063150061545,-0.0344125727956159,-0.00861649731320337,0.0010806354549592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,39408,-0.0108401272981174,0.00331881711234759,-0.0173450088383187,-0.00433524575791617,0.00109316848390634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,39600,-0.0150588309055659,0.00461079256518362,-0.0240959843333258,-0.00602167747780599,0.00109413603600765
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,41689,-0.0308831737297802,0.009462567695255,-0.04942980641248,-0.0123365410470804,0.00110241772664772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,41765,-0.0200731984890972,0.00615234944467767,-0.0321318034006654,-0.00801459357752894,0.00110641987250487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,41805,-0.00960535685715046,0.00294832132078261,-0.0153840666458844,-0.00382664706841655,0.00112520682858803
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,39625,-0.0225340878529046,0.00691904318026836,-0.0360954124862306,-0.00897276321957857,0.00113007821206901
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,41703,0.00990741265881782,0.00304449153222608,0.00394020925565469,0.0158746160619809,0.00113996737073498
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",39385,-0.0299888409996009,0.00921541677918245,-0.0480510578867985,-0.0119266241124033,0.00114061100028294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,39334,-0.0273860444718494,0.00841831140545458,-0.0438859348265404,-0.0108861541171584,0.00114485362815941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,41736,0.0254258510320993,0.00782327466125391,0.0100922326960417,0.040759469368157,0.00115684620798149
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,39633,0.00882696990541949,0.00271776623144494,0.00350014809178742,0.0141537917190516,0.00116617199408573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,41636,-0.027237694391635,0.00839309140455318,-0.0436881535445593,-0.0107872352387108,0.00117642829627697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",41802,-0.0121002530816436,0.00372903812462913,-0.0194091678059167,-0.00479133835737055,0.00117795770786485
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,39600,-0.010638791661057,0.0032826087549153,-0.017072704820691,-0.00420487850142297,0.00119483840398129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,39600,-0.00880274019157948,0.00271848287006385,-0.0141309666169046,-0.00347451376625435,0.00120682205544188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,41865,-0.020975963796769,0.00648385402569476,-0.0336843176871308,-0.00826760990640729,0.00121894950056562
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,41805,0.0229266275627014,0.00709473736676249,0.00902094232384695,0.0368323128015559,0.00123445168680944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,41805,-0.0367427608793412,0.0113744189758824,-0.0590366220720707,-0.0144488996866117,0.00123964041626602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,41740,-0.0124882097381659,0.00387811351320757,-0.0200893122240527,-0.00488710725227901,0.00128423252945962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,41534,-0.01269024655834,0.00394255561535093,-0.0204176555644279,-0.00496283755225219,0.00129051620406513
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,39589,-0.0241749918428611,0.00751298036559333,-0.038900433359424,-0.00944955032629817,0.0012956909527196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,41794,-0.0174618988513001,0.0054288774782224,-0.028102498708616,-0.0068212989939842,0.00130084605640684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,41750,-0.0107552453290882,0.00334689804846777,-0.017315165504085,-0.00419532515409136,0.00131445565183053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,39633,-0.00793731872045989,0.00247598596663249,-0.0127902512150596,-0.00308438622586021,0.00135108628375186
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,39600,-0.018332563831164,0.00573056203896463,-0.0295644654275347,-0.00710066223479334,0.00138254705716655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,41698,-0.0120357427888587,0.00376734769849923,-0.0194197442779172,-0.00465174129980023,0.00140282461411502
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,39600,-0.0162907679212913,0.00510926071407863,-0.0263049189208854,-0.00627661692169717,0.00143424263676912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,41533,-0.0248410847805568,0.00779313468629326,-0.0401156287656916,-0.00956654079542205,0.00143820081897912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",39308,0.0259640389446604,0.00816985210130406,0.00995112882610443,0.0419769490632164,0.00148700707209771
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,41877,-0.020722165988511,0.00652298340442995,-0.0335072134611937,-0.00793711851582831,0.00149254330041872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,39328,-0.0153809759087861,0.00485949169557654,-0.0249055796321161,-0.00585637218545609,0.00155441181791732
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,41521,-0.0150716420142845,0.00477337338202714,-0.0244274538430577,-0.00571583018551128,0.00159526823073845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,41925,-0.00781500832182403,0.00247720093276965,-0.0126703221500525,-0.00295969449359553,0.00160979749747714
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,39427,-0.02248634582994,0.00714005684914739,-0.0364808572542689,-0.00849183440561115,0.00164094162344567
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,39259,-0.0253421347750463,0.00805036477712109,-0.0411208497382036,-0.00956341981188898,0.00164874004555881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,41705,-0.011321650118858,0.00359677917083977,-0.018371337293704,-0.00427196294401207,0.00164918722725924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,39308,0.0143578152417424,0.00456856682212088,0.00540342427038548,0.0233122062130993,0.00167831406136985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,41805,-0.00902263298454662,0.00287184368702684,-0.0146514466111192,-0.003393819357974,0.00168308828062723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,39522,-0.0143849781908574,0.00460017257784004,-0.0234013164434238,-0.00536863993829088,0.00177032469256082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,41744,-0.00910089813023731,0.00292036088665859,-0.0148248054680881,-0.00337699079238647,0.00183492616477995
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,39600,-0.0251983206731595,0.00809192700897325,-0.041058497610747,-0.0093381437355719,0.00185038764436992
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,39600,-0.028009541488054,0.00901141213787018,-0.0456719092782796,-0.0103471736978285,0.00188691525492052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,41911,-0.0117544199572039,0.00378200147840529,-0.0191671428548783,-0.00434169705952958,0.00188761732933132
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,39655,-0.00884532081746078,0.00285039640699384,-0.0144320977751687,-0.00325854385975285,0.00191929793015676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,41862,0.0101029078162342,0.00325887287767536,0.00371551697599049,0.0164902986564779,0.00193845309951276
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,39250,0.0103589459709225,0.00334232932095715,0.00380798050184652,0.0169099114399986,0.00194471392066616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,41692,0.0115071088489846,0.00371327002726951,0.00422909959553636,0.0187851181024328,0.00194642199078721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,39596,-0.00844351256180412,0.00272546226413418,-0.0137854185995071,-0.00310160652410113,0.00195315139186305
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,39308,-0.0207784194500417,0.00671164878823776,-0.0339332510749877,-0.0076235878250957,0.0019674032197902
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,39600,-0.0103222332548355,0.00333515449861364,-0.0168591360721183,-0.0037853304375528,0.00197320956292459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,39650,0.00507424994599204,0.00164311953299284,0.00185373566132607,0.00829476423065801,0.00201885270504311
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,39241,-0.0183570372151331,0.00594637785531043,-0.0300119378115416,-0.00670213661872471,0.00202642235675066
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,41740,-0.0334604649158018,0.0108422680484397,-0.0547113102907436,-0.01220961954086,0.00203213400623747
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,39633,-0.0168800417748179,0.00547316210649103,-0.0276074395035403,-0.00615264404609548,0.00204640474021632
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",39600,-0.0480104690944748,0.0155836116120648,-0.0785543478541218,-0.0174665903348278,0.00206933585595022
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,39598,-0.00900057256634848,0.00292159318479484,-0.0147268952085464,-0.0032742499241506,0.00207019588284027
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",39625,-0.0238662283769643,0.00775404418893554,-0.039064154987278,-0.00866830176665069,0.00208971502238028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,41466,-0.0162887552139055,0.00529326531828106,-0.0266635552377364,-0.00591395519007465,0.00209351816244492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,39250,-0.0218380375409832,0.00710050662626646,-0.0357550305284655,-0.00792104455350096,0.00210639715387375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,41466,-0.0222881960373698,0.00726147133981996,-0.036520679863417,-0.00805571221132272,0.00214951992072593
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,41636,-0.0314541187158707,0.0102506750536428,-0.0515454418210105,-0.0113627956107309,0.00215583365756532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,39308,-0.025796812752854,0.00841118684942388,-0.0422827389777248,-0.00931088652798323,0.00216783846111769
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,39427,-0.0241873048870308,0.00789404959257902,-0.0396596420884857,-0.00871496768557591,0.0021894164665642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,39241,0.0219032470581427,0.00715673040921675,0.00787605545607782,0.0359304386602075,0.00221510557688057
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,39063,-0.00788524154002894,0.00257645181650476,-0.0129350871003783,-0.0028353959796796,0.00221524447143016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",41708,-0.0207400453308877,0.00678644772522532,-0.0340414828723293,-0.00743860778944604,0.00224689374732762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,41488,-0.0242160377353889,0.00792761853553202,-0.0397541700650317,-0.00867790540574612,0.00225789317735305
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,41465,-0.0169707231827246,0.00555968298446303,-0.0278677018322721,-0.00607374453317703,0.00227435262263279
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,41622,-0.0151902902006395,0.00497650255994583,-0.0249442352181334,-0.00543634518314571,0.00227474821789673
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,39250,-0.021888128343569,0.0071919384473433,-0.0359843277003619,-0.00779192898677617,0.00234471723796435
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,41911,0.00823165070444963,0.00270690552267835,0.00292611588000006,0.0135371855288992,0.00236266619445116
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,41802,0.00757715857059348,0.00249392622951405,0.00268906316074595,0.012465253980441,0.00238425596134953
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,41465,-0.0185087139324675,0.00609273318995405,-0.0304504709847774,-0.00656695688015751,0.00238762625051594
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,41802,-0.0109732558645299,0.00361552588543961,-0.0180596865999915,-0.00388682512906822,0.00240974204493859
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,41866,-0.0100472282373506,0.00331171123448667,-0.0165381822569445,-0.00355627421775676,0.00241923277729328
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,39427,-0.0111640436675414,0.0036821813655962,-0.01838111914411,-0.00394696819097287,0.00243586202349754
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,39655,0.0467316124337717,0.0154406089767661,0.0164680188393101,0.0769952060282333,0.00247939867026428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",41521,-0.0286320904651827,0.00946447004144536,-0.0471824517464156,-0.0100817291839497,0.00248941939563851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,39650,0.00587825388120737,0.00194914680162487,0.00205792615002262,0.00969858161239212,0.00256877434537945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,39589,-0.0144090049054219,0.00478319895333075,-0.0237840748539502,-0.00503393495689362,0.00259763529694643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,41765,0.00864378081403553,0.00287681998642812,0.00300521364063641,0.0142823479874347,0.0026640413406952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,39308,0.0107555755105926,0.00358493201457218,0.00372910876203114,0.0177820422591541,0.00270407870794694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,41836,-0.0212819184854518,0.00709675167222857,-0.0351915517630198,-0.00737228520788377,0.00271526376879958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,41521,-0.01638947127806,0.00547622284544132,-0.027122868055125,-0.00565607450099503,0.00276914948008842
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,41465,-0.0184180151858233,0.00615558501857777,-0.0304829618222357,-0.00635306854941086,0.00277607320549335
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,39328,-0.0138076965073124,0.00462212279321255,-0.022867057182009,-0.00474833583261578,0.00282084041033577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,41689,-0.0235965754925283,0.00790875288150915,-0.0390977311402862,-0.00809541984477035,0.00285402088906002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,39562,-0.0143961685794856,0.00483460204241111,-0.0238719885826114,-0.00492034857635982,0.0029102114141685
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",39589,-0.0165834480384837,0.00557114700196811,-0.0275028961623412,-0.00566399991462624,0.00292035545712615
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,41765,-0.0111777022612603,0.00376377498407658,-0.0185547012300504,-0.00380070329247022,0.00298519933574945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",39600,0.0132141071609931,0.0044513586984324,0.00448944411206557,0.0219387702099206,0.00299847545852067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,39334,-0.020394536636991,0.00687387566714992,-0.0338673329446049,-0.0069217403293772,0.00301419887057914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,39600,-0.0242508294300433,0.00817494888794671,-0.0402737292504189,-0.00822792960966775,0.00301876699913524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,40938,0.0157650968783541,0.00531624851477145,0.00534524978940208,0.0261849439673061,0.00302813875503588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,41466,-0.019636029287537,0.00662320706675732,-0.0326175151383813,-0.00665454343669261,0.00303502996630342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,39598,0.00965804975148312,0.00326419134395881,0.00326023471732385,0.0160558647856424,0.00309509470362453
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,39625,-0.0168370128452523,0.00570882709783479,-0.0280263139570085,-0.00564771173349612,0.0031916908130763
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,41764,-0.0075217520287512,0.00255204954067989,-0.0125237691284838,-0.00251973492901861,0.00321085196688476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,41911,0.00771012011746893,0.00261774969610047,0.00257933071311202,0.0128409095218258,0.00323175338656394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,41758,-0.0133642189465149,0.00453810953380288,-0.0222589136327685,-0.00446952426026123,0.00323638160666079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,39334,-0.0106287232359593,0.00360909274715322,-0.0177025450203796,-0.00355490145153904,0.00323663484496299
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,41758,-0.00971335384026903,0.00330015527088433,-0.0161816581712023,-0.00324504950933575,0.00325298526165425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,39408,-0.0244108116895353,0.00831558337785687,-0.0407093551101348,-0.00811226826893583,0.00333658065201408
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,38213,-0.0335152305092336,0.011430405970138,-0.0559188262107041,-0.011111634807763,0.00337459157362438
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,39250,-0.0272628372631375,0.00929881988717308,-0.0454885242419967,-0.00903715028427821,0.00337655560445196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,39328,-0.0257266542489279,0.00878189334650896,-0.0429391652080854,-0.0085141432897703,0.00340210624516131
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,41386,-0.0228460499407397,0.00784198106924269,-0.0382163328364553,-0.00747576704502399,0.00358249146490254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,39600,-0.0180641757391825,0.0062040072894103,-0.0302240300264267,-0.00590432145193831,0.00360195796482241
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,41447,0.0174032933448728,0.0059915266550299,0.00565990110101422,0.0291466855887314,0.00368289707019227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,39250,0.0119427801889322,0.00411809546563401,0.0038713130762895,0.0200142473015748,0.00373837885228879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,39600,0.0142677569942958,0.00492235765269632,0.00461993599501097,0.0239155779935806,0.0037561941962364
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,39250,-0.023311180745629,0.00805181563986997,-0.0390927393997741,-0.00752962209148381,0.00379752601004661
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,40174,0.00957286785728343,0.00330712135897986,0.0030909099936829,0.0160548257208839,0.00380324185695078
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,41465,-0.00975390964769521,0.00337080823946637,-0.0163606937970493,-0.00314712549834113,0.00381442419101217
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,39308,0.0122766884466294,0.0042546090503508,0.00393765470794185,0.020615722185317,0.00391568765682452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,39600,-0.0155489207626859,0.00539022436507027,-0.0261137605182236,-0.00498408100714815,0.00392607629761111
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,41728,0.0093355458900962,0.00323688107736072,0.00299125897846919,0.0156798328017232,0.0039315024108868
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,41570,0.0117690953388974,0.0040865243302912,0.00375950765152665,0.0197786830262682,0.00398355508081737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,41625,-0.031156539648933,0.010854641475367,-0.0524316369406523,-0.0098814423572138,0.00410687660136149
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,41465,-0.0219078786546516,0.00763441606600849,-0.0368713341440283,-0.00694442316527498,0.00411633897238437
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,41836,-0.0131525921011938,0.00458562503618951,-0.0221404171721252,-0.00416476703026233,0.00413437809036044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,41758,-0.0136632073216476,0.00476828975378483,-0.0230090552390659,-0.00431735940422935,0.00417101254317688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,41534,0.0141636954945922,0.0049446065287004,0.00447226669833937,0.0238551242908449,0.00418375254212032
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,39250,0.0103395766850927,0.00361773860751294,0.0032488090143673,0.017430344355818,0.00427117521396039
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,41689,0.00809868075162774,0.00283827541577615,0.0025356609367065,0.013661700566549,0.00433245968407015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,41925,0.0080889637082269,0.00283506902536853,0.00253222841850458,0.0136456989979492,0.00433507017062233
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,39259,-0.0196219338920875,0.00688268329532832,-0.033111993150931,-0.00613187463324402,0.00436775589653082
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,41836,-0.0141187404431776,0.00495334780858023,-0.0238273021479948,-0.0044101787383603,0.0043739581927758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,41758,-0.00914639788818268,0.00321174968670977,-0.0154414272741338,-0.00285136850223153,0.00440917728726058
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,39600,0.0105200982877641,0.00370165366142266,0.00326485711137567,0.0177753394641525,0.00449140271742954
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,39650,0.00612924838906029,0.00215928257933802,0.00189705453355776,0.0103614422445628,0.00454005481306791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,39334,-0.0171609202725226,0.00605817338675273,-0.029034940110558,-0.00528690043448724,0.00462442909526055
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,41740,-0.0253692877129715,0.00897898006555318,-0.0429680886414557,-0.00777048678448725,0.00472915526876849
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,39368,0.0103721741914452,0.00367862610832151,0.00316206701913501,0.0175822813637554,0.00481746293291815
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,39498,0.0330738605738187,0.0117344058668466,0.0100744250747995,0.056073296072838,0.00483299491659341
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,39328,-0.014786947103712,0.00524826195008745,-0.0250735405258834,-0.00450035368154061,0.00484884935233037
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,39600,-0.0356996685138186,0.0126722505588379,-0.0605372796091409,-0.0108620574184963,0.0048537795754914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,41865,0.00898860181338151,0.00319126069279035,0.00273373085551243,0.0152434727712506,0.00486020143226269
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,39334,-0.0124401998802197,0.00442048087490059,-0.0211043423950248,-0.0037760573654145,0.00489849250061811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,41840,0.010544413109226,0.00375316477344526,0.0031882101532733,0.0179006160651787,0.00496955160835495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,41614,-0.0154704064403097,0.00551417725113804,-0.0262781938525402,-0.00466261902807912,0.00503023229371027
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,41466,-0.0114519357167376,0.00408414304462379,-0.0194568560842002,-0.00344701534927497,0.00505485752509349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",39625,-0.00889536626731954,0.00317358396821055,-0.0151155908450122,-0.00267514168962686,0.00507274677479819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,41534,-0.0111996265587216,0.00399801823402144,-0.0190357422974036,-0.00336351082003954,0.00509736330637785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,39427,0.0100799884698836,0.00359894073663487,0.00302606462607927,0.017133912313688,0.00510631813753039
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,41521,-0.021743454315653,0.00776413312698613,-0.0369611552445458,-0.00652575338676016,0.00510992919691109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,39314,-0.0254357975116605,0.00909798106340488,-0.043267840395934,-0.0076037546273869,0.00518695527794353
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,41689,-0.0111492209576459,0.00399436735887733,-0.0189781809810455,-0.00332026093424637,0.00525832745734106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,39241,-0.0199408962128809,0.00714385851659051,-0.0339428589053983,-0.00593893352036351,0.00525848019245201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,39250,-0.0369006209935332,0.0132600615369209,-0.0628903416058982,-0.0109109003811681,0.00539803858385003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,41758,0.0108185236938536,0.00388961704371168,0.00319487428817871,0.0184421730995285,0.00542044617749737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,39250,-0.0208937682641706,0.00751328617578719,-0.0356198091687135,-0.0061677273596277,0.005430209276782
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,39241,0.0144771135004913,0.00521660841390406,0.00425256100923935,0.0247016659917433,0.00552646483582421
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,41805,-0.0273117226143236,0.00986273614887478,-0.0466426854661182,-0.00798075976252905,0.00562754538232781
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,39655,-0.0141561639463425,0.00511479054345437,-0.0241811534115131,-0.00413117448117194,0.00565487321867293
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,39259,0.0148346331385807,0.00536366232067171,0.00432185499006414,0.0253474112870973,0.00568870679013639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,39567,-0.0258240689878645,0.0093754818055014,-0.0442000133266472,-0.00744812464908172,0.00588921274390833
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,39600,-0.015702857315594,0.00570396548720173,-0.0268826296705094,-0.00452308496067861,0.00591538083819709
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,41877,-0.013464490580748,0.00489995131917872,-0.0230683951663383,-0.00386058599515774,0.00600624574712898
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,41744,-0.0115863628027298,0.00422287313693067,-0.0198631941511139,-0.00330953145434566,0.00608305214030042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,41465,-0.0113263264957711,0.00412844498680625,-0.0194180786699113,-0.0032345743216308,0.00608750388881977
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",39250,0.0136026744527877,0.0049589104203971,0.00388321002880939,0.023322138876766,0.00609681465295476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,39250,0.0169548660523887,0.00618901692359219,0.00482439288214804,0.0290853392226294,0.00616334921281407
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,39408,0.00945276456781099,0.00345105352103212,0.00268869966658804,0.0162168294690339,0.00617094981245633
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,39600,-0.0102274780946771,0.00373669273279166,-0.0175513958509488,-0.00290356033840549,0.00620943035744539
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,39308,-0.0226189327433471,0.00826452130780826,-0.0388173945066513,-0.0064204709800429,0.00621288448129274
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,41865,-0.010240729022858,0.0037469326472598,-0.0175847170114872,-0.00289674103422878,0.00628250554095143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,39600,0.0146508037479162,0.00536877901179445,0.00412799688479911,0.0251736106110334,0.00636490140955522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,41827,0.00695421060446837,0.00255106348364414,0.00195412617652586,0.0119542950324109,0.00641905142123029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,39408,-0.0126506329247966,0.0046414004832765,-0.0217477778720185,-0.00355348797757465,0.00642867607235964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,41465,-0.012611688454691,0.00462784969242681,-0.0216822738518476,-0.00354110305753447,0.00643548050931875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,39655,-0.0118806087010868,0.00435976905631951,-0.0204257560514731,-0.00333546135070059,0.00643920018102014
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",39625,-0.025708827580798,0.0094594996603465,-0.0442494469150772,-0.00716820824651891,0.00658244490786443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,39655,-0.0071626787167422,0.0026402157096881,-0.0123375015077309,-0.00198785592575353,0.0066797629638226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,41617,-0.0103023556362132,0.0037977956618297,-0.0177460351333994,-0.00285867613902697,0.00668212195319379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,41802,-0.0201434428896864,0.00742925980762684,-0.0347047921126351,-0.00558209366673784,0.00670932948355302
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,39655,0.0153634494005807,0.00567061483810325,0.00424904431789836,0.0264778544832631,0.00675273473945398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,39427,0.0096692252428548,0.00357069525003466,0.00267066255278686,0.0166677879329227,0.00678087719126986
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,39598,-0.0141008615560633,0.00521443171553298,-0.0243211477185079,-0.00388057539361865,0.00685745833251063
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,41636,-0.00971896809535009,0.00359641427185423,-0.0167679400681844,-0.00266999612251581,0.00689289725094675
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",39427,-0.0144056391912445,0.00533323638373345,-0.024858782503362,-0.0039524958791269,0.00692167707938629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,41274,-0.0175822086253382,0.00652047931416585,-0.0303623480811032,-0.00480206916957312,0.00701735063462261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,39630,0.00532119112847665,0.00197396346309811,0.00145222274080436,0.00919015951614894,0.00703498031863264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,39630,0.00416731826143677,0.00154671336527485,0.00113576006549806,0.00719887645737547,0.00706422739893649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,39589,0.0135654020452955,0.00504620272158286,0.00367484471099314,0.023455959379598,0.00719381043941396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,41838,-0.0117077094877731,0.00437364645191277,-0.0202800565335221,-0.00313536244202404,0.00744036963639024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,39598,-0.0392316073977972,0.0146555668690239,-0.067956518461084,-0.0105066963345104,0.0074415216908776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",39308,-0.0250311260061598,0.00935980829330274,-0.0433763502610332,-0.00668590175128643,0.00749945784958692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,41728,-0.0189922045868579,0.00710317653339741,-0.0329144305923168,-0.00506997858139895,0.00750984468129631
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,41879,-0.00584255749169967,0.0021852411731123,-0.0101256301909998,-0.00155948479239956,0.00751237818125198
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,41466,-0.0105131759840303,0.00393272686858002,-0.0182213206464471,-0.00280503132161343,0.00752142437277445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",39308,-0.00895734478015386,0.00335254510501776,-0.0155283331859887,-0.00238635637431906,0.00755587800140383
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,41911,-0.0156861142835082,0.00587340445604864,-0.0271979870173635,-0.00417424154965282,0.00757847686135343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,41814,-0.00997496918270183,0.00373790869575531,-0.0173012702263822,-0.00264866813902142,0.00762619476773402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",39600,0.0251979008796139,0.00944499695614448,0.00668570684557074,0.0437100949136571,0.00764486093183924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,41740,-0.00982444124188092,0.00368285829185407,-0.0170428434939149,-0.00260603898984695,0.00764858334211869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,39334,-0.0257830580186803,0.00967956683429645,-0.0447550090139013,-0.00681110702345922,0.00774114670852253
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,41431,-0.00824965945000897,0.00310134981458849,-0.0143283050866024,-0.00217101381341553,0.00782326191962777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,39308,-0.00845693564113532,0.00318151204146469,-0.0146926992424061,-0.00222117203986453,0.00786876992562188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,39625,-0.0259023380147368,0.00975707114707238,-0.0450261974629986,-0.00677847856647491,0.00794871660276508
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,39328,0.0137528131995022,0.00518881896613288,0.00358272802588173,0.0239228983731226,0.00804976532074444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,39566,-0.0261598015255562,0.00987131724933151,-0.045507583334246,-0.00681201971686644,0.00805876949490625
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,39250,0.00982886048481342,0.00371894036329229,0.00253973737276054,0.0171179835968663,0.00823148387069575
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,39598,-0.0262590790193768,0.00993724843456121,-0.0457360859511168,-0.00678207208763688,0.0082415478078303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,41911,-0.0178265924761906,0.00674662293590153,-0.0310499734305576,-0.00460321152182361,0.0082441754501698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,41877,-0.0123464900646602,0.00467424839231922,-0.0215080169136059,-0.00318496321571453,0.0082664532846503
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,41877,-0.0131339554050743,0.00497609740974794,-0.0228871063281802,-0.00338080448196833,0.00831477911610681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,39619,-0.0133943211777114,0.00507659589458927,-0.0233444491311064,-0.00344419322431647,0.00834042071524005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,41740,-0.0292702428958142,0.0110952629476284,-0.0510169582731658,-0.00752352751846258,0.00834740164451579
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,39408,0.00599332032390037,0.00227197706314996,0.00154024528012645,0.0104463953676743,0.00835328644232184
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,39308,-0.0179633346048166,0.00681180584505372,-0.0313144740611219,-0.00461219514851131,0.0083741785088016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,41865,-0.0142398441854591,0.00540842416213137,-0.0248403555432366,-0.00363933282768157,0.00847572062878871
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,39250,0.012876892121756,0.00489153111185176,0.00328949114252651,0.0224642931009854,0.0084884577465282
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,39241,0.00735715716402186,0.00279869853135079,0.00187170804257431,0.0128426062854694,0.00858154180742188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,41465,-0.0171799484931517,0.00655008048304912,-0.030018106239928,-0.00434179074637543,0.00872977252580474
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,41787,0.0102962199694169,0.00393876309635566,0.00257624430055977,0.018016195638274,0.00895712230771197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,41903,0.00838690687914432,0.00321213744758053,0.00209111748188647,0.0146826962764022,0.00903778604402172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,41865,-0.0131203375689749,0.00502986174248718,-0.0229788665842498,-0.00326180855370004,0.00910449826467044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,39250,0.00730752515866188,0.00280282194550939,0.00181399414546349,0.0128010561718603,0.0091412553826087
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,39259,0.0104004252314131,0.00399121389543085,0.00257764599636861,0.0182232044664575,0.00917793507857776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,39650,0.0091955769274697,0.00352917448304231,0.00227839494070678,0.0161127589142326,0.00918395098690332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,39250,0.0121053429633,0.00464815152179162,0.0029949659805884,0.0212157199460116,0.00921806131040539
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,41802,-0.0196695245347442,0.00755973426600434,-0.0344866036961127,-0.00485244537337572,0.00928176886919056
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,39308,-0.00861510956510274,0.00331350815105375,-0.0151095855411681,-0.00212063358903738,0.00933527161089867
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,39334,-0.0118111249640354,0.0045528347276694,-0.0207346810302674,-0.00288756889780336,0.00949303880455585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,39408,-0.0205597136115366,0.0079336755677365,-0.0361097177243002,-0.00500970949877311,0.00957012733331061
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,39589,-0.0143381748349534,0.00553989413544071,-0.0251963673404172,-0.00347998232948956,0.00966150210173044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,41740,-0.0102760410262126,0.00397347303194196,-0.0180640481688189,-0.00248803388360637,0.00971581286195275
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",39308,-0.00703123906565096,0.00272140232974813,-0.0123651876319573,-0.00169729049934464,0.00978830339199924
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,41447,-0.0111803711832869,0.00434386091831234,-0.0196943385831791,-0.00266640378339472,0.0100689934987103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,39650,-0.011290481848361,0.00438925412072277,-0.0198934199249776,-0.00268754377174433,0.0101154471454506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,39250,0.0116754057385848,0.00454734122218852,0.00276261694309529,0.0205881945340743,0.0102563051853766
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,41245,-0.00883597780344229,0.00344271513412876,-0.0155836994663347,-0.00208825614054992,0.0102823215272909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,39334,-0.0242448675178452,0.00944630277088644,-0.0427596209487827,-0.00573011408690783,0.0102835772512504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,41465,-0.0127999714746154,0.00500177486115165,-0.0226034502024726,-0.00299649274675813,0.0105061166961357
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",41805,-0.0297615925063478,0.0116307691131954,-0.0525578999682107,-0.00696528504448488,0.01051243525381
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,39250,-0.0125759423032388,0.0049232317628584,-0.0222254765584413,-0.00292640804803634,0.0106506450511528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,41534,-0.013469256469429,0.00527336086725411,-0.0238050437692471,-0.00313346916961097,0.0106543465725822
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,39308,-0.0105115883883965,0.00411892854585592,-0.0185846883382741,-0.00243848843851888,0.0107237979572846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",39308,-0.0170505544864351,0.00668403457941681,-0.0301512622620921,-0.00394984671077815,0.0107571445111385
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,39589,-0.0122130483412094,0.00478986162527798,-0.0216011771267542,-0.00282491955566451,0.0107928384356927
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,39600,-0.00791056025748994,0.00310774843622358,-0.0140017471924882,-0.00181937332249171,0.0109278116775014
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,39372,-0.0120890501118492,0.00475144813806656,-0.0214018884624596,-0.00277621176123874,0.0109639302708509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,39408,-0.0227935503966558,0.00898074593925878,-0.040395812437603,-0.0051912883557086,0.0111612379930699
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,41466,-0.0195316898572569,0.00769785886805828,-0.0346194932386512,-0.0044438864758627,0.0111831857289998
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,39250,-0.0187335990617503,0.00738646314511814,-0.0332110668261819,-0.00425613129731878,0.0112202132625864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,39650,0.00796384669589029,0.00314223746892919,0.00180506125678907,0.0141226321349915,0.0112760557866237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,41774,0.00841404080601044,0.0033204807515288,0.00190589853301398,0.0149221830790069,0.0112889165549783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,41783,-0.0177422538182932,0.00700234086856071,-0.0314668419206722,-0.00401766571591423,0.0112960697495839
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,41722,-0.012896513750824,0.00509391357663939,-0.0228805843610372,-0.00291244314061078,0.0113610701757799
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,41877,-0.00903936912060275,0.00357558718954746,-0.0160475200121158,-0.00203121822908973,0.0114803296849385
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,41819,-0.00689302155083443,0.00272667108906414,-0.0122372968854001,-0.00154874621626872,0.0114830183603177
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,39250,0.0106138124615798,0.00420735896357055,0.0023673888929815,0.0188602360301781,0.0116609390670947
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,39334,0.0154798643885328,0.00614152489234362,0.00344247559953927,0.0275172531775262,0.0117323815870227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,41614,-0.0107923191384784,0.00428974126661398,-0.0192002120210418,-0.00238442625591499,0.0118867151093099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,41465,-0.0228078345926936,0.00906662972410579,-0.0405784288519409,-0.00503724033344624,0.0118957417416335
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",39241,-0.0253356209532738,0.0100925353898428,-0.0451169903173657,-0.00555425158918188,0.0120764629102191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",41740,-0.0255090613677193,0.0102076234487072,-0.0455160033271855,-0.00550211940825321,0.0124658148347571
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,39578,0.0151758734303523,0.00607786898167472,0.00326325022626987,0.0270884966344348,0.012542718103304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",41877,0.0193192433021584,0.00774443069432172,0.0041401591412878,0.0344983274630289,0.0126220386872987
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,41534,-0.015778565348902,0.00633802206511829,-0.0282010885965338,-0.00335604210127012,0.0128044205095705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,39604,-0.00855856967552635,0.00344627139879279,-0.0153132616171602,-0.00180387773389249,0.0130272115525837
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",41689,-0.00915598355519501,0.00368698420672674,-0.0163824726003794,-0.00192949451001061,0.0130286173486334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,41534,-0.01264912272035,0.00510191273670298,-0.0226488716842878,-0.00264937375641213,0.0131770558153812
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,41740,-0.0126193027163593,0.0050940213107422,-0.022603584485414,-0.00263502094730457,0.0132513851475224
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,39328,-0.0217472806429254,0.00878117357616004,-0.0389583808521991,-0.00453618043365171,0.0132800837139977
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",39328,-0.0104199221599689,0.00420791196286711,-0.0186674296071884,-0.00217241471274936,0.0132916572598622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,41614,0.00866846397933161,0.00350176948266482,0.00180499579330857,0.0155319321653547,0.0133193796864285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,39589,-0.00902094098497594,0.00365031204319493,-0.016175552589638,-0.00186632938031387,0.0134781059221904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,39408,-0.0104052111930875,0.00421066691909872,-0.018658118354521,-0.00215230403165405,0.0134830401437074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,41799,0.0127935479675479,0.00518280590956785,0.00263524838479491,0.0229518475503009,0.0135821658802509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",39600,0.00954180657098064,0.00386703477183105,0.00196241841819179,0.0171211947237695,0.0136221329449883
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,41744,-0.0141869634548298,0.00574982222556402,-0.0254566150169353,-0.00291731189272436,0.0136234483059944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,41865,0.0183882779494062,0.00747103753269025,0.00374504438533329,0.0330315115134791,0.0138570567342595
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",41744,-0.0248531333697255,0.0101094541045927,-0.0446676634147272,-0.00503860332472385,0.0139683687006619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,41805,-0.0075039596982602,0.00305297878654052,-0.0134877981198796,-0.00152012127664078,0.0139874103174605
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",41740,-0.0107618162670261,0.00438624058901419,-0.0193588478214939,-0.00216478471255823,0.0141586756693659
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,41465,-0.0170285035074878,0.00694162708599744,-0.0306340925960428,-0.00342291441893285,0.0141762809993537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,41765,-0.00871216991411017,0.00355206375685374,-0.0156742148775435,-0.00175012495067685,0.0141914775236272
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,39600,0.0114159567212306,0.00465851176425704,0.00228527366328681,0.0205466397791744,0.0142789298612846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,39408,0.0137016607842672,0.00559924624489121,0.00272713814428047,0.024676183424254,0.0144187152430223
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,41689,-0.0220502787395904,0.00901206418440584,-0.0397139245410258,-0.00438663293815493,0.0144280908465421
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,39241,0.0122079088028909,0.00499291719433056,0.00242179110200298,0.0219940265037788,0.0144994954314307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,39625,-0.0194767580607328,0.00796794115744845,-0.0350939227293317,-0.00385959339213383,0.0145252739203442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,41636,-0.00744309620223431,0.00304700490545891,-0.0134152258169338,-0.00147096658753485,0.014588682138053
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,39295,-0.00977196855590738,0.00400376455521478,-0.0176193470841284,-0.00192459002768641,0.0146751381094794
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,41521,0.00842463867817449,0.0034627396699686,0.00163766892503603,0.0152116084313129,0.0149902467856111
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,39589,-0.0135261408818552,0.00556760230733037,-0.0244386414042227,-0.00261364035948767,0.0151381958456404
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,41877,-0.0057061250628836,0.00235789899517294,-0.0103276070934226,-0.00108464303234464,0.0155336721050789
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,39023,0.0133907669801309,0.00554180292070013,0.00252883325555859,0.0242527007047031,0.0156953642611655
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,39250,-0.014443426816271,0.00597903880870939,-0.0261623428813414,-0.00272451075120062,0.0157227056741488
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,39158,-0.0102211916060541,0.00423423974664756,-0.0185203015094833,-0.00192208170262489,0.0157980583656287
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,39427,-0.018299479627844,0.00760563305257487,-0.0332065204108907,-0.00339243884479723,0.0161430223634409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,41744,-0.076781165792775,0.0319204552857695,-0.139345258152883,-0.0142170734326668,0.0161689127440036
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,39600,0.00658539134197075,0.00274077061344477,0.00121348093961901,0.0119573017443225,0.0162886905057041
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,39334,-0.0163788759502498,0.00685349510754132,-0.0298117263610308,-0.00294602553946879,0.0168720619038907
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,39588,-0.024812640370488,0.0103833777622797,-0.0451640607845563,-0.00446121995641976,0.0168811820305149
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,39308,-0.0159660523631405,0.00668459150681014,-0.0290678517164883,-0.00286425300979259,0.0169351761074332
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,41466,-0.0182866962669116,0.00767136667421719,-0.0333225749483773,-0.00325081758544586,0.0171511930605073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,39328,-0.0335355768569655,0.0140795231324297,-0.0611314421965277,-0.00593971151740336,0.0172423613432283
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,41293,0.0123622300612318,0.00519520707302752,0.00217962419809786,0.0225448359243657,0.0173487046143244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,41534,-0.0166788521303079,0.00701719796680821,-0.030432560145252,-0.0029251441153638,0.0174754797948747
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,41534,-0.0201862941546838,0.00850973048793429,-0.036865365911035,-0.00350722239833259,0.0176998107678282
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,41557,0.0103729149372609,0.00437648786475088,0.00179499872234919,0.0189508311521727,0.0177956219836863
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,39625,-0.0251355098797629,0.0106144352434972,-0.0459398029570175,-0.00433121680250837,0.0178992872464097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,39633,-0.0161217367988563,0.00682096514349883,-0.029490828480114,-0.00275264511759863,0.0181176987394608
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,39600,-0.00685778038030013,0.00290334990759741,-0.0125483461991911,-0.0011672145614092,0.0181928141514409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,39328,0.00953759444361226,0.00403892486036391,0.00162130171729899,0.0174538871699255,0.0182229127291261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,41863,-0.00708202230312082,0.00300349229852491,-0.0129688672082296,-0.00119517739801199,0.0183916306749846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,39250,-0.0164807010551079,0.00699806810322205,-0.0301969145374232,-0.00276448757279271,0.0185389606130109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,39408,-0.0073394688190517,0.00311677588014672,-0.0134483495441393,-0.00123058809396413,0.0185490988240768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,39433,-0.00615476377160788,0.00261400215801872,-0.0112782080013246,-0.00103131954189119,0.018563563174396
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,41521,-0.0129517325960853,0.00550283793007323,-0.0237372949390288,-0.00216617025314172,0.0186051989183305
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,39655,-0.00546026170391318,0.00232166484815271,-0.0100107248062925,-0.000909798601533879,0.0186965791474238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,39308,-0.0227715964706462,0.00969195049639478,-0.04176781944358,-0.00377537349771246,0.0188148369986097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,41521,-0.0151578149186497,0.00645716290521337,-0.0278138542128679,-0.0025017756244315,0.0189178255940025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,41716,-0.0222580928133365,0.00950683620306348,-0.0408914917713409,-0.00362469385533205,0.0192330339672456
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,39546,0.0181896171854341,0.00778954340619136,0.00292211210929906,0.0334571222615692,0.0195544673159663
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,41689,-0.0215133962719274,0.00925374770302217,-0.0396507417698509,-0.00337605077400393,0.0200962327449062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,41865,-0.0277825193603461,0.0119771947291584,-0.0512578210294965,-0.00430721769119571,0.0203766430146964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,41636,-0.0198309764869647,0.00855113440704662,-0.0365911999247761,-0.00307075304915335,0.0204047361779225
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,39308,0.0237946123447638,0.0102645130022079,0.00367616686043622,0.0439130578290913,0.0204602769917101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,41465,-0.0161865132838539,0.00698357017549812,-0.0298743108278302,-0.00249871573987755,0.0204758446161885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,41720,-0.0118555373120882,0.00511518565483818,-0.021881301195571,-0.00182977342860537,0.0204801761297392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,39250,-0.0170822306460795,0.00737168783504087,-0.0315307388027596,-0.00263372248939938,0.0205076014859864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,41689,-0.022184214829549,0.00957759777172328,-0.0409563064621266,-0.00341212319697135,0.0205593977069151
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,41855,-0.00749312302550483,0.00323577400928096,-0.0138352400836955,-0.00115100596731415,0.0205891442597201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,39241,0.0199037181927583,0.00862199172057092,0.00300461442043934,0.0368028219650774,0.0209913808207327
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,41865,-0.00718493949535216,0.00311778638531101,-0.0132958008105617,-0.00107407818014258,0.0212099482917366
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,41744,-0.00975652430317472,0.00423692829984248,-0.018060903770866,-0.00145214483548346,0.0213092840397614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,41689,-0.00597027437032743,0.00259478057355255,-0.0110560442944904,-0.000884504446164431,0.0214141505812329
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,41734,0.00718017459268767,0.00312869027936737,0.00104794164512762,0.0133124075402477,0.0217519231440441
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",39600,0.0226974014931016,0.00989042354748857,0.00331217134002402,0.0420826316461792,0.02175835600287
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,41758,-0.0217610048148358,0.00948569095353614,-0.0403529590837666,-0.00316905054590493,0.0218011532304652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,41591,-0.0136775527572171,0.00597207560395697,-0.0253828209409727,-0.0019722845734614,0.022022713110391
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,41805,-0.0208526854376097,0.00911768496753827,-0.0387233479739847,-0.00298202290123471,0.022208113245586
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,41636,-0.0192601487636948,0.00842818371977311,-0.0357793888544501,-0.00274090867293955,0.0223166462361736
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,41689,-0.00520390204699864,0.00227745210685576,-0.00966770817643593,-0.000740095917561348,0.0223307079412301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,41759,-0.00993955295725933,0.00435033879979787,-0.0184662170048632,-0.00141288890965551,0.0223417630197553
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,41465,-0.0179913089929023,0.00787929701598579,-0.0334347311442344,-0.00254788684157016,0.0224251214329414
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,39589,-0.0105212393017476,0.00460790381109884,-0.0195527307715014,-0.00148974783199391,0.0224315442620999
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,41466,-0.0154040111030673,0.00674892846386736,-0.0286319108922473,-0.00217611131388724,0.0224797357299128
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",39308,0.0224102877890415,0.00982645092806501,0.00315044397003405,0.0416701316080489,0.0225911804995158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,39542,-0.00788384145695566,0.00345762474621985,-0.0146607859595466,-0.00110689695436476,0.022619000126005
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,39250,-0.0105950352631299,0.00465843874952732,-0.0197255752122034,-0.00146449531405635,0.0229632672555046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,39408,-0.00702216399910448,0.00309086125918862,-0.0130802520671142,-0.000964075931094794,0.0231114049235781
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,39334,-0.0213405011808137,0.00941587037132512,-0.039795607108611,-0.00288539525301647,0.0234442995858538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,39408,-0.0175067917069246,0.00772610472911463,-0.0326499569759893,-0.00236362643785993,0.0234755257711377
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,39625,-0.0216316045108993,0.00955330080543587,-0.0403560740895536,-0.00290713493224495,0.023574586114761
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,41844,-0.0120611903681967,0.00533269398762758,-0.0225132705839468,-0.00160911015244665,0.0237293466398307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,41840,-0.00730452096726596,0.00323181571845419,-0.0136388797754362,-0.000970162159095753,0.0238255701908436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,41744,-0.00861773315302266,0.00381508619096022,-0.0160953020873047,-0.00114016421874063,0.0239086135073261
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,39241,0.00803966339609375,0.00356734879175439,0.00104765976425516,0.0150316670279323,0.0242365590227064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,41925,-0.00657345023198262,0.00291797539690821,-0.0122926820099227,-0.000854218454042516,0.0242915236543629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,41802,0.00736017442977612,0.00327059184376137,0.000949814416003831,0.0137705344435484,0.0244392866227164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,41534,-0.0184109118796081,0.00818948773012579,-0.0344623078306547,-0.00235951592856156,0.0245856168128465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,39650,-0.00513828564953165,0.00228687528004166,-0.0096205611984133,-0.000656010100649989,0.0246687160604062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,41070,-0.0100417477193118,0.00447180383776105,-0.0188064832413235,-0.00127701219730014,0.0247490187419066
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,39629,0.00472871044572808,0.00210746189790694,0.000598085125830468,0.00885933576562569,0.0248654154114062
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,41855,0.00600057859781706,0.00267547877432132,0.000756640200147268,0.0112445169954869,0.0249258153901042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,41612,0.00833867507533454,0.00372245739201238,0.00104265858699027,0.0156346915636788,0.0251012746519588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,39250,0.0139553241974559,0.00624328330135642,0.00171848892679733,0.0261921594681145,0.0254213223441445
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,39600,-0.011712454909803,0.00524148874163315,-0.021985772843404,-0.00143913697620207,0.0254658291171322
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,39259,0.006980739633396,0.00313223554878448,0.000841557957778417,0.0131199213090136,0.025856210001072
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,39633,0.00811566506503784,0.0036523420793218,0.000957074589567122,0.0152742555405086,0.0263005308297453
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,41465,-0.00880935882245161,0.00396678723049295,-0.0165842617942178,-0.00103445585068543,0.026383264409157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,41685,-0.00763158101495272,0.00344002391536736,-0.0143740278890728,-0.000889134140832687,0.0265400751127032
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,41865,-0.00869219457623871,0.00392480641516646,-0.016384815149965,-0.000999574002512451,0.0267988913688202
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,39600,-0.0103165964706428,0.00467142065652998,-0.0194725809574415,-0.00116061198384401,0.0272335017868749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,39589,-0.0197359120287983,0.00895665061659312,-0.0372909472373208,-0.00218087682027576,0.0275807264073381
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,41877,-0.0259298050843283,0.0117920655301027,-0.0490422535233295,-0.00281735664532707,0.0279008171933574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,39633,0.0112161971648088,0.0051017973634398,0.00121667433246675,0.0212157199971508,0.0279356387159407
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,39334,-0.0102039730871964,0.00465261905402676,-0.0193231064330888,-0.00108483974130391,0.0283166865728331
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,41521,0.00794620283393374,0.0036240746020621,0.000843016613892027,0.0150493890539755,0.0283528472157582
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,41765,-0.00584560216519468,0.00267399777829692,-0.0110866378106566,-0.000604566519732714,0.0288265064751575
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",39615,-0.00535640326779918,0.00245083401684122,-0.010160037940808,-0.000552768594790376,0.0288700391857856
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,39250,-0.0131205989381563,0.00601314729777735,-0.0249063676417999,-0.00133483023451272,0.0291323993714933
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,41466,-0.0189608605962301,0.00869207384966929,-0.0359973253415819,-0.00192439585087832,0.0291721320688547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,41465,0.00877161845272614,0.00402151580519933,0.000889447474535452,0.0166537894309168,0.0291887272767207
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,39259,0.0108864671102415,0.00499698904522619,0.00109236858159813,0.0206805656388848,0.0293828311967402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,39598,0.00925017960524088,0.00424618542258783,0.000927656176968734,0.017572703033513,0.0293923658107436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,41819,0.00641498551043417,0.00294828407421644,0.000636348724969942,0.0121936222958984,0.0295851042294109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,39328,-0.012585338533898,0.00578514360926455,-0.0239242200080565,-0.00124645705973945,0.0296175501869428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,41764,0.00883300715870161,0.00406855446523543,0.000858640406840173,0.016807373910563,0.0299457200338282
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,39598,-0.0105141273323314,0.00484692998510329,-0.0200141101031338,-0.0010141445615289,0.030086242009904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,39600,0.0083171394750055,0.00383626556214132,0.000798058973208509,0.0158362199768025,0.0301777621189008
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,41689,-0.00539071820070235,0.00248656244278367,-0.0102643805885583,-0.000517055812846353,0.0301812127807489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,39598,-0.0127023470621752,0.00587558768953728,-0.0242184989336683,-0.00118619519068214,0.0306485118093275
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,39476,0.00823474469463381,0.00380920373399668,0.000768705376000329,0.0157007840132673,0.0306551739628651
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,39250,0.00820750081283648,0.00380252317201303,0.000754555395690931,0.015660446229982,0.030916265101628
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,39598,-0.00635641512516223,0.00294763635705537,-0.0121337823849908,-0.000579047865333716,0.0310705570732092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,39600,-0.00603682135137583,0.00280285107375788,-0.0115304094559413,-0.000543233246810377,0.0312763772814814
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,41466,-0.00880272221622993,0.00408885738786218,-0.0168168826964398,-0.000788561736020054,0.0313485093643018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,41865,-0.01578324837731,0.00733286736150226,-0.0301556684058544,-0.00141082834876554,0.0313840106205512
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",41758,-0.0175645119122489,0.00816358365696629,-0.0335651358799029,-0.001563887944595,0.0314494739678547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,39600,-0.00621255589461151,0.00290085455132107,-0.0118982308152008,-0.000526880974022221,0.0322452022864247
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,41465,-0.00679907252328432,0.00317645441305751,-0.013024923172877,-0.000573221873691602,0.0323363828900578
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",41598,-0.0092744636902578,0.00433339275947722,-0.0177679134988332,-0.000781013881682448,0.0323546197176099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,39334,0.00676680072986425,0.00316286292573419,0.000567589395425224,0.0129660120643033,0.0324213794956007
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,41783,0.0117014621669993,0.0054702633045122,0.00097974609015539,0.0224231782438432,0.0324455611439875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",39259,-0.00725646886864426,0.00339275902011983,-0.0139062765480791,-0.000606661189209392,0.0324736714327334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,39600,0.0164825097010362,0.00771830327775557,0.00135463527663523,0.0316103841254371,0.0327414395709531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,41636,0.00916337328914367,0.00429441973683714,0.000746310604942882,0.0175804359733445,0.0328789022294428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,39598,-0.0122537096475116,0.00574305780609589,-0.0235101029474596,-0.000997316347563691,0.0328930140473575
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,41925,0.00518258798622624,0.00242914989054166,0.00042145420076458,0.00994372177168791,0.0329020549758346
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,39259,-0.0124471661588906,0.00583454206143779,-0.0238828685993086,-0.00101146371847251,0.0329181513824705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,41287,-0.0141542541589151,0.00663584861100336,-0.0271605174364817,-0.00114799088134853,0.0329439975814085
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,39241,0.00588691020699292,0.00276676466063385,0.000464051472150564,0.0113097689418353,0.0333829382608775
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",41617,-0.0162945125909986,0.00766202575823672,-0.0313120830771426,-0.00127694210485462,0.0334672205812824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,41877,-0.0121303122226254,0.00570609168372515,-0.0233142519227267,-0.000946372522524131,0.0335339024576236
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,41534,-0.0183342781183257,0.00862510252980058,-0.0352394790767348,-0.00142907715991656,0.0335481287791887
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,39241,0.0155290359727804,0.00730573241483341,0.00120980043970687,0.0298482715058538,0.0335598754749835
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,39633,-0.00588412661178564,0.00277133877351484,-0.0113159506078747,-0.000452302615696546,0.0337586851108006
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,41465,-0.0151660686698687,0.00716420799350204,-0.0292079163371327,-0.0011242210026047,0.0342856196684953
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,39625,-0.0139129748587504,0.00657612737164315,-0.0268021845071709,-0.00102376521032979,0.0343944746957989
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,39334,-0.0182542051595003,0.00863790939301645,-0.0351845075698125,-0.00132390274918804,0.0346009731643305
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,39414,0.0121024387948438,0.0057449801210821,0.000842277757522918,0.0233625998321647,0.035174281255392
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,41689,-0.00955174780978696,0.00453878610023693,-0.0184477685662513,-0.000655727053322584,0.035356320325764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,39600,-0.0105354506707499,0.00501082824454782,-0.0203566740300637,-0.000714227311436229,0.0355289476806798
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,41534,0.0127009428013293,0.00606154774408486,0.000820309222922951,0.0245815763797356,0.0361610624831048
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,41534,-0.0106890358242129,0.00511136950423871,-0.0207073200525208,-0.000670751595905045,0.0365271479477594
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,41703,-0.0194839051885733,0.00932376413764579,-0.0377584828983591,-0.00120932747878755,0.0366636517216489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,41908,-0.0133478473457521,0.00639049673577879,-0.0258732209478785,-0.000822473743625625,0.0367534540621128
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,39381,-0.0114791345355475,0.0055007061147603,-0.0222605185204777,-0.000697750550617294,0.0369253595029054
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,39241,-0.0326291649181089,0.0156381653404668,-0.0632799689854239,-0.0019783608507939,0.0369563342274097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,39221,0.00915111830235752,0.00438667922314166,0.000553227024999868,0.0177490095797152,0.0369919878447252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,41740,-0.0146927894778768,0.0070520974474337,-0.0285149004748468,-0.00087067848090672,0.0372282513945081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,38782,-0.0125994486124864,0.0060530613986188,-0.0244634489537792,-0.000735448271193524,0.0374130657669808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,41786,-0.0168266540501845,0.00809146737379797,-0.0326859301028285,-0.000967377997540458,0.0375856127472584
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,39589,-0.0239391582989502,0.0115131254866422,-0.046504884252769,-0.00137343234513144,0.0376135844980662
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,39598,-0.00637509214843348,0.00306850210704744,-0.0123893562782465,-0.000360828018620508,0.0377701983539347
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,39650,0.00570761572877621,0.002750360427037,0.000316909291783692,0.0110983221657687,0.0379888015102011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,39643,-0.0252642794595824,0.0121827111344306,-0.0491423932830664,-0.00138616563609845,0.0381227427870371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,39633,0.00902110149843216,0.00435179361672746,0.000491586009646326,0.017550616987218,0.0381990034972574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,39535,-0.0210871620314568,0.0101745278561839,-0.0410292366295773,-0.00114508743333636,0.0382380630898165
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,39241,-0.0201350512857877,0.00972727682517834,-0.0392005138631372,-0.00106958870843811,0.0384803793879395
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,41299,-0.00806895727920094,0.00390207346135098,-0.0157170212634489,-0.00042089329495303,0.0386730160623791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",39328,-0.0188389192284374,0.0091265182874003,-0.036726895071742,-0.000950943385132796,0.0390231568811286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,41447,-0.00799091898381374,0.00387561114471873,-0.0155871168274624,-0.000394721140165038,0.0392423279570067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,39308,-0.0125990064261973,0.00612269575767361,-0.0245994901112376,-0.00059852274115706,0.0396378326909985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,39600,-0.0258304891233841,0.0125742551416672,-0.0504760292010518,-0.00118494904571634,0.0399764207131194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,41662,-0.00622181734797976,0.00303163254583912,-0.0121638171378244,-0.000279817558135085,0.0401604688918704
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,39598,-0.0103218517212909,0.00503722524895766,-0.020194813209248,-0.000448890233333936,0.0404745868288903
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,39589,-0.00960328305949199,0.00468757088771977,-0.0187909219994227,-0.000415644119561244,0.0405181555486086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,39334,-0.0269273076444179,0.0131596873618532,-0.0527202948736501,-0.00113432041518574,0.0407613429518698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,39241,-0.0165036538265395,0.0080898540466614,-0.0323597677579959,-0.000647539895083201,0.0413706375028808
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,39334,-0.0227579475595483,0.0111653060009415,-0.0446419473213937,-0.000873947797702897,0.0415470459028437
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,41758,0.00530959197592308,0.00260763757937779,0.000198622320342614,0.0104205616315035,0.0417533277021123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,41802,-0.0119895365932091,0.00588896733840453,-0.023531912576482,-0.000447160609936261,0.0417771136555526
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,39600,-0.0196425802699272,0.00967023160881726,-0.038596234223209,-0.000688926316645324,0.0422544494154477
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,39241,-0.01320928935974,0.00650895996486008,-0.0259668508908658,-0.000451727828614291,0.04244230903696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,41465,-0.0102554579833462,0.0050572007111335,-0.0201675713771678,-0.000343344589524498,0.0425918161379976
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,39259,0.00619708729023726,0.00305693126645281,0.000205502007989754,0.0121886725724848,0.0426642500812333
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,41521,-0.0166099382672978,0.00819391071585649,-0.0326700032703765,-0.000549873264219042,0.0426719047049086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,39427,-0.0160710834525934,0.00792814621981763,-0.031610250043436,-0.000531916861750874,0.0426774362231864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,39334,0.00475077417308308,0.00234843129294027,0.000147848838920152,0.009353699507246,0.043102380406643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,39655,0.00570663300225429,0.00282332452660409,0.000172916930110263,0.0112403490743983,0.0432783726898705
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,41865,0.00968335468388322,0.0047915142336021,0.000291986786023091,0.0190747225817433,0.0433062004293613
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,41534,0.015698029699489,0.00777276548986219,0.000463409339359077,0.0309326500596189,0.0434434402073952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,39308,-0.0219759813421986,0.0108815742852973,-0.0433038669413812,-0.000648095743015959,0.0434540129126906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,41534,0.00776729944020966,0.0038564852035701,0.000208588441212276,0.0153260104392071,0.0440209906203411
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,39589,-0.00611101672999531,0.00303514623167231,-0.012059903344073,-0.000162130115917596,0.0440950535729576
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,41925,0.0158317548644494,0.00787041185528686,0.000405747628087202,0.0312577621008117,0.0442871154724303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,39250,0.0110876270596665,0.00552033499998584,0.000267770459694281,0.0219074836596388,0.0446147253468919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,41745,-0.0199878526049242,0.0099612844715664,-0.0395119701691944,-0.000463735040654088,0.0448176440633928
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,39334,0.00819715156519654,0.00408554983057932,0.00018947389726108,0.016204829233132,0.0448411212011417
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",39600,-0.0100164694986298,0.00499864767104529,-0.0198138189338786,-0.000219120063381078,0.0451121215090268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,41534,-0.00668885916220876,0.0033427383804094,-0.0132406263878112,-0.000137091936606337,0.0454119689114691
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,39328,-0.0130117273079721,0.00652552512125451,-0.0258017565456309,-0.000221698070313248,0.0461801683216362
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,41595,0.00520551682779687,0.00261267574566651,8.46723662905041e-05,0.0103263612893032,0.0463471622327993
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,41640,0.0124067419706663,0.00622991704756434,0.000196104557440225,0.0246173793838924,0.046449200647301
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,39241,-0.00928284409947523,0.00466381726530222,-0.0184239259394676,-0.000141762259482883,0.0465728494278478
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,39427,0.00740677385854928,0.00372658195617686,0.000102673224442625,0.0147108744926559,0.0468864556630665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,39520,0.0143942992225904,0.00724540300158646,0.000193309339480903,0.0285952891056998,0.0469827895420928
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,41466,-0.0074617095227251,0.00375998481358676,-0.0148312797573552,-9.21392880950372e-05,0.0472207535445283
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,41689,0.0145113936473429,0.00731478614543709,0.000174412802286155,0.0288483744923996,0.0472941037212833
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,41698,-0.00530370692644327,0.00267435803221849,-0.0105454486695915,-6.19651832950317e-05,0.0473692817596469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,39600,-0.0136297659882457,0.00688684980314117,-0.0271279916024024,-0.000131540374088995,0.0478296191402201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,41802,-0.0129055740107969,0.00653096055374553,-0.0257062566961382,-0.000104891325455669,0.0481686963399476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,39250,-0.0124565714872141,0.00630673543697654,-0.0248177729436881,-9.53700307400798e-05,0.0482800946352374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,41465,-0.00640616391487874,0.00325004487736075,-0.0127762518745058,-3.60759552516746e-05,0.0487338224783807
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,39522,-0.0207446605872222,0.0105275403325984,-0.041378639639115,-0.000110681535329369,0.0488047633613473
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],41689,0.0118737621588773,0.0060284207895948,5.80574112714529e-05,0.0236894669064831,0.0489017739146185
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,39589,-0.0179175924076751,0.00909687508100167,-0.0357474675664384,-8.77172489118158e-05,0.0489044264404245
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,41465,0.011353154467874,0.00576857425791614,4.67489223583504e-05,0.0226595600133896,0.0490775066216946
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,39589,-0.008350880661825,0.00424857244118338,-0.0166780826465444,-2.36786771055791e-05,0.0493730616319394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,41466,-0.0128111218576891,0.0065429384210626,-0.0256352811629718,1.30374475935981e-05,0.050250724305791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,39250,-0.00927670675429829,0.00475206914167203,-0.0185907622719755,3.73487633788874e-05,0.0509476904151679
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,39427,0.0110806494412375,0.0056802768965729,-5.26932760453649e-05,0.0222139921585204,0.0511157128302827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,41829,-0.0173255146689477,0.00888671168160546,-0.0347434695648944,9.24402269990125e-05,0.051245160293295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,39334,-0.00756987469550623,0.00388449299357544,-0.0151834809629141,4.37315719016259e-05,0.0513522597811094
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,41636,-0.0127361047269772,0.00653847561327971,-0.0255515169290055,7.93074750509905e-05,0.0514518777721448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,41899,-0.00794576693270177,0.00408405529067524,-0.0159505153024252,5.89814370217014e-05,0.0517288831142206
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,39259,0.011500996939154,0.00591354372376858,-8.95487594324441e-05,0.0230915426377404,0.0518184551449055
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,39427,-0.0109075191899953,0.00561658525656772,-0.0219160262928681,0.000100987912877411,0.0521606178712482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,39625,-0.00832717390801309,0.00429237037082364,-0.0167402198348274,8.58720188012582e-05,0.0524058548988535
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,39241,0.00907852543112761,0.00468597552171998,-0.000105986591443556,0.0182630374536988,0.0527250735670242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,39250,0.00732166230764284,0.00378043568666201,-8.79916382147041e-05,0.0147313162535004,0.052805450111342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,39408,-0.0123178108986482,0.0063645972290578,-0.0247924214676015,0.000156799670305104,0.0529717243248509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,41173,-0.0058321381276391,0.00301810057427732,-0.0117476152532226,8.33389979444394e-05,0.0533342003232192
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,39408,0.00611271669064171,0.00316439845440372,-8.95042799895808e-05,0.012314937661273,0.0534207735236881
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,41925,-0.00669513086961766,0.00346671330311032,-0.0134898889437139,9.96272044785657e-05,0.0534718719558954
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,39600,-0.00612104994088207,0.00317634460512758,-0.0123466853669321,0.000104585485167983,0.053996178798944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,41855,-0.0124060558709408,0.00644241854903587,-0.0250331962270511,0.000221084485169479,0.0541653337420772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,39241,0.0099024248692275,0.00514426682645682,-0.000180338110627858,0.0199851878490829,0.0542630073646653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,41877,0.00577078433244796,0.00299919348027587,-0.000107634888892744,0.0116492035537887,0.0543618893073636
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,39650,0.00395980329021156,0.00206143832800711,-8.0615832682384e-05,0.0080002224131055,0.0547708485109163
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,41521,-0.00991947336499106,0.00516437144299354,-0.0200416413932584,0.000202694663276283,0.0547850451587402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,39440,-0.00803508599764383,0.00418365374056477,-0.0162350473291508,0.000164875333863106,0.05480954639861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,39241,0.0109246603024695,0.00569825114506279,-0.000243911941853608,0.0220932325467925,0.0552398714049748
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,41750,0.0194607694102722,0.0101545695187135,-0.000442186846406206,0.0393637256669505,0.0553289346175248
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,41765,-0.0164367115067177,0.00858597970443052,-0.0332652317274015,0.000391808713966116,0.0555950023361273
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,39241,0.00614835726930566,0.00321194032540626,-0.000147045768490607,0.0124437603071019,0.0556189680522745
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,41521,-0.00991461883099986,0.00517972699876696,-0.0200668837485831,0.000237646086583386,0.0556268952128758
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,39650,-0.00484503911388764,0.00253246272525398,-0.00980866605538544,0.00011858782761015,0.0557517342649581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,39598,-0.00787541172938989,0.00412149574199489,-0.0159535433836999,0.000202719924920094,0.056054461401653
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,41827,0.0085849686586598,0.00449611505338815,-0.000227416845980972,0.0173973541633006,0.0562296411848955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,39259,0.0125414663210866,0.00657167296487557,-0.000339012690069482,0.0254219453322428,0.0563646886735104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,39328,-0.00454821538020336,0.00238416955382727,-0.00922118770570481,0.0001247569452981,0.0564601941193424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,41587,0.00616544857674596,0.00323655508014664,-0.000178199380341447,0.0125090965338334,0.0568097234565437
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,41877,-0.0121466740775022,0.0063840575947708,-0.024659426963253,0.000366078808248547,0.0571068836429692
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,39259,0.0143557736920015,0.0075522419989716,-0.000446620625982816,0.0291581680099859,0.057346971250804
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,41758,0.00576698390532815,0.00304215726109698,-0.000195644326421937,0.0117296121370782,0.0580230787013495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,39308,-0.0185003504915158,0.00976001215127479,-0.0376299743080144,0.000629273324982794,0.0580497386938369
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,41762,-0.00727340355571218,0.00385003995276706,-0.0148194818631356,0.000272674751711249,0.0588901944007187
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,41925,0.0126854518854762,0.00673449487063948,-0.000514158060977205,0.0258850618319295,0.0596336756631339
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,41740,-0.0112819966637843,0.00599324035904109,-0.0230287477675048,0.000464754439936233,0.0597965357957435
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,39334,0.00869231528104123,0.00461793116915564,-0.000358829810503825,0.0177434603725863,0.059822808292728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,39308,0.0113547224895628,0.00603360166852833,-0.000471136780752763,0.0231805817598783,0.0598747230828806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",41758,-0.00772483544815842,0.00410865393801221,-0.0157777971666624,0.000328126270345521,0.0601113771063329
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,39600,-0.00494386351931448,0.00263172361546248,-0.0101020418056209,0.000214314766991987,0.0603303571097109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,39328,-0.0182480566584501,0.00972884463383972,-0.0373165921407759,0.000820478823875755,0.0607283835623684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,41636,-0.00600920391959953,0.00320552435069667,-0.012292031646965,0.000273623807765936,0.060864619663873
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,39633,-0.0169845979318533,0.00909146852229909,-0.0348038762355595,0.000834680371852938,0.061761964564461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,39250,0.00917764364613252,0.0049307082854705,-0.000486544593389661,0.0188418318856547,0.0627260248910749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,39259,0.00604534176741096,0.0032491738460477,-0.000323038970842523,0.0124137225056645,0.0628312948680237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,39633,-0.00729477070161464,0.00392556246733577,-0.0149888731375927,0.000399331734363466,0.0631567277835469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,41733,-0.0130571079604494,0.00702846933951734,-0.0268329078659034,0.000718691945004573,0.0632275150183518
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,39259,0.0082302037576436,0.00443544162654611,-0.000463261830386771,0.016923669345674,0.0635446663676214
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,39589,-0.0103394940400227,0.00557479534704079,-0.0212660929202226,0.000587104840177259,0.0636678685218078
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,41728,-0.0180543524514094,0.00974070397227133,-0.0371461322370612,0.00103742733424246,0.0638337680250242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,39241,0.0059804842249379,0.00323207000398366,-0.000354372982870076,0.0123153414327459,0.0642897738453595
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,41636,-0.0183518363551988,0.00993212580449922,-0.0378188029320172,0.00111513022161969,0.0646647862198443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,39250,0.00645260414795642,0.00349578231369098,-0.000399129186877904,0.0133043374827907,0.0649452821664042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,39250,0.016251621489319,0.00882996866910523,-0.00105511710212726,0.0335583600807652,0.0657216026995329
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,39250,0.0133038728763179,0.00724095300847588,-0.000888395020294846,0.0274961407729306,0.066192039976073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,39250,0.0123395413744941,0.00672679071877722,-0.00084496843430925,0.0255240511832974,0.0666243626931622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,41786,-0.00598612252418434,0.00327586839273715,-0.0124068245739492,0.000434579525580471,0.0676713835804242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,39250,0.00688770150973581,0.00376937261928001,-0.000500268824053005,0.0142756718435246,0.0676855579504856
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,39250,-0.00683386238205289,0.00374060201180984,-0.0141654423252002,0.000497717561094392,0.0677364855394064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,39328,-0.00780004923194049,0.00426973476777478,-0.0161687293767791,0.000568630912898082,0.0677541737344492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,41709,0.0140174849102368,0.00772042454058716,-0.00111454718931404,0.0291495170097876,0.0694489807941642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,39334,-0.00637840411994867,0.00351502038478853,-0.0132678440741342,0.000511035834236845,0.0696111979710146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,39589,0.0118359830978473,0.00652927065340078,-0.000961387382818264,0.0246333535785128,0.0698965359390723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,39328,0.0079184133834303,0.00437191787096522,-0.000650545643661531,0.0164873724105221,0.0701380055779333
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,41819,0.00434583644385016,0.0024010406417903,-0.000360203214058827,0.00905187610175915,0.0703215300471694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",39334,-0.00953022172060913,0.00526776136675652,-0.0198550339994519,0.00079459055823365,0.0704541563852241
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,39427,-0.0102236178292199,0.00565142348631605,-0.0213004078623993,0.000853172203959585,0.070473430509569
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,41534,-0.0125901555859428,0.00696317486755743,-0.0262379783263554,0.00105766715446973,0.0706132818738623
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,41466,-0.00968012591505183,0.00535681470750337,-0.0201794827417584,0.000819230911654766,0.0707751010208768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,39250,0.00663812617549848,0.00367996592573541,-0.000574607038942932,0.0138508593899399,0.0712822336359641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,41740,-0.0287482607085765,0.0159441045526988,-0.0599987056318662,0.00250218421471322,0.0714008695418898
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,39427,0.015841578827518,0.00878639293917776,-0.00137975133327038,0.0330629089883064,0.0714211497667177
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,41609,-0.00532615205072529,0.00295506509414016,-0.01111807963524,0.000465775533789421,0.0715086796300241
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,41465,-0.014230443079612,0.00790060352674823,-0.0297156259920385,0.00125473983281453,0.0716972424480703
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,39250,0.0132887250404862,0.00738012577634949,-0.00117632148115881,0.0277537715621312,0.0717927230491603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,41534,0.00525338748302052,0.00291888188937045,-0.000467621020145568,0.0109743959861866,0.0719163927070384
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,39328,0.0114501476292577,0.00636863381614155,-0.00103237465037979,0.0239326699088951,0.0722214381484797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,39600,-0.0115831967625405,0.00644323135137737,-0.0242119302112401,0.00104553668615916,0.0722470590470937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,41758,-0.00557608016416026,0.00310260387042724,-0.0116571837501977,0.000505023421877128,0.0723226794604352
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,39334,0.00875742586998312,0.00487280362929663,-0.000793269243438274,0.0183081209834045,0.0723312177269719
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,41736,0.00650085298301505,0.00362872209765036,-0.000611442328379645,0.0136131482944097,0.0732362229373483
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,41740,0.00607338622629678,0.00339329444115997,-0.000577470878376751,0.0127242433309703,0.0735058730772109
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,41805,-0.00730886789868837,0.00408559530303771,-0.0153166346926423,0.000698898895265532,0.0736480607849348
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,41925,0.00570122331475482,0.00318695484863497,-0.000545208188569718,0.0119476548180794,0.0736495961550962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,41765,-0.0245289182844967,0.0137464055540863,-0.0514718731705059,0.00241403660151244,0.074383694946847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,39589,-0.00666392660102192,0.00374397485987186,-0.0140021173263708,0.000674264124326924,0.075118828103345
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,41805,-0.00787087524661205,0.00442407571325915,-0.0165420636446,0.000800313151375874,0.0752462859477362
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",39328,-0.0106741797417977,0.00600652796869383,-0.0224469745604376,0.0010986150768422,0.0755806933363447
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,41466,0.00638957217923997,0.0035958108676574,-0.000658217121368526,0.0134373614798485,0.0756002681215496
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,41465,-0.0109348031998611,0.00615589034762926,-0.0230003482812144,0.00113074188149227,0.0757045644958196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,39589,0.0083064006924742,0.0046868439464271,-0.000879813442522906,0.0174926148274713,0.0763757591081514
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,39655,-0.0141721972382535,0.00800624877412385,-0.0298644448355363,0.0015200503590292,0.0767310448372198
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,39583,0.00463088191824596,0.00262089956243234,-0.000506081224121427,0.00976784506061336,0.0772718201020071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,41534,-0.00759053716487309,0.00429952858772328,-0.0160176131968107,0.000836538867064538,0.0775143196707756
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,41840,-0.0136636145580696,0.00775562805601473,-0.0288646455478585,0.00153741643171923,0.0781316389235399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,39655,0.0113939568404115,0.0064715500820963,-0.00129028132049728,0.0240781950013202,0.0783299601904748
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,39250,-0.00726197720829404,0.00412925380889493,-0.0153553146737281,0.000831360257140027,0.0786630161065208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,41534,-0.00703701474483844,0.00400197965058785,-0.0148808948599906,0.000806865370313754,0.078705936540836
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,41373,0.0125944769910576,0.0071725033946522,-0.00146362966246067,0.026652583644576,0.0791228242234868
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,39408,-0.00571755590845006,0.00326239634045643,-0.0121118527357447,0.000676740918844537,0.0797053583419785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,39328,-0.00900323352304739,0.00513811514518462,-0.0190739392076093,0.00106747216151447,0.0797603582016556
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,39250,-0.0208732064933186,0.0119336931407144,-0.0442632450491189,0.00251683206248158,0.0803027749027834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,41740,-0.012911458053384,0.00738314362611201,-0.0273824195605635,0.00155950345379559,0.0803532442196422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,41673,-0.012828911985767,0.00733683544439577,-0.0272091094567827,0.00155128548524873,0.0803902223816652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,41465,-0.00972609545927664,0.00556981256489954,-0.0206429280864797,0.00119073716792646,0.0807973041718466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,41738,-0.0172482604067902,0.00988388171204985,-0.0366206685624079,0.00212414774882752,0.080992631667003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,39334,-0.0103055519069182,0.00591278705900804,-0.021894614542574,0.00128351072873752,0.0813751289913658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,39241,-0.00676473112348384,0.00388686607661386,-0.014382988633647,0.000853526386679323,0.0818163852852922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,41534,0.00836081686061332,0.00480881665102476,-0.00106446377539521,0.0177860974966219,0.0821213197635342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,39241,0.00776876382019269,0.00447273291198942,-0.000997792687306567,0.0165353203276919,0.0824308390008687
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,41758,0.00635838346770451,0.00366970493304046,-0.000834238201054797,0.0135510051364638,0.0831779731679601
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,39334,0.00839571989790798,0.0048485756245655,-0.0011074883262404,0.0178989281220564,0.0833762441454756
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,39600,-0.0121846689227856,0.00704129246485461,-0.0259856021539006,0.00161626430832944,0.0835763205527289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,39600,0.0211595374963311,0.0122448273208414,-0.00284032405251802,0.0451593990451802,0.0840093217713991
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,41692,0.012249018806869,0.00709225984492366,-0.00165181048918137,0.0261498481029194,0.0841738788787865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,41740,-0.0101838926365121,0.00589934135375284,-0.0217466016898676,0.00137881641684351,0.0843212389304258
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,41715,-0.007525783390763,0.00436871502171836,-0.016088464833331,0.001036898051805,0.0849747298511193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,39250,-0.013341032740455,0.00774696474719025,-0.0285250836449479,0.00184301816403791,0.0850807967159864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,39250,0.0121069776196686,0.00703934352969519,-0.00169013569853401,0.0259040909378711,0.0854793969734287
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,39334,-0.00609385384213921,0.00354769832855953,-0.0130473425661159,0.000859634881837461,0.0858816099662713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,41802,0.00704479602822577,0.00410490697928783,-0.00100082165117838,0.0150904137076299,0.0861509232789529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,39427,0.0111113421992661,0.00647472673881476,-0.00157912220881082,0.023801806607343,0.0861705487831275
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,41521,-0.008540113634847,0.00497745522703939,-0.0182959258798442,0.00121569861015021,0.0862301324725064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,39633,0.00496252466516451,0.00289897207987806,-0.000719460611396483,0.0106445099417255,0.0869575492956353
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,39328,-0.0108636888392473,0.00634953595082912,-0.0233087793028724,0.00158140162437778,0.0871206972270242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,41877,0.00755538575089891,0.00443305754289511,-0.00113340703317551,0.0162441785349733,0.0883431545223956
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",39334,0.00627134121795704,0.00368135075845533,-0.00094410626861542,0.0134867887045295,0.0884953475615081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,39427,0.00495162972281424,0.00290903228253707,-0.000750073550958407,0.0106533329965869,0.0887546443196762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,41465,-0.0144610468729867,0.00850200609457366,-0.0311249788183511,0.00220288507237762,0.0889862712646198
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,41689,-0.0210760895215188,0.012416639053753,-0.0454127020668747,0.00326052302383704,0.0896435208673238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,39241,0.00723066164596994,0.00426439683326241,-0.00112755614722439,0.0155888794391643,0.0899931172678134
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,39600,-0.0159331868122773,0.00940297976702663,-0.0343630271556495,0.00249665353109484,0.0902018975414099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,39308,0.0481352803501578,0.0284185235463674,-0.00756502580072235,0.103835586501038,0.0903324763643939
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,41805,-0.0229684753590954,0.013610480290103,-0.0496450167276974,0.0037080660095065,0.0915197172261158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,41521,0.00933228375835111,0.00553215853432213,-0.00151074696892026,0.0201753144856225,0.0916437477737512
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,39334,-0.00713407517078424,0.00422976825103432,-0.0154244209428115,0.00115627060124304,0.0917026165706067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,39427,0.012462246767149,0.00741560558867994,-0.0020723401866637,0.0269968337209617,0.0928804907630506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,39408,-0.0156322166754631,0.00930269210764027,-0.0338654932064381,0.0026010598555118,0.0929089812265728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,41636,0.00652853676833388,0.00388549016985909,-0.00108702396458994,0.0141440975012577,0.0929355521582032
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,39598,0.00678495020613849,0.00404016865901542,-0.00113378036553174,0.0147036807778087,0.0931077744172108
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,39600,-0.0185185304263681,0.0110426750985475,-0.0401621736195212,0.003125112766785,0.0935715274152941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,39408,-0.0124564821025156,0.00747829224619352,-0.0271139349050549,0.00220097070002367,0.0958050750113399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",39600,0.0124703058693845,0.00748822312320641,-0.00220661145210001,0.0271472231908691,0.0958769241792096
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",39334,-0.00497318434556036,0.00299325596630266,-0.0108399660395136,0.000893597348392854,0.0966496759173378
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,39308,-0.0092857343759826,0.00559852671957315,-0.020258846746346,0.00168737799438077,0.0972250629623071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,39410,0.00936323295348303,0.0056484136616693,-0.0017076578233888,0.0204341237303549,0.0974121402959978
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,39406,0.00680388088079008,0.00411661474479094,-0.00126468401900016,0.0148724457805803,0.0984035904180681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,39427,-0.0152943745938825,0.00925679048450941,-0.0334376839435209,0.00284893475575596,0.0985160609941615
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,41925,0.00733454140595468,0.00444088759598812,-0.00136959828218203,0.0160386810940914,0.0986409946266176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,39600,-0.0138715983559365,0.00840671393352626,-0.030348757665648,0.00260556095377494,0.0989588271379279
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,41593,0.0184910649441079,0.0112148179541755,-0.00348997824607616,0.040472108134292,0.0992114551287271
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,39241,0.00754797964481447,0.00457901864975752,-0.00142689690871027,0.0165228561983392,0.0993034829123278
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,41636,0.00213237661347019,0.00129408201885335,-0.000404024143482378,0.00466877737042276,0.0994196808834981
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,39334,0.00963573688892382,0.00584956092922942,-0.00182940253236585,0.0211008763102135,0.0995342676880142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,39408,0.00799298931077766,0.00485725692915441,-0.00152723427036499,0.0175132128919203,0.0998799968339119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,39308,-0.0128721916683049,0.00784658099550076,-0.0282514904194863,0.00250710708287662,0.100933914879568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,39241,0.00697746011909004,0.00425676418263418,-0.00136579767887296,0.015320717917053,0.10121231410573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,41534,-0.016186744441929,0.00987599341886767,-0.0355436915429097,0.00317020265905163,0.101237766082869
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,41466,-0.0116234458174729,0.00710626120498794,-0.0255517177792492,0.0023048261443035,0.101934678026412
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,39308,-0.0136772900138044,0.00837343664819854,-0.0300892258442736,0.00273464581666472,0.102411319817452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,39427,0.028916912916356,0.0177327149504797,-0.00583920838658419,0.0636730342192963,0.102980643918042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",39241,0.00840135538963995,0.00515654540472452,-0.00170547360362012,0.0185081843829,0.103287499081212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,39598,0.0156220222041974,0.00960017859227628,-0.00319432783666409,0.0344383722450589,0.103709748862935
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,41862,-0.0117175758786542,0.00721405600893118,-0.0258571256561593,0.00242197389885097,0.10434192823757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,41888,-0.0082234820985494,0.00506395361730032,-0.018148831188458,0.00170186699135924,0.104415483767289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,39600,0.00524047956787781,0.0032399680006657,-0.00110985771342697,0.0115908168491826,0.105810297503102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,41846,0.00384770423848943,0.00238412758137632,-0.000825185821008158,0.00852059429798703,0.106576511351754
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,41740,-0.00838016377738248,0.00519559527192073,-0.0185635305103471,0.00180320295558215,0.106782380133521
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,39580,-0.0147267572369735,0.00913991042800992,-0.032640981675873,0.00318746720192593,0.107152161669602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",39598,0.0102077328295891,0.00633848118882047,-0.00221569030049899,0.0226311559596772,0.107330904324644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,39259,0.0128759466083929,0.00800857770286044,-0.00282086568921358,0.0285727589059993,0.107915298368638
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,41521,0.00664709538230965,0.0041383672960655,-0.00146410451797873,0.014758295282598,0.108251764744634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,41863,-0.00483725531137248,0.00301943672386708,-0.010755351290152,0.00108084066740698,0.109170805647836
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,39259,0.00979020008157814,0.00611529510138345,-0.00219577831713343,0.0217761784802897,0.109420584693128
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,39408,-0.00639638749824135,0.00400000263801456,-0.0142363926687499,0.00144361767226718,0.109828543560401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",39250,0.00724227484274424,0.00454454576338327,-0.00166503485348697,0.0161495845389755,0.111051053384486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",39600,-0.0176874628734351,0.0111061398583803,-0.0394554969958605,0.0040805712489903,0.111282233068784
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,39250,0.00725380440938532,0.00456013162869353,-0.001684053582854,0.0161916624016246,0.111706638170845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,39334,-0.00689239991683791,0.00433591282791967,-0.0153907890595605,0.00160598922588464,0.111952736785252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,41728,0.0117416811533209,0.00740395793820056,-0.00277007640555219,0.026253438712194,0.112793917722803
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,41666,0.00686062318445846,0.00433140291350425,-0.00162892652600988,0.0153501728949268,0.113234683086064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,39334,-0.00827456900848552,0.00522629295782324,-0.0185181032058191,0.00196896518884803,0.113392181175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,39334,0.00777965138681358,0.00491747518513488,-0.00185859997605079,0.0174179027496779,0.113669486237143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,39625,-0.00566520657331543,0.00358157319996286,-0.0126850900452426,0.00135467689861178,0.113731948371001
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,41865,0.00505927282357488,0.00320259332780652,-0.00121781009892589,0.0113363557460756,0.114189689256996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,41802,-0.0120849037828259,0.00765270590990165,-0.0270842073662331,0.00291439980058135,0.114321620242914
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,39598,-0.00615067358624856,0.00389598865401847,-0.0137868113481248,0.00148546417562765,0.11442914994538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,41636,-0.00548504887439418,0.00347792947550701,-0.0123017906463879,0.00133169289759955,0.114796365235176
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,41877,-0.00444754842940122,0.00282098581096563,-0.00997668061889385,0.00108158376009141,0.114912870252412
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,39589,-0.00769205144137123,0.00489323277922054,-0.0172827876886435,0.00189868480590102,0.115984577468847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",39408,-0.0175510536606843,0.0111958288203507,-0.0394948781485717,0.00439277082720308,0.116993934164136
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,41765,-0.00768279695092183,0.00490153674891347,-0.0172898089787922,0.00192421507694856,0.117039145953436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,39600,-0.00730135029201861,0.00467495021424055,-0.0164642527119301,0.00186155212789287,0.118363221259988
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,39427,0.00689163717402759,0.00441466637328953,-0.0017611089176199,0.0155443832656751,0.118534648916527
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,41740,-0.00572196878013355,0.0036677325052545,-0.0129107244904324,0.00146678693016528,0.118764244662665
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,41802,0.00699716418411802,0.00448638725295331,-0.00179615483167047,0.0157904831999065,0.118868148512436
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",41466,-0.00972206423867372,0.00624572729045221,-0.02196368972796,0.00251956125061261,0.119591405992216
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,41758,0.00889519901865287,0.00571829235788033,-0.00231265400279258,0.0201030520400983,0.119834636575749
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,39598,-0.00726529999986724,0.00467151279759741,-0.0164214650831582,0.00189086508342368,0.119918895793962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,39259,0.0108155759426773,0.00695488662179451,-0.00281600183603994,0.0244471537213946,0.119950856614295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,41765,-0.0112803693776317,0.00725495387869985,-0.0255000789798834,0.00293934022462,0.120005692973153
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,39328,-0.00523432670607118,0.00336759746434275,-0.011834817736183,0.00136616432404061,0.120137418066081
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,39334,-0.00696822912879592,0.00448334030994968,-0.0157555761362973,0.00181911787870544,0.120154412128452
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,41576,-0.0115715358578556,0.00744658391002517,-0.026166840321505,0.00302376860579369,0.120223397131845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,39334,0.00705450345106255,0.00454742511048852,-0.00185844976549495,0.0159674566676201,0.120854922774719
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,39308,-0.00678565079397416,0.00437787314810743,-0.0153662821642647,0.0017949805763164,0.121173951833232
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,41466,-0.00835638128347118,0.0053979683325838,-0.0189363992153354,0.00222363664839307,0.121632338816683
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,39427,-0.0096603220233005,0.00625564383796511,-0.0219213839457121,0.00260073989911112,0.122555302064575
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,39328,-0.0133309809752547,0.00864274113420873,-0.0302707535983038,0.00360879164779444,0.122994198087501
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,41780,-0.00371085027251361,0.00240657975819148,-0.00842774659856891,0.00100604605354169,0.123107266221691
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,39427,-0.0107974795641021,0.00700836563848387,-0.0245338762155305,0.00293891708732626,0.123429789971755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,39250,-0.0163699529180641,0.0106271106080871,-0.0371990897099148,0.00445918387378669,0.123493697398785
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,39328,-0.0115278353353785,0.00748739972083395,-0.026203138788213,0.00314746811745604,0.123679732527173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,39589,-0.00649185647240115,0.00421986468112817,-0.0147627912474124,0.00177907830261007,0.123978670082308
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,41911,0.0120299748327671,0.00782049350608831,-0.00329819243916596,0.0273581421047002,0.124008122130866
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,41925,-0.00399622087307305,0.00260521024769738,-0.00910243295855991,0.00110999121241381,0.125069603704315
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,39625,-0.00530155963421518,0.00345636074133281,-0.0120760266872275,0.00147290741879714,0.12509377848274
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,39250,0.00657978987698715,0.00429932412916589,-0.00184688541617799,0.0150064651701523,0.125941452540191
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,39545,-0.00770079680070216,0.00504031299752384,-0.0175798102758489,0.00217821667444457,0.126580919338479
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,39625,0.00627218207527462,0.00410540232566428,-0.00177440648302736,0.0143187706335766,0.126594011047641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,39250,-0.00959773403449666,0.00629170600205903,-0.0219294777985324,0.00273400972953904,0.127174565034067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,39427,-0.00646683300678357,0.00424068137510768,-0.0147785685019946,0.00184490248842748,0.127300427793819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,39328,-0.00830429741589171,0.00544750332094615,-0.0189814039249462,0.00237280909316276,0.127432643988238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,41636,-0.0161712522829576,0.0106159513614786,-0.0369785169514557,0.00463601238554046,0.127708546437451
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,41764,0.00538918348528518,0.00354147657949294,-0.00155211061052099,0.0123304775810913,0.128099893628364
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,39241,0.00503751398135527,0.00331372639007565,-0.001457389743193,0.0115324177059035,0.128491405082777
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,39241,0.012788568411063,0.00846569359067406,-0.00380419102665811,0.0293813278487842,0.130911303958481
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,41758,0.0037598094733628,0.00249169236070197,-0.00112390755361306,0.00864352650033867,0.131338618863014
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",39224,0.00427253846380002,0.00283712166021053,-0.00128821999021263,0.00983329691781266,0.132111992945524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,41521,0.00473319839901338,0.00314332104389282,-0.00142771084701656,0.0108941076450433,0.132144146761686
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,39427,-0.010997429963141,0.00730616180933573,-0.025317507109439,0.00332264718315703,0.132294969209642
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,39259,0.0135189770597446,0.00898196523919927,-0.00408567480908597,0.0311236289285752,0.132321669677467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,41703,-0.0166436278894724,0.0110782706783147,-0.0383570384189691,0.00506978264002436,0.133026461484964
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,41534,-0.00677497484576156,0.00451631825032092,-0.0156269586163906,0.00207700892486745,0.133610280628045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,41454,0.0136895191238844,0.00912967686547289,-0.00420464753244242,0.0315836857802113,0.133780775351681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,39655,-0.00429916798673631,0.00287298778453667,-0.00993022404442818,0.00133188807095555,0.134575361867486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,41465,0.00604166905488294,0.00404156708565927,-0.00187980243300922,0.0139631405427751,0.134969563397834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,39250,0.00809859986910322,0.00542540676352656,-0.00253519738740884,0.0187323971256153,0.135540760399402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,41765,0.00544079102557042,0.00364828079718539,-0.00170983933691295,0.0125914213880538,0.135898805419731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,39589,-0.00551378465847411,0.00370323643647632,-0.0127721280739677,0.00174455875701948,0.136539845006088
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,41747,0.00352662301103885,0.00236936215862937,-0.00111732681987471,0.0081705728419524,0.136662260882246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,39655,0.00419775999063236,0.00282068018593916,-0.00133077317380839,0.00972629315507311,0.136724461620146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,41708,-0.0104779195423087,0.0070485104872929,-0.0242930000974028,0.00333716101278536,0.137159392628252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,41534,-0.00748417449625704,0.00503777474478604,-0.0173582129960377,0.00238986400352359,0.137406367787768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,39427,-0.0112305581953026,0.00757872539041823,-0.0260848599605224,0.00362374356991709,0.138408472083343
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,39328,-0.00982356573693295,0.00665778262846015,-0.0228728196887148,0.00322568821484894,0.140107214442937
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,39241,0.0121723912140709,0.00826659573328186,-0.00403013642316152,0.0283749188513034,0.140921064579573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,39636,-0.00557028278908041,0.00378524158564297,-0.0129893562969406,0.00184879071877981,0.141163058942897
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,39308,-0.00435365632104963,0.00295996306407972,-0.0101551839266459,0.00144787128454662,0.141361560022463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,41925,0.0036694318295615,0.00249683951112371,-0.00122437361224097,0.00856323727136398,0.141685428270535
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,41836,-0.0157662049846717,0.0107349309859796,-0.0368066697171918,0.00527425974784837,0.141942698211235
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,39250,0.00499300885315014,0.00340170909185747,-0.0016743409668905,0.0116603586731908,0.142189666308056
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,41740,0.00797636863234575,0.005437123926359,-0.00268039426331789,0.0186331315280094,0.142394592776507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,39427,0.0065707386234983,0.00448746972077891,-0.00222470202922837,0.015366179276225,0.143157054978442
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,39308,-0.00284085434456163,0.001942678720924,-0.00664850463757268,0.000966795948449414,0.143677756061028
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,41740,0.0105566822323129,0.00722524505731708,-0.00360479808002861,0.0247181625446543,0.144016594710962
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,39241,0.00661084861573095,0.00452543812658366,-0.00225901011237303,0.0154807073438349,0.144094486619106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,41740,-0.0106487915209292,0.00729054902870564,-0.0249382676171923,0.00364068457533381,0.144141035109129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,41765,0.00439857525508158,0.00301241293990442,-0.00150575410713109,0.0103029046172942,0.14427266998927
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,39625,0.00753975054911717,0.00516366134022243,-0.00258102567771879,0.0176605267759531,0.144275727404049
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,39334,-0.0142733882613522,0.00977869699409421,-0.0334396343697769,0.00489285784707242,0.144417995024328
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,41750,0.00507799532683967,0.00347980730182606,-0.00174242698473942,0.0118984176384188,0.144513356937519
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,39258,-0.00870427324227306,0.0059702585001239,-0.0204059799025159,0.00299743341796977,0.144886797513418
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,41727,-0.00771004345343692,0.00531241424433129,-0.0181223753723262,0.00270228846545241,0.146713077841801
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,39334,0.00451176272263349,0.00310951299714677,-0.00158288275177418,0.0106064081970412,0.146821676548068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,41891,0.00595334844104599,0.00410658997245743,-0.00209556790497056,0.0140022647870625,0.14716409526751
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,41502,-0.00562604787215346,0.00388256483291189,-0.0132358749446608,0.00198377920035384,0.147346679104616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,41720,-0.00674764565477939,0.00465917131023137,-0.0158796214228329,0.0023843301132741,0.147570993771148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,41765,-0.0101611476410894,0.0070309300094705,-0.0239417704596516,0.00361947517747275,0.148423617388319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,39595,-0.00944911608276531,0.00654193544431577,-0.0222713095536242,0.00337307738809359,0.148657369529817
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,39328,-0.00618102791669362,0.0042805123378838,-0.0145708320989459,0.00220877626555863,0.148770273531299
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,39250,0.00555001326551282,0.00384574472628421,-0.00198764639800424,0.0130876729290299,0.149005672183673
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,41765,0.00602104722557502,0.00417602352442411,-0.00216395888229624,0.0142060533334463,0.149378771227942
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,41764,-0.00531468999225542,0.00369624158390532,-0.0125593234967099,0.001929943512199,0.150496625014139
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,39328,0.00554820114601173,0.00386918543532606,-0.00203540230722734,0.0131318045992508,0.151616953848504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,39241,0.0178520017121668,0.0124495994310034,-0.0065492131725999,0.0422532165969335,0.151618239687563
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,39589,-0.00995355148413405,0.00694807714272,-0.0235717826838652,0.00366467971559715,0.152011484886891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",39598,-0.0151351885615242,0.0105760108075852,-0.0358641697443911,0.00559379262134277,0.152433777524031
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,41747,-0.011665141662528,0.00818304049666615,-0.0277039010359937,0.00437361771093762,0.154028785807696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,39408,-0.0126747223491735,0.0088967129350055,-0.0301122797017842,0.00476283500343731,0.15428661347218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,39250,0.00596561399928582,0.00419291757428228,-0.00225250444630745,0.0141837324448791,0.154828211516148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,41466,-0.00445719586888688,0.00313710615093327,-0.0106059239247161,0.00169153218694233,0.15539956668583
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,41911,0.00139148815020689,0.000980510579097113,-0.000530312584823455,0.00331328888523723,0.155879726790629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,39408,-0.0126792261663126,0.00893877160276011,-0.0301992185077224,0.00484076617509721,0.15608742477612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,39241,0.00506220124173936,0.00357251248317283,-0.00193992322527939,0.0120643257087581,0.156516209197886
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",39328,-0.0116419458316608,0.00824148039084622,-0.0277952473977194,0.00451135573439774,0.157801284276515
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,39427,0.0110898345613357,0.00785646649826508,-0.00430883977526388,0.0264885088979352,0.1581097667904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,39328,-0.00549583774223469,0.00390355649336181,-0.0131468084692238,0.00215513298475447,0.159188099266438
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",41617,-0.0145368776518957,0.0103443531410209,-0.0348118098082967,0.00573805450450528,0.159957154894844
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,39600,-0.0117245806740075,0.00836831547366762,-0.028126479002396,0.00467731765438108,0.161221891090781
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,41689,0.0038478628824603,0.0027500440370618,-0.00154222343018082,0.00923794919510143,0.161776575210568
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,41925,-0.0106827050058218,0.00764167589907469,-0.0256603897680082,0.00429497975636461,0.162150401337075
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,41562,-0.00504485361420218,0.00361301010107508,-0.0121263534123093,0.00203664618390498,0.162647450268011
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,39328,-0.0115480499479761,0.00828942267689981,-0.0277953183946997,0.00469921849874753,0.163616403728795
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,41465,-0.0146279379344292,0.0105016795676897,-0.0352112298871011,0.00595535401824262,0.163669825596229
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,39334,-0.00253605803434367,0.00182363500181794,-0.00611038263790683,0.00103826656921949,0.164357085170217
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,41694,-0.00646552967750006,0.00466821739527561,-0.0156152357722403,0.00268417641724014,0.166072880653624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,39169,-0.0122695776603484,0.0088813391828437,-0.029677002458722,0.00513784713802528,0.167154218628941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,39328,-0.00552744446499153,0.00400213330120835,-0.0133716257353599,0.00231673680537684,0.167269442267496
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,41752,-0.00460060982317113,0.00333194973906611,-0.0111312313117407,0.00193001166539845,0.167377437909667
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',39250,-0.00635875938909269,0.00460587829095932,-0.015386280839373,0.00266876206118757,0.167438716545211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,39598,-0.0147046604166141,0.0106517234718942,-0.0355820384215267,0.00617271758829855,0.167462071554448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,41636,0.00749019423747686,0.0054395120098361,-0.00317124930180189,0.0181516377767556,0.168536677239922
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,41689,-0.00832692721255522,0.00604833416315272,-0.0201816621723345,0.00352780774722411,0.168619076649615
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,41534,0.00893417689619867,0.0064906747921909,-0.00378754569649549,0.0216558994888928,0.168702010013126
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,41465,-0.00676945303698536,0.00492641255148705,-0.0164252216379,0.00288631556392925,0.169430195633415
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",41521,-0.0122081568317087,0.00890153474212623,-0.0296551649262761,0.00523885126285868,0.17025339018102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,39241,0.00942262138195649,0.00687140442718954,-0.00404533129533501,0.022890574059248,0.170316517103202
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,39308,-0.0113072765086789,0.0082565808725203,-0.0274901750188187,0.00487562200146086,0.170875953467467
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",39250,0.0122833997669713,0.00897128785458259,-0.00530032442801053,0.0298671239619532,0.170968689195367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,39625,-0.0103727046563219,0.00758221356907086,-0.0252338432517008,0.00448843393905701,0.171330193951378
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,41465,0.0179978080406006,0.0131647264544389,-0.0078050558100996,0.0438006718913007,0.171610457878912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",39250,0.00804157996697437,0.00588231650068414,-0.00348776037436654,0.0195709203083153,0.171630005541104
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,39655,0.00413255200966836,0.00302722813917411,-0.00180081514311289,0.0100659191624496,0.172240798143352
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,41534,0.00923490776603877,0.00676780914632886,-0.00402999816076579,0.0224998136928433,0.172423203532368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,41686,-0.00659772882415077,0.00484001321228852,-0.0160841547202363,0.00288869707193473,0.172854475174701
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,39595,-0.00289607660244258,0.00212470653136531,-0.00706050140391858,0.00126834819903343,0.172895352927365
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,39241,0.0036866226795018,0.00270730004934131,-0.00161968541720717,0.00899293077621078,0.173310657616155
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,39596,-0.00450542536971858,0.00330881841382459,-0.0109907094608148,0.00197985872137762,0.173338862463606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,41840,-0.00886287736424236,0.00651224030119667,-0.0216268683545878,0.00390111362610311,0.173550522905016
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,41636,0.00884376927929741,0.00650081228220073,-0.00389782279381603,0.0215853613524108,0.173723774537035
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,41925,-0.0127374065190394,0.00936667145079127,-0.0310960825625903,0.00562126952451147,0.173895728939325
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,41534,0.00877903218351407,0.00646026503000856,-0.00388308727530271,0.0214411516423309,0.174193240985019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,41925,-0.00249419445178466,0.00183601487919975,-0.00609278361501616,0.00110439471144684,0.174333565282916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,39600,-0.012344019138081,0.00909555814029625,-0.0301713130930616,0.00548327481689965,0.174762013889148
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,39221,-0.0124373646724239,0.00917777692037561,-0.0304258074363601,0.00555107809151233,0.175395110448997
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,39334,-0.0086872385920216,0.00642267069061624,-0.0212756731456294,0.00390119596158622,0.176215217765977
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,39328,-0.00516901111018551,0.00382301824658254,-0.0126621268734873,0.00232410465311627,0.176379515401212
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,41740,0.00698506173189168,0.005167650431163,-0.0031435331131878,0.0171136565769711,0.176497752913879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,39334,0.00315158808634461,0.00233496712946373,-0.0014249474874043,0.00772812366009352,0.177129295800077
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,39259,0.00698502030068745,0.00518116079286659,-0.00317005485333106,0.017140095454706,0.177636408367164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,41805,-0.0041460782423133,0.00308392686757648,-0.0101905749027632,0.00189841841813659,0.178837246129123
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,41866,0.00596909454588394,0.00444418726271528,-0.00274151248903801,0.0146797015808059,0.179254804430458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,41758,0.0108553900731456,0.00808507820172273,-0.00499136320223097,0.0267021433485221,0.179410103329273
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,41739,0.00476088317990562,0.00354732809133929,-0.00219187987911939,0.0117136462389306,0.179585471412121
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,41354,-0.0177087346984861,0.0131974335967373,-0.0435757045480912,0.00815823515111908,0.179674461023971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",41466,-0.00398459851640792,0.00297001317613032,-0.00980582434162335,0.00183662730880751,0.179746254512505
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,41534,-0.00807049364677685,0.00601760793865635,-0.0198650052065433,0.0037240179129896,0.179896452027466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,41840,-0.00990981307353794,0.00739214779341795,-0.0243984227486371,0.00457879660156123,0.180077764174328
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,41465,-0.0051520539099279,0.00385023839181985,-0.0126985211578948,0.00239441333803901,0.180883265083748
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,41689,-0.00297139746420206,0.00222368229028491,-0.00732981475316049,0.00138701982475637,0.181490508103523
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,41465,-0.0108221153951594,0.0081020705747563,-0.0267021737216817,0.00505794293136295,0.181663725042811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,39259,0.00585412792045399,0.00438668292143251,-0.00274377060555373,0.0144520264464617,0.182061120175564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,39589,0.00507908018751813,0.00381096667467093,-0.00239041449483689,0.0125485748698732,0.182640254772929
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,39427,-0.0105915487297438,0.00795439886251155,-0.0261821705002665,0.0049990730407788,0.183041555134471
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,39385,0.00411759416127902,0.00310062452017028,-0.00195962989825472,0.0101948182208128,0.184209961026671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,39250,-0.0138847519176518,0.0104631318541041,-0.0343924903516958,0.00662298651639221,0.184531569167643
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,39328,-0.0104713473996808,0.0078927246694658,-0.0259410877518337,0.0049983929524722,0.184633262460847
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,41704,-0.00375517736527939,0.00283063614546154,-0.00930322421038401,0.00179286947982522,0.184657669850972
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,39598,-0.00398035547441844,0.00300340400469284,-0.0098670273236164,0.00190631637477952,0.185105364907285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,39327,0.010036516151631,0.00758175319993949,-0.00482372012025039,0.0248967524235124,0.185606831282307
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,41534,-0.00993149726773035,0.00751556621938151,-0.0246620070577181,0.0047990125222574,0.186372419657422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,41521,0.0196056574090253,0.0148792621466847,-0.00955769639847679,0.0487690112165274,0.187644254730917
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,41765,0.0116406192851815,0.00884979110505927,-0.00570497128073464,0.0289862098510977,0.18841344186596
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",41925,0.00416006823053494,0.00316451034280253,-0.00204237204135803,0.0103625085024279,0.188666684079987
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,41786,-0.00457049106470562,0.00347803217102293,-0.0113874341199106,0.00224645199049933,0.188834544083229
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,39250,0.00960128341796391,0.00730735430579509,-0.00472113102139446,0.0239236978573223,0.188901223223087
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,39427,0.00961882639496581,0.0073250724882951,-0.00473831568209259,0.0239759684720242,0.189164493724398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,41465,-0.00437481538787319,0.00333638153530001,-0.0109141231970612,0.00216449242131484,0.189798225433652
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,39241,-0.00803494162774888,0.00612812468634177,-0.0200460660129788,0.003976182757481,0.189832575162844
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,41640,0.0178003156775388,0.0136115211813341,-0.00887826583787594,0.0444788971929535,0.190984940180538
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,39241,-0.00822286799347629,0.00631136906419513,-0.0205931513592987,0.00414741537234616,0.192648715875428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,41689,-0.00625164915895008,0.00480431339818726,-0.0156681034193971,0.00316480510149696,0.193193211181461
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,41689,-0.0263887766147003,0.0202848284756676,-0.0661470404270087,0.0133694871976082,0.193311481921317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,39259,0.00647521337463954,0.00498140999048044,-0.00328835020670212,0.0162387769559812,0.193671713052448
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,41521,0.00377948212418416,0.00290806272196893,-0.00192032081087495,0.00947928505924326,0.193741970080071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,39600,-0.00630893439480687,0.00486156095292444,-0.0158375938625388,0.00321972507292503,0.194411521856848
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,41663,0.00299530087784266,0.00230975492768386,-0.00153181878041771,0.00752242053610303,0.194721323534727
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,39328,-0.00700366340803446,0.00541284856441744,-0.0176128465942926,0.00360551977822373,0.195729181747743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,41534,0.00506494639914419,0.00391625028721322,-0.00261090416379371,0.0127407969620821,0.195925130405446
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,41666,0.00453842844105066,0.00354179369833554,-0.00240348720768699,0.0114803440897883,0.200078521667945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,41534,0.00396980297552756,0.00309887516154151,-0.0021039923410938,0.0100435982921489,0.20020032512603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,39427,-0.00775470838962258,0.00605871857875412,-0.0196297968039807,0.0041203800247355,0.200598762874434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,41534,0.0058196614170986,0.00456812087637926,-0.00313385550060476,0.014773178334802,0.20269597243497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,39427,0.00505527875926021,0.00397391066614664,-0.00273358614638719,0.0128441436649076,0.203358922709372
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,39250,0.00773371073343136,0.00609056193400195,-0.00420379065721246,0.0196712121240752,0.204188585852872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,41728,-0.00542030460712306,0.00427332951648835,-0.0137960304594402,0.00295542124519411,0.204676510035403
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,41521,-0.00786723922829983,0.00620542590281231,-0.020029873997812,0.0042953955412123,0.204892211938387
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,39427,0.00526159855266608,0.00415075400808326,-0.0028738793031771,0.0133970764085093,0.204959246667267
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,41465,-0.0062835572659247,0.00496117019799058,-0.0160074508539862,0.00344033632213683,0.205340097364074
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,41281,0.00317501831888488,0.00251725739116797,-0.00175880616780434,0.00810884280557411,0.207223758544247
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,41534,-0.00428910978632487,0.00340353380381092,-0.0109600360417943,0.00238181646914453,0.207622449984064
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,39579,-0.00819543769841278,0.00651129287216619,-0.0209575717278585,0.00456669633103295,0.208183601230202
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,39241,0.00534807602922574,0.00425484381112522,-0.0029914178405797,0.0136875698990312,0.208803577250994
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,41466,-0.00883511238462941,0.00703202311016896,-0.0226178776805606,0.00494765291130175,0.208989745447269
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,39328,-0.00815289752552484,0.00650306870463174,-0.0208989121866031,0.00459311713555337,0.209978371091945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,41877,0.00831037881734435,0.00663513435634902,-0.00469448452109972,0.0213152421557884,0.210416757149038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,41666,0.00530848492343625,0.00423977072276976,-0.00300146569319248,0.013618435540065,0.2105671830616
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,39250,0.00644645864253856,0.00515043329503294,-0.003648390615726,0.0165413079008031,0.210730663384721
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,39650,0.00245073983078737,0.00195903873661203,-0.0013889760929722,0.00629045575454695,0.210964246424054
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,39328,0.00478150413663158,0.00382743035025798,-0.00272025934987406,0.0122832676231372,0.21159261630397
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,39250,-0.00524450887229879,0.00420495801576998,-0.013486226583208,0.00299720883861038,0.212344168496524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,41723,-0.0149327766535419,0.0119877021047147,-0.0384286727787827,0.00856311947169897,0.212906102502036
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,41534,-0.00563994740039687,0.00453005746960594,-0.0145188600408245,0.00323896524003076,0.213152209022809
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,39600,0.0103242622826753,0.00834310079255334,-0.00602821527072925,0.0266767398360798,0.215942379270297
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,39334,0.0115644275327349,0.00935199501670318,-0.00676548270000331,0.0298943377654732,0.216272585067246
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",39250,0.0053378634008393,0.00431940329158749,-0.00312816705067217,0.0138038938523508,0.216564922306727
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,39427,-0.00549224799278321,0.00444795680342368,-0.0142102433274936,0.00322574734192721,0.216939198268887
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,39241,0.00526968995802298,0.00427872866580192,-0.00311661822694878,0.0136559981429947,0.218125082136444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,41758,-0.00577865976614692,0.00470629791283882,-0.015003003675311,0.00344568414301717,0.219522703351581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,39221,0.010060206199686,0.00820806129464388,-0.00602759393781604,0.026148006337188,0.220357779154459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,39600,0.00780127051341331,0.0063667287754255,-0.00467751788642067,0.0202800589132473,0.220481478197262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,39250,-0.00853347201990555,0.00697902198800861,-0.0222123551164024,0.00514541107659133,0.221458074467174
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,39308,0.00618312035722699,0.00506038473593856,-0.00373523372521259,0.0161014744396666,0.221784581601797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,41637,0.00621543134713408,0.00509813678563817,-0.00377691675271672,0.0162077794469849,0.222806503040634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,41521,0.00778287647344222,0.00639140440380727,-0.00474427615802002,0.0203100291049045,0.223356467149773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",39334,-0.00577410941196717,0.0047437154840178,-0.0150717917606421,0.00352357293670772,0.223550164891425
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,39241,-0.00383358817104202,0.00314963179067177,-0.0100068664807587,0.00233969013867464,0.223572471261587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,39598,-0.0109938565568149,0.00904242621597515,-0.0287170119401262,0.00672929882649635,0.224084064246819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,39328,-0.00847516345712751,0.00697317017459984,-0.0221425769993432,0.00519225008508819,0.224241821496111
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,41802,-0.0108113011457464,0.00891606934992591,-0.0282867970716012,0.00666419478010835,0.225318410537383
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,41765,-0.00554420035763056,0.00457565697045182,-0.0145124880197161,0.00342408730445501,0.225659296373544
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,39259,0.00933828646115646,0.0077073018733369,-0.00576802521058387,0.0244445981328968,0.225686455090498
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,41465,0.0113473641595398,0.00938324690283237,-0.00704379977001166,0.0297385280890912,0.226561497617238
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,41708,-0.0100066093593549,0.00828057721413663,-0.0262365406990627,0.00622332198035287,0.226898531953555
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,39259,-0.00614260494514064,0.00511895344936688,-0.0161757537058997,0.00389054381561844,0.230176571278757
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,41689,0.0108467081563294,0.00906872441506954,-0.00692799169720692,0.0286214080098657,0.231696118421042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,39328,-0.0070446103383436,0.00591040862460851,-0.0186290112425763,0.00453979056588907,0.2333272017726
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,41732,0.00542692668208396,0.00455345226123967,-0.00349783974994579,0.0143516931141137,0.233350681820603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,41896,-0.00659983267216988,0.00555077834173176,-0.0174793582219641,0.00427969287762436,0.234463933436919
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,39259,-0.00746665513869745,0.00628034363127596,-0.0197761286559983,0.00484281837860343,0.234508350805321
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,39259,0.00960605693140001,0.00808909290906268,-0.00624856517036283,0.0254606790331629,0.235044292228465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,41689,0.00413084073730111,0.00348755221286862,-0.00270476159992139,0.0109664430745236,0.236255404897841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,39308,-0.0149052715852958,0.0126012124892448,-0.0396036480642155,0.00979310489362393,0.236897146371018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,39250,0.0062557405390481,0.00529426123010207,-0.00412101147195196,0.0166324925500482,0.23738772774209
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,41786,-0.0108934568760806,0.00928470470356264,-0.0290914780950634,0.00730456434290215,0.240709113344566
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,41617,-0.0093057181412362,0.00793159792002318,-0.0248516500644816,0.00624021378200923,0.240718505974999
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,41466,0.00562905352148959,0.00479812474564813,-0.00377527097998074,0.0150333780229599,0.240746223814124
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,41740,-0.00763092113599692,0.0065154644208839,-0.0204012314009294,0.00513938912893552,0.24153906509716
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,39600,0.00927638587247155,0.00794098359680699,-0.00628794197727015,0.0248407137222132,0.242765189053149
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,41925,0.0050606293659088,0.00433587238459097,-0.0034376805078895,0.0135589392397071,0.243169202722032
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",39600,-0.00516644730645092,0.00444221678243696,-0.0138731922000274,0.00354029758712552,0.244841105798893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,41466,0.0066967351726611,0.00576344406877958,-0.00459961520214687,0.0179930855474691,0.245284283382368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,39589,-0.0138952618007453,0.0119591831055202,-0.0373352606875648,0.00954473708607429,0.245305161954349
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,39334,-0.00542087952909616,0.00467263085784452,-0.0145792360104714,0.00373747695227909,0.246019916475273
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,39328,-0.00770887582466878,0.00666265749424084,-0.0207676845133808,0.00534993286404328,0.247287016688708
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,39598,-0.012090653182295,0.0104578045014392,-0.0325879500051159,0.0084066436405259,0.24765029773189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,41765,0.00431922502109016,0.00374479110783369,-0.00302056555026387,0.0116590155924442,0.248769048237036
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,41802,0.00413185449234774,0.003587925701104,-0.00290047988181611,0.0111641888665116,0.249506421281503
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,41911,0.00969455681442843,0.00842978945402378,-0.00682783051545818,0.026216944144315,0.250149926336295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,39633,0.00392874477833597,0.00341692707780219,-0.00276843229415632,0.0106259218508283,0.250255756132198
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,41534,0.00415698401567708,0.00362065851406215,-0.00293950667188473,0.0112534747032389,0.25093643687443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,41736,0.0107307130868837,0.00935879951846651,-0.00761253396931063,0.0290739601430781,0.251571680296677
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,39250,0.0061433996179454,0.00535891591892842,-0.00436007558315431,0.0166468748190451,0.251660192041508
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",39400,0.00759574708449791,0.00662619529592296,-0.0053915956955111,0.0205830898645069,0.251687737234289
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,41534,-0.00652591699671977,0.00569317067269563,-0.0176845315152032,0.00463269752176366,0.251704203877345
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",39308,-0.00534418802887488,0.00466429519377102,-0.0144862066086661,0.00379783055091632,0.251917841839587
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,39334,0.0040195275712032,0.00353469386915092,-0.00290847241233259,0.010947527554739,0.25549500471827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,39259,-0.0120175381428814,0.010586885675481,-0.0327678340668241,0.00873275778106127,0.256344533650433
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,39259,-0.00472838606145743,0.0041731712710141,-0.0129078017526451,0.0034510296297302,0.257221322443326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,41732,-0.00355884793423458,0.003143990923371,-0.00972107014404174,0.00260337427557258,0.257675134242178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,41650,-0.00558556762253717,0.00493502108482134,-0.015258208948787,0.00408707370371266,0.257729886960306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,39334,0.0033669829147751,0.00298155949503867,-0.0024768736955007,0.00921083952505089,0.258809580745504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,39259,0.00854829557630218,0.00757949187181286,-0.00630750849245102,0.0234040996450554,0.259421717990911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,39650,0.00180140599801418,0.00160079050829542,-0.00133614339824484,0.00493895539427321,0.260476728609496
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,39600,-0.00272076064461257,0.00241853969631024,-0.00746109844938064,0.0020195771601555,0.260630490671353
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,41805,0.00409816406949479,0.0036458841835616,-0.00304776893028595,0.0112440970692755,0.261011322807399
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,39427,0.00623191919029141,0.00555322360190058,-0.00465239906943373,0.0171162374500166,0.261795282080363
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,39250,0.00720120173133475,0.00641806002694099,-0.00537819592146959,0.0197805993841391,0.261878568449
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,39241,0.00598942663996281,0.00536023088893317,-0.00451662590234621,0.0164954791822718,0.263856165434806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,41534,-0.00527751857802384,0.00472587670240162,-0.014540236914731,0.00398519975868334,0.264131410158049
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,41689,-0.003401811600253,0.00304813769609985,-0.0093761614846087,0.00257253828410269,0.264429993635804
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,41466,-0.00346390955858432,0.00310435075644401,-0.00954843704121458,0.00262061792404594,0.26451825190423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,39328,0.00485885165925495,0.00435721831458818,-0.00368129623733789,0.0133989995558478,0.264820994566965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,39241,0.00555663886589958,0.0049845633048205,-0.0042131052115486,0.0153263829433478,0.264974409911678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,39600,-0.0105659243899983,0.0094816247244327,-0.0291499088498864,0.0080180600698898,0.265149979735218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,39600,-0.00741103073162358,0.0066572332723939,-0.0204592079455156,0.00563714648226847,0.265634055570187
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,39655,0.0087237129935844,0.00785053943683342,-0.0066633443026091,0.0241107702897779,0.266495827127675
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,39598,-0.00453141239208027,0.00407796745434302,-0.0125242286025926,0.00346140381843204,0.266509205413498
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,39328,-0.00829521863706928,0.00746760134068859,-0.0229317172648189,0.00634127999068036,0.266667404044572
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,41743,0.00767166967296882,0.00694051399208435,-0.00593173775151651,0.0212750770974541,0.269029907927754
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,39625,0.00403123884503201,0.00365123927233039,-0.00312519012873555,0.0111876678187996,0.269585075664404
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,41686,-0.00348853160709135,0.00316121032763267,-0.00968450384925137,0.00270744063506868,0.269811710462812
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",41447,-0.00549107219827926,0.00498012446709062,-0.0152521161537769,0.00426997175721836,0.270222702091865
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,41534,0.00745119899571985,0.00676761158630537,-0.00581331971343867,0.0207157177048784,0.270913375394472
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,41802,0.00500245338943999,0.00455210635696682,-0.00391967507021497,0.0139245818490949,0.27181795456845
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,39328,-0.0123374539378821,0.0112495769100571,-0.0343866246815941,0.00971171680582985,0.272795504075335
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,39334,-0.00750945699773673,0.00685141484597392,-0.0209382300958456,0.00591931610037214,0.273083798740345
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,39221,0.00623759083924522,0.00572156052631881,-0.00497666779233964,0.0174518494708301,0.275653977082619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,41636,0.012112274788594,0.011121327694742,-0.0096855274931002,0.0339100770702882,0.276128463959251
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,41786,0.00564850648851139,0.00518718862759536,-0.00451838322157551,0.0158153961985983,0.276202856300367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,39259,0.00807201367846287,0.00741440966635564,-0.00646022926759418,0.0226042566245199,0.276314036239406
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,39250,-0.00577346666072575,0.00531003567149282,-0.0161811365768517,0.00463420325540018,0.276940097332523
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,41447,0.0106221922823081,0.00977282491266258,-0.00853254454651053,0.0297769291111268,0.27709647396732
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,39224,0.00561071317933198,0.00517184549295966,-0.00452610398686895,0.0157475303455329,0.278009578449706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,38964,0.0128583017245013,0.0118551391755965,-0.0103777710596679,0.0360943745086704,0.278115944913497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,39259,-0.00945971909972948,0.00875484592653041,-0.0266192171157291,0.00769977891627013,0.279938539423065
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,39427,-0.00749116803911328,0.00693498289414149,-0.0210837345116306,0.00610139843340405,0.280077220568626
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,39633,-0.0159712683171492,0.0147888974529873,-0.0449575073250043,0.013014970690706,0.280188097851049
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,39334,0.0035434826438883,0.00329909092841706,-0.00292273557580914,0.0100097008635857,0.282811642599021
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",41758,0.00434704146736952,0.00404896837226756,-0.00358893654227489,0.0122830194770139,0.283014042388317
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,39328,0.00772239192699078,0.00719935697335858,-0.00638834774079203,0.0218331315947736,0.283452205766102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,39589,0.006166406919132,0.00575365016802405,-0.00511074741019513,0.0174435612484591,0.283861155185622
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,41534,-0.0063746399171337,0.00596200471939945,-0.0180601691671566,0.00531088933288922,0.284994640765211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,41465,-0.00367161003882802,0.00343461780884431,-0.0104034609441629,0.00306024086650683,0.285089253953041
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,39334,-0.00465132936323829,0.00435553693866885,-0.0131881817630292,0.00388552303655266,0.285584307981554
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,41911,0.00676393584579637,0.00633870680893039,-0.0056599294997072,0.0191878011912999,0.285953028974285
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,39259,0.00394092630185193,0.00369681020882699,-0.00330482170744897,0.0111866743111528,0.286432304879369
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",39250,0.00572632018646845,0.00537784419740606,-0.00481425444044744,0.0162668948133843,0.286991285104114
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,41689,-0.00339098066021069,0.00318848239054082,-0.00964040614567069,0.00285844482524931,0.287570671942197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,39600,-0.00751410670138391,0.00707993239389798,-0.0213907741934239,0.00636256079065612,0.288565692553817
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,39241,0.00691020635623533,0.00651691708467181,-0.00586295112972141,0.0196833638421921,0.289009932368732
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,39241,0.00588708262392065,0.00555414760076605,-0.00499904667358081,0.0167732119214221,0.289194363975614
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,39625,-0.00321004061246602,0.00303596154751509,-0.0091605252455956,0.00274044402066356,0.290380056884515
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,39334,-0.00974940369671109,0.00922073099434446,-0.0278220364456262,0.00832322905220406,0.290382416167185
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,39598,-0.00538803033318941,0.00510793890260831,-0.0153995905823017,0.00462352991592288,0.291524180851803
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,39334,-0.00574428477067984,0.00544946464683943,-0.0164252354784851,0.00493666593712544,0.291860518995557
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,39241,-0.00694810952357482,0.00659537375870784,-0.0198750420906422,0.00597882304349255,0.292143922036008
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",41466,-0.00586459771165445,0.00557702198824493,-0.0167955608086145,0.00506636538530562,0.293019203562295
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,39259,0.0054971982062959,0.00523042731048158,-0.004754439322248,0.0157488357348398,0.293280739230822
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,39250,-0.00410267397067782,0.00390371855900248,-0.0117539623463227,0.00354861440496704,0.293298229296366
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,39600,-0.0041944791878304,0.00399244336616881,-0.0120196681855213,0.00363070980986047,0.293463327884294
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,41466,-0.00771201928598399,0.00734140543418803,-0.0221011739369925,0.00667713536502454,0.293515978508965
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,41753,0.0214075756431377,0.0204284567309519,-0.0186321995495281,0.0614473508358035,0.294690498523325
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,39625,-0.00297706843644258,0.00285345475406982,-0.00856983975441943,0.00261570288153427,0.296822658981632
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,41740,0.00493549447513724,0.00473173193118278,-0.00433870010998102,0.0142096890602555,0.296938307758102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,39600,-0.00937720411503151,0.0090180703470486,-0.0270526219952468,0.00829821376518374,0.298444627276274
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,39589,0.00587237158817537,0.00565120053935162,-0.0052039814689538,0.0169487246453045,0.298763886986522
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,39408,0.00383085443371659,0.00369718074945693,-0.00341561983521899,0.0110773287026522,0.300152751575449
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,39462,0.00147976029756973,0.00143020276018156,-0.00132343711238613,0.00428295770752558,0.300855098124835
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,41758,0.00392291599337352,0.00379809912456454,-0.00352135829077297,0.01136719027752,0.301687007025262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,39259,-0.00475798533989419,0.00460795362076854,-0.0137895744366005,0.00427360375681215,0.301833612773101
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,39625,-0.00331919418539459,0.00321531113387701,-0.00962120400779354,0.00298281563700435,0.301950093843516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,39427,0.00678704095084814,0.00657613393457916,-0.00610218156092701,0.0196762634626233,0.302061638632985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,39334,-0.0117044997539941,0.0113475928805022,-0.0339457817997783,0.0105367822917902,0.302352047383516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,39406,0.00557066071546828,0.00540215396999265,-0.00501756106571731,0.0161588824966539,0.302473630855681
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,41832,-0.0064295601813309,0.00624040664764565,-0.0186607572107164,0.00580163684805456,0.302882826275557
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,39334,-0.00397423098561363,0.00386906402357612,-0.0115575964718228,0.00360913450059557,0.304358153883589
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,39334,0.00370281243109655,0.0036277368191365,-0.00340755173441099,0.0108131765966041,0.307422020082918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,39408,0.00286182894925873,0.00280724113334328,-0.00264036367209411,0.00836402157061156,0.308014399217134
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,39334,0.00401857136151785,0.00395332369279995,-0.00372994307637005,0.0117670857994058,0.309412111978933
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,39328,-0.00590696048686351,0.00581426004193133,-0.0173029101690489,0.00548898919532189,0.309679139071634
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,41740,-0.00965299318837262,0.00954952826641703,-0.02837006859055,0.00906408221380476,0.312114232662229
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,39385,-0.0111829756581632,0.0110970175713434,-0.0329331300979964,0.0105671787816699,0.313598998587303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,39259,0.00625609966107795,0.00622255214873881,-0.00594010255045012,0.018452301872606,0.314731300326477
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,41521,-0.00294538175201569,0.00293160279081803,-0.00869132322201904,0.00280055971798765,0.31506007221254
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,41740,-0.00734786892646396,0.00732397044573868,-0.0217028510001118,0.00700711314718385,0.31575243362052
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,39650,-0.00175856422231901,0.00175952883867823,-0.00520724074612833,0.00169011230149032,0.317597774319913
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,41683,0.00386542807096148,0.0038789368411739,-0.00373728813773936,0.0114681442796623,0.319017245358277
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,39598,-0.00732504403180232,0.00739468993636362,-0.021818636307075,0.00716854824347037,0.321911702610891
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,41534,0.00505562464122233,0.00511773457959808,-0.00497513513478991,0.0150863844172346,0.323237844203193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,39625,-0.00326145890787528,0.00330487512503241,-0.00973901415293881,0.00321609633718824,0.323731472531304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,41802,-0.00720989853675111,0.0073150839145594,-0.0215474630092875,0.00712766593578532,0.324337311503818
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,39259,-0.00467591430382257,0.00476011531228988,-0.0140057403159107,0.00465391170826558,0.32596888308379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,39334,0.00309834931644254,0.00316196266381604,-0.00309909750463689,0.00929579613752198,0.327166606454259
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",39250,-0.00656159334518885,0.00671649465406606,-0.0197259228671583,0.00660273617678063,0.328622443641851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,39259,0.00327681231460777,0.00335814472100939,-0.00330515133857064,0.00985877596778618,0.329195367836615
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,39655,0.00274661785574125,0.00282559308263951,-0.00279154458623218,0.00828478029771468,0.331046924619252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",41521,-0.00449668522545099,0.00462669333046512,-0.0135650041531626,0.00457163370226065,0.331118280396266
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,39308,0.00222345373653379,0.00228973559003057,-0.00226442801992612,0.0067113354929937,0.331544011012126
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,39589,0.00498187836515126,0.00513962348252583,-0.00509178366059937,0.0150555403909019,0.332412852037371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,41465,-0.00541461648827279,0.00559297739418611,-0.0163768521808776,0.00554761920433197,0.333007711823588
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,39250,-0.0067223156105839,0.00697635779042091,-0.0203959768798089,0.00695134565864108,0.335275772385492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,39195,-0.00451433285772554,0.0046908323448282,-0.0137083642535888,0.00467969853813773,0.335883970857952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,41534,-0.00370149212278021,0.00384704628262248,-0.0112417028367203,0.00383871859115985,0.335984866499668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,39259,0.00344194111602044,0.00358095981935201,-0.0035767401299095,0.0104606223619504,0.336484294037127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,41521,-0.00486952848587254,0.00507456104313721,-0.0148156681304215,0.00507661115867639,0.337276537779249
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,41415,0.00309495176785539,0.00322997919256019,-0.00323580744956259,0.00942571098527337,0.337982224997092
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,39476,-0.00573901275591728,0.00598937141446906,-0.0174781807282766,0.00600015521644207,0.337983463488996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,39241,-0.00764543441581233,0.00798633405850467,-0.0232986491704815,0.00800778033885683,0.338430223175476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,41689,-0.00322002911858303,0.00336697746934481,-0.00981930495849885,0.0033792467213328,0.338910067176155
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,39250,0.0039980293853767,0.00418486419733254,-0.00420430444139507,0.0122003632121485,0.339420073833056
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",41124,0.00300680823034106,0.00315938150908314,-0.0031855795274619,0.00919919598814401,0.34126352567353
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,39655,0.00289157129650327,0.00304573873456197,-0.00307807662323819,0.00886121921624472,0.342446820527819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,39308,0.00391513184666446,0.004137852159583,-0.00419505838611822,0.0120253220794471,0.344080736978042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,41740,-0.00999805068314658,0.0105821764994386,-0.0307391166220463,0.0107430152557532,0.344777865636206
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,39241,0.00601744180434131,0.00638362501314875,-0.00649446322143024,0.0185293468301129,0.345887953811354
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,41689,0.0032666488410443,0.00347966342465737,-0.00355349147128413,0.0100867891533727,0.347859495716952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,39259,0.00404089553152546,0.00430763473054971,-0.00440206854035197,0.0124838596034029,0.34822580147204
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,39600,0.00693941138741414,0.00740711668966976,-0.0075785373243386,0.0214573600991669,0.348852530786377
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,39250,0.00745999753026673,0.00796287772951696,-0.00814724281958652,0.02306723788012,0.348858546107027
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,39308,-0.00884631924617454,0.00944604428940347,-0.0273605660534053,0.00966792756105627,0.349031551929036
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,39625,0.00986530888414779,0.010546198485721,-0.0108052401478655,0.030535857916161,0.34958339933696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,41465,-0.00479789239824609,0.00513920946013694,-0.0148707429401145,0.0052749581436223,0.350535172087171
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,41443,-0.0116359088398182,0.0125461450716113,-0.0362263531801763,0.01295453550054,0.3537109238935
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,39259,0.00825088910412495,0.0089331013452414,-0.00925798953254819,0.0257597677407981,0.355699388622775
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,39308,-0.00251482468101329,0.00274176462384146,-0.00788868334374256,0.00285903398171597,0.35904356757896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,41865,-0.00454486466860525,0.0049734794490761,-0.0142928843887944,0.00520315505158391,0.360828078554157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,39250,-0.00463736478055071,0.0050839164962918,-0.0146018411132826,0.00532711155218121,0.361703124173633
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,39576,-0.00373092829384141,0.00409024118916584,-0.0117478010246065,0.00428594443692365,0.361707890304046
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,39598,0.0021214646884068,0.00232752371297547,-0.00244048178902512,0.00668341116583872,0.362068520742783
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,39334,0.004548958390346,0.00499468866813246,-0.00524063139919362,0.0143385481798856,0.362442743469537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,39416,0.00211901340731499,0.00233507402293354,-0.00245773167763474,0.00669575849226473,0.364177667701629
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,41521,-0.00811773802070364,0.00895305533906224,-0.0256657264852656,0.00943025044385835,0.364582209395773
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,41824,0.010772177016934,0.0118886628863638,-0.0125296022403391,0.034073956274207,0.36490568530611
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,41465,0.00306472230493228,0.00338323446915007,-0.00356641725460186,0.00969586186446642,0.36502918734454
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,39241,-0.00361685007168519,0.00400925195531997,-0.0114749839041123,0.00424128376074195,0.367010405010217
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,41437,-0.00723015284268745,0.00804126890729424,-0.0229910399009842,0.00853073421560926,0.36859983948482
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,41744,-0.00223200354509739,0.00249556875080492,-0.00712331829667504,0.00265931120648025,0.371131392882021
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,39328,-0.0026325853695912,0.00295070653695528,-0.00841597018202354,0.00315079944284114,0.372312110219606
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,41465,-0.00438282287109325,0.0049246050268213,-0.014035048723663,0.00526940298147651,0.373490771439559
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,39600,-0.00622425719940436,0.00700029454950136,-0.019944834516427,0.0074963201176183,0.373946112498404
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,39241,0.00442746203078278,0.00498388037355291,-0.00534094350138093,0.0141958675629465,0.374369149839585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,39633,-0.00794496567171487,0.008945385431955,-0.0254779211183467,0.00958798977491692,0.374472120863097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,41765,-0.00634647535711474,0.00716950746421383,-0.0203987099869738,0.00770575927274437,0.376062882481166
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,39427,-0.00428158452378395,0.00484024830682425,-0.0137684712051595,0.00520530215759158,0.376403099590351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,39427,0.00806318707890173,0.00914811541238276,-0.00986711912936848,0.0259934932871719,0.378118666894164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,39427,0.00397693671176446,0.00451656730490586,-0.00487553520585103,0.01282940862938,0.378596156603577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,39107,0.0101743014433333,0.0115707739606822,-0.0125044155196037,0.0328530184062704,0.379253128058351
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,41911,-0.00343093790074196,0.00390608521527813,-0.0110868649226871,0.00422498912120318,0.379765781532639
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,41466,-0.00987969593618297,0.0113118637707926,-0.0320509489269365,0.0122915570545706,0.382465528304389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,39259,-0.00681707936621517,0.00788791391140741,-0.0222773906325737,0.00864323190014335,0.387473516025453
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,39397,-0.00307409982291382,0.00355885164597375,-0.0100494490490224,0.00390124940319472,0.387722549222971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,39250,0.00469827159234231,0.00544062431625201,-0.00596535206751164,0.0153618952521963,0.387852521233379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,41521,0.00558603957896063,0.00646939030602153,-0.00709396542084156,0.0182660445787628,0.387902343892141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",39598,-0.00985085937839527,0.0114316300907546,-0.0322568543562742,0.0125551355994837,0.388860640570864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,41765,-0.00420253022150567,0.00487919428243519,-0.0137657510150786,0.0053606905720673,0.389079473545286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,39334,-0.00917364772842953,0.0106895021790778,-0.0301250719994219,0.0117777765425629,0.390805486921021
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,39589,0.00371754208803919,0.00433706579621296,-0.0047831068725382,0.0122181910486166,0.391377352819067
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,39259,0.00555748029751725,0.00648435076256174,-0.00715184719710376,0.0182668077921383,0.391430770075259
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,39259,-0.00840710451279099,0.00981351433910887,-0.0276415926174444,0.0108273835918624,0.39163746694582
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,41466,-0.0067120165919103,0.00783552160382677,-0.0220696389354108,0.00864560575159018,0.391674264215897
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,41740,0.00406402596212272,0.00475493379611347,-0.00525564427825968,0.0133836962025051,0.392734690869826
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,39250,0.00445079112274399,0.00521633493005843,-0.00577322534017053,0.0146748075856585,0.393544829257941
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,39328,0.00379160862499536,0.00444416393425648,-0.00491895268614734,0.0125021699361381,0.393586420443791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,39259,-0.00318890159860261,0.00373796500831905,-0.0105153130149079,0.00413750981770273,0.393616545904706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,39334,-0.00776731965014652,0.0091717565671922,-0.0257439625218432,0.0102093232215502,0.397084389540039
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,39427,-0.00392886725773507,0.00464224703444138,-0.0130276714452402,0.00516993692977004,0.397388063071548
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,39328,-0.00696384537702119,0.00826198856394034,-0.0231573429623442,0.00922965220830187,0.399315674374506
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,41466,0.00413578297883288,0.00491787402016566,-0.00550325010069182,0.0137748160583576,0.400380544992306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,39328,-0.00306580934798398,0.00364901740475337,-0.0102178834613006,0.00408626476533263,0.400829588548047
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,39633,0.00231714817110078,0.00277219259813457,-0.00311634932124298,0.00775064566344455,0.403255164770314
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,39408,0.00572125474270935,0.00684699536906231,-0.00769885618065279,0.0191413656660715,0.403406214171113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,39328,0.00575054443219192,0.00689819445753688,-0.00776991670458037,0.0192710055689642,0.40450786344912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,41534,0.00426483811351858,0.00514513956504651,-0.00581963543397258,0.0143493116610097,0.407172779890535
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,41818,0.00329880884265733,0.0039898675530785,-0.00452133156137653,0.0111189492466912,0.40836729411042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,41429,0.0042127503201962,0.00510575328600491,-0.00579452612037342,0.0142200267607658,0.409330907948694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,39318,-0.00319776406618732,0.00387567030281847,-0.0107940778597115,0.00439854972733688,0.409340726057627
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,39308,-0.0053921151457439,0.0065354432984846,-0.0182015840107737,0.00741735371928592,0.409357444428316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",39589,-0.00328922447756439,0.00399277938874936,-0.0111150720795131,0.00453662312438435,0.410074954788591
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",39250,0.00537517019666233,0.00654674440777663,-0.00745644884257985,0.0182067892359045,0.411639150388051
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,41459,-0.00946029777297747,0.0115249865224897,-0.0320492713570573,0.0131286758111023,0.411746308800355
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,39334,0.00892782027165515,0.0109013809297425,-0.0124388863506402,0.0302945268939505,0.412826090606561
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,41614,-0.00224274802572971,0.00274311942485065,-0.00761926209843698,0.00313376604697756,0.413606095962684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",39408,0.00777910682968788,0.00954949026771153,-0.0109378940950267,0.0264961077544025,0.415313739024894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,39625,0.00463537840713898,0.0057024495081658,-0.00654142262886598,0.0158121794431439,0.416307305768417
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,39250,-0.00504036266798789,0.00620105895017585,-0.0171944382103325,0.00711371287435677,0.416337778083132
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,41765,-0.00350337044354668,0.00432180367837763,-0.0119741056531668,0.00496736476607347,0.417594600739963
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,41736,-0.003734039851451,0.00460714629866279,-0.0127640465968301,0.00529596689392808,0.41767406008333
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,39334,0.00481144641769749,0.00594644186110365,-0.00684357963006567,0.0164664724654606,0.418458122758657
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,41597,-0.00479684308122343,0.00594284620791036,-0.0164448216487277,0.00685113548628088,0.419587591784646
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,39259,-0.00417928091208094,0.00518190535283817,-0.0143358154036438,0.00597725357948187,0.41996434400305
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,39328,-0.00505143455580701,0.00628772031073098,-0.0173753663648397,0.00727249725322571,0.421772396274144
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,39241,-0.0071736611258041,0.0089442727323373,-0.0247044356811852,0.010357113429577,0.422547949316418
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,41466,-0.00945966667553872,0.0118651801005458,-0.0327154196726085,0.0137960863215311,0.425313134544476
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,41637,-0.00499113868686505,0.00626418033972297,-0.0172689321527221,0.00728665477899197,0.425596560535716
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,39259,-0.00628324417665096,0.00789185179945891,-0.0217512737035904,0.00918478535028851,0.425951807833145
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,41765,-0.00416864770052538,0.0052674422181063,-0.0144928344480137,0.00615553904696296,0.428725540032345
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",41521,-0.0078097764956061,0.0098721222188277,-0.0271591360445084,0.0115395830532962,0.428903670135275
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",41465,-0.00663953741163133,0.00839771969047414,-0.0230990680049606,0.00981999318169799,0.429171152445076
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,41466,0.00413225922446052,0.00523013844993215,-0.00611881213740649,0.0143833305863275,0.429492100364632
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,39250,0.00541927103076934,0.00687200316517761,-0.00804985517297878,0.0188883972345175,0.430362590095585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,41534,-0.00237111721646943,0.00301077956649925,-0.00827224516680797,0.00353001073386911,0.430978722987755
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,39600,-0.0218095027087307,0.0277193755036565,-0.0761394786958974,0.0325204732784361,0.431418056885607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,39313,0.00329225112423765,0.00418481121390726,-0.00490997885502058,0.0114944811034959,0.431466491458156
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,39328,0.00484329788797038,0.00615811849387978,-0.00722661436003398,0.0169132101359747,0.43159791664602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,39259,0.00271088953100671,0.00345078753691859,-0.00405265404135372,0.00947443310336714,0.432127674551342
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,41805,0.00366382572281732,0.0046691714121679,-0.00548775024503176,0.0128154016906664,0.432652738760685
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,41925,-0.00272366719155975,0.00347857784862731,-0.00954167977486928,0.00409434539174977,0.43365103172686
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,41836,-0.00245546534289495,0.00314191560618353,-0.00861361993101467,0.00370268924522478,0.434511546774507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,39589,0.00493168119197366,0.00631445663862032,-0.00744465381972216,0.0173080162036695,0.434810884272519
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,41775,0.00793767526522916,0.0101802080271432,-0.0120155324679715,0.0278908829984298,0.435571823136603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,39241,-0.00522241152318227,0.0067467483642489,-0.0184460383171101,0.00800121527074556,0.438910449109904
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",41534,-0.00952266364870504,0.0123121637095034,-0.0336545045193318,0.0146091772219217,0.439278862947172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,41925,-0.00161211215676235,0.00208637044003036,-0.00570139821922185,0.00247717390569715,0.439721108687429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,41740,-0.00699730398199529,0.00907287410958761,-0.024780137236787,0.0107855292727964,0.44058243975868
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,39427,-0.00521369056365517,0.00678532358857657,-0.0185129247972652,0.0080855436699549,0.442279650971374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,39250,0.00323606396217537,0.00422746008975238,-0.0050497578137393,0.01152188573809,0.443998818609319
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,39427,-0.00608761803489977,0.00795571890372683,-0.0216808270862044,0.00950559101640483,0.444176477542196
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,39259,0.00269231828226072,0.00352512380877583,-0.0042169243829399,0.00960156094746134,0.445032302118134
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,41765,0.00209895624754363,0.00275233859697065,-0.00329562740251883,0.0074935398976061,0.445710698819698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,39250,0.00398454949977802,0.00522589594337268,-0.00625820654923243,0.0142273055487885,0.445800923634189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,41466,0.00697850786232352,0.00915357825752465,-0.0109625055224248,0.0249195212470718,0.445847028340189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,41521,0.00183707320130387,0.00244205228998525,-0.00294934928706722,0.00662349568967496,0.4519047413353
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,39589,0.00715044045340598,0.00950537900279726,-0.0114801023920766,0.0257809832988886,0.451915634390688
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,41758,-0.00346067636212083,0.00460537556948012,-0.0124872124783019,0.00556585975406021,0.452399646018309
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,39600,-0.0137855376558264,0.0183511559206603,-0.0497538032603206,0.0221827279486677,0.452543474094982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,39334,-0.00525412221069014,0.00699759450343469,-0.0189694074374221,0.00846116301604186,0.452761253525162
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,39589,-0.00311789190812039,0.00416440808151361,-0.0112801317478871,0.00504434793164628,0.454054129085885
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,39600,-0.00192628710669724,0.00257508137465506,-0.00697344660102115,0.00312087238762667,0.454446580557166
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,41765,-0.00655958665625256,0.00877577525800714,-0.0237601061619466,0.0106409328494414,0.454796148377781
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,39427,-0.00559287610402278,0.0074865276664537,-0.020266470330272,0.00908071812222647,0.45504431279303
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,41734,-0.00189288086897604,0.00253398011673583,-0.00685948189777827,0.00307372015982618,0.455077475538003
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",39334,-0.00340560017959622,0.00456572339565275,-0.0123544180350756,0.00554321767588318,0.455740573650996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,41559,0.013360626582739,0.0179263683514691,-0.0217750553861404,0.0484963085516185,0.456100383279827
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,41802,0.00292929160703393,0.00393671186517583,-0.0047866636487107,0.0106452468627786,0.456831633855
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,41740,0.00959383351838998,0.0129155778816525,-0.0157206991296489,0.0349083661664289,0.457609384667738
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",39241,0.00411316956319969,0.00553863259783814,-0.00674255032856308,0.0149688894549624,0.457720491153044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,41689,0.00310338915331059,0.0041796962203701,-0.00508881543861482,0.011295593745236,0.457802889712402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,39334,0.00207284317568684,0.00279558503944956,-0.0034065035016343,0.00755218985300797,0.458424576937401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,41805,-0.00286195489530329,0.00386812705915795,-0.0104434839312529,0.00471957414064629,0.459385172559129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,39334,-0.00298303412503655,0.00407455375283102,-0.0109691594805854,0.00500309123051226,0.46411553091288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,39408,-0.00287530523691378,0.00393153865455144,-0.0105811209998346,0.00483051052600704,0.464585222333278
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,39250,-0.00373239539789001,0.0051262386359459,-0.013779823124344,0.00631503232856395,0.466570644426508
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,39334,-0.00443417290843416,0.00609727330397165,-0.0163848285842186,0.00751648276735028,0.467095623504283
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,41521,-0.00376117385042029,0.00517331395606793,-0.0139008692043134,0.00637852150347285,0.467218452073607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,39250,0.00311618631872681,0.00428930478300246,-0.005290851055958,0.0115232236934116,0.467547360715416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,39328,-0.00285264962747909,0.00392768210797769,-0.0105509065591154,0.00484560730415718,0.467674764400042
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,39328,0.00528577752292109,0.00728376585943377,-0.00899040356156911,0.0195619586074113,0.468042855672531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,41466,-0.00393821854348394,0.00543618307858226,-0.0145931373775052,0.00671670029053728,0.46880542817018
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,39250,-0.00452386927636002,0.0062646811788546,-0.016802644386915,0.00775490583419499,0.470234820410401
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,41585,0.00900283021095609,0.012469327761385,-0.0154370522013585,0.0334427126232707,0.470308683378697
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,39427,-0.0039719537698887,0.00550678847745675,-0.0147652591857039,0.00682135164592654,0.47075089301173
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,41765,-0.00418685842045021,0.00581418221277074,-0.0155826555574809,0.00720893871658044,0.471469243501952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,39600,0.00337444641684115,0.0047119985404164,-0.00586107072237499,0.0126099635560573,0.473920661950358
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,39427,-0.00284337327226067,0.00397824407769364,-0.0106407316645402,0.00495398512001886,0.47479085851799
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,39259,0.00426727685801364,0.00597250615738848,-0.00743883521046779,0.0159733889264951,0.47494185734465
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,41758,0.00287367795196751,0.00402454546890867,-0.00501443116709349,0.0107617870710285,0.475216416283201
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,41925,-0.00173041276662738,0.00243395227273773,-0.00650095922119333,0.00304013368793857,0.477129090397866
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,39600,-0.00397687440207483,0.0056048254445142,-0.0149623322733226,0.007008583469173,0.478001538323752
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,39259,-0.00464106088491316,0.0065784309353016,-0.0175347855181043,0.00825266374827799,0.480516642765141
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,39334,-0.00464047074875021,0.00658842075399901,-0.0175537754265883,0.00827283392908785,0.481237997849079
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,39334,0.0032128796541299,0.00457196458404367,-0.00574817093059568,0.0121739302388555,0.482236134352727
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,39600,-0.00855800376083975,0.0121979666866866,-0.0324660184667454,0.0153500109450659,0.482948079976737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,39259,-0.00365358044877102,0.00522376921146378,-0.01389216810324,0.00658500720569798,0.484308228895558
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,41465,-0.00400583233367989,0.00574095239846333,-0.015258099034668,0.00724643436730823,0.48533714237918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,39625,-0.00731165123635829,0.0105169355801356,-0.0279248449734241,0.0133015425007076,0.486928084014593
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,41764,0.00256990932191117,0.0037073153829273,-0.00469642882862634,0.00983624747244868,0.488196565863466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,39241,-0.00523299099167555,0.00758187709330727,-0.0200934700945578,0.00962748811120669,0.490085182702497
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,39600,-0.0122067182900193,0.0177208170363327,-0.0469395196812313,0.0225260831011927,0.490941660721326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",39259,-0.00401854038931513,0.00583945339276212,-0.0154638690391289,0.00742678826049864,0.491360305075038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,41925,-0.00251194940137231,0.00369629048921863,-0.00975667876024083,0.00473277995749621,0.496778076188668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,39589,-0.0030895140374435,0.00454623123107541,-0.0120001272503513,0.00582109917546431,0.496786671184864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,39427,0.00200454185544009,0.00295151736716164,-0.00378043218419672,0.00778951589507691,0.497053299035249
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,39259,0.00334029646807355,0.00492639170114333,-0.00631543126616737,0.0129960242023145,0.497760298479876
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,39328,-0.0021786485084377,0.00321389105503537,-0.00847787497630703,0.00412057795943164,0.497859236832486
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,39427,-0.00383751155731442,0.00567939149487883,-0.0149691188872769,0.00729409577264809,0.499251524070971
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,39334,-0.00217001408451382,0.00322044249627351,-0.0084820813772099,0.00414205320818226,0.500437202507398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,41465,-0.00346337643178219,0.00514834213034376,-0.013554127007256,0.00662737414369158,0.501139536697916
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,39250,0.00344509631346436,0.00516726241383667,-0.00668273801765552,0.0135729306445842,0.504968026301911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,41636,-0.00398560368106607,0.00598999771653882,-0.0157259992054822,0.00775479184335002,0.505821487317551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,39655,0.00161457250028974,0.00243268909587844,-0.00315349812763201,0.00638264312821149,0.506897035578263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,39259,-0.00531706213190921,0.00802547394656794,-0.0210469910671824,0.0104128668033639,0.507650339938208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,39308,-0.0051906704607794,0.00784083806072705,-0.0205587130598044,0.0101773721382456,0.507982552674252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,41617,-0.00563715208282612,0.00852889485573953,-0.0223537860000756,0.0110794818344233,0.508657653445894
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,41465,-0.00626369702379599,0.00948454337609039,-0.0248534020409332,0.0123260079933412,0.509001922401761
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,41534,-0.00437553548930719,0.00663784303998101,-0.01738570784767,0.00863463686905558,0.509791719211734
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,39633,0.00595036241710943,0.00904072146032815,-0.0117694516451337,0.0236701764793526,0.510440445443443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,41466,-0.00422757152724339,0.00642774959390965,-0.0168259607313063,0.00837081767681952,0.510738627419083
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",39259,0.0037696628980498,0.00573994508351989,-0.00748062946564918,0.0150199552617488,0.511361015029237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,41836,-0.00190494395724942,0.00290071717554883,-0.00759034962132511,0.00378046170682628,0.511375720928298
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,41534,0.0033444647722106,0.00509392598669175,-0.00663963016170523,0.0133285597061264,0.511475969933244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,39259,0.00366209751458406,0.0055846565575949,-0.00728382933830194,0.0146080243674701,0.512003872376726
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,39250,0.00486004632238401,0.00743134777897023,-0.00970539532439764,0.0194254879691657,0.513130705513409
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,39328,0.00196998981203209,0.00301578172035335,-0.00394094235986048,0.00788092198392466,0.513623995112608
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,41466,-0.0103397762229047,0.0158541291569001,-0.0414138693704289,0.0207343169246195,0.514295479749911
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,39625,0.00460310792610314,0.00706390908247298,-0.0092421538755439,0.0184483697277502,0.51464864506002
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,39427,0.00550020364822324,0.00845325857095251,-0.0110681831508437,0.0220685904472902,0.515279305807158
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,41805,0.00829975100160965,0.0127975940409949,-0.0167835333187403,0.0333830353219596,0.516647057911264
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,41865,-0.00192369299184576,0.00297403810493496,-0.00775280767751828,0.00390542169382677,0.517754052771263
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,39625,0.00193066658284574,0.00299110265243038,-0.0039318946159178,0.00779322778160928,0.518636182533696
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,41785,0.00367247413684587,0.00570170492328287,-0.00750286751278856,0.0148478157864803,0.519521112595085
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,39328,-0.00278265650716414,0.00433642867327058,-0.0112820567067745,0.00571674369244619,0.521086157712345
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,39589,0.00515921566125424,0.0080706672716763,-0.0106592921912313,0.0209777235137398,0.522670281113952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",41636,-0.00393097201662385,0.00615876689083612,-0.0160021551226626,0.00814021108941495,0.52330747178996
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,41350,-0.00178142457460466,0.00280857950273261,-0.00728624039996058,0.00372339125075127,0.525909772340357
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,41758,-0.00165409133564757,0.0026108346409064,-0.00677132723182411,0.00346314456052896,0.526386290103921
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",39241,0.00382872552218064,0.00606033017944823,-0.0080495216295379,0.0157069726738992,0.527551751533542
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,41534,-0.00342103276342218,0.00542540850080566,-0.0140548334250013,0.00721276789815693,0.528340946173906
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,39427,0.00265293367086137,0.00421909482899969,-0.00561649219397802,0.0109223595357008,0.529498410818284
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,41636,-0.00287391132057304,0.00457231379526303,-0.0118356463592886,0.00608782371814249,0.529657080599768
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,39241,0.00203329047991701,0.00324709267260528,-0.00433101115838934,0.00839759211822336,0.531205065962379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,39301,-0.0044502215537838,0.00711723954740502,-0.0184000110666976,0.00949956795913003,0.531804877658649
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,41865,-0.00213839786789236,0.00342061205973254,-0.00884279750496813,0.00456600176918341,0.531882938574129
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,39259,0.00381545544001403,0.00610393807500578,-0.00814826318699729,0.0157791740670254,0.531931308046422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",41911,0.00438637383930475,0.00702201877101609,-0.00937678295188678,0.0181495306304963,0.532204975890932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,39650,-0.0012374440281376,0.00199286989010342,-0.00514346901274029,0.0026685809564651,0.534654748776078
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,41805,-0.00583418827160002,0.00939821521822865,-0.0242546900993282,0.0125863135561281,0.534757602898428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",41465,-0.00331036985774517,0.00534420208818028,-0.0137850059505785,0.00716426623508818,0.535642766474169
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,41732,0.0018854803607654,0.00305068993358664,-0.00409387190906442,0.00786483263059522,0.536552785479794
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,39655,0.00159281392269471,0.0025776851510459,-0.00345944897335526,0.00664507681874468,0.536638063470547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,41466,-0.00388733041489363,0.00629190487325826,-0.0162194639664798,0.00844480313669256,0.536698044765776
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,41740,0.00297819872292449,0.00482326067864199,-0.00647539220721381,0.0124317896530628,0.536938203787526
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",39308,-0.0057889851429399,0.00937716612639677,-0.0241682307506776,0.0125902604647978,0.537017609270756
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,39259,0.00355469609575916,0.00576710284655527,-0.00774882548348916,0.0148582176750075,0.537660432223154
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,41689,-0.00473479098207621,0.00770561403928815,-0.019837794499081,0.0103682125349286,0.538922131227556
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,39334,-0.00581224456620627,0.00946699015780576,-0.0243675452755056,0.012743056143093,0.539262359190992
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,39259,-0.00709291121334689,0.011580841428046,-0.029791360412317,0.0156055379856232,0.540240290920982
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,39259,-0.00326985339851742,0.00534150623089442,-0.0137392056110705,0.00719949881403563,0.540445339687277
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,41466,-0.00250787338901694,0.00410960216596938,-0.0105626936343169,0.00554694685628305,0.541708817650561
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,39427,0.0030945338837461,0.00509277765253278,-0.00688731031521814,0.0130763780827103,0.543444418718551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,39589,-0.00402130962241957,0.00661902078444025,-0.0169945903599225,0.00895197111508333,0.543506188086225
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,39334,-0.00132680892976515,0.00218452188941347,-0.00560847183301556,0.00295485397348526,0.54361949527298
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,39600,0.010131884736413,0.0166817016274353,-0.0225642504533602,0.0428280199261862,0.543621127126531
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,39466,-0.00211364978743035,0.0034844883219367,-0.00894324689842628,0.00471594732356557,0.544136850885469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,39328,0.00311366073971922,0.00515436785148464,-0.00698890024919068,0.0132162217286291,0.545801912783163
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,41465,0.00227657256305942,0.00378862284961764,-0.00514912822219116,0.00970227334831,0.547919097066221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,41466,-0.0041961265636885,0.00700523871820785,-0.0179263944513759,0.00953414132399888,0.549184518766658
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,39259,0.0061472613223612,0.0102872568557866,-0.0140157621149805,0.0263102847597029,0.550145728524274
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,41689,-0.00216013786868216,0.00363239701433412,-0.00927963601677703,0.00495936027941271,0.552063252970023
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,39259,0.00331751708482643,0.00559609832101823,-0.0076508356243693,0.0142858697940222,0.553309643960099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,39589,0.00658762994082073,0.0111758107579412,-0.015316959144744,0.0284922190263855,0.555568664059272
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,39600,0.00234946683374851,0.00400930732373342,-0.00550877552076899,0.010207709188266,0.557885402268226
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,41447,0.00219031686209871,0.00376331260933686,-0.00518577585220154,0.00956640957639896,0.560564557584864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,41810,0.00222533075484137,0.00382817529904396,-0.0052778928312848,0.00972855434096754,0.561046006528718
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,39334,0.00192126252773783,0.00332102156215804,-0.00458793973409193,0.00843046478956758,0.562928257382867
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,41765,-0.00181436796528372,0.00315636071820051,-0.00800083497295672,0.00437209904238928,0.565416712264398
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,39259,0.00209596361733993,0.00369249634393317,-0.00514132921676907,0.00933325645144894,0.570299673762574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,39334,0.00181548921416842,0.00319914061095208,-0.00445482638329766,0.0080858048116345,0.570391295563862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,39328,-0.00303167722833178,0.00536743089477438,-0.0135518417820896,0.007488487325426,0.572202320323099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,41826,0.00933434393332057,0.016560413713142,-0.0231240669444377,0.0417927548110788,0.57299916448315
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,41521,0.00638636778611465,0.0113882292293183,-0.0159345615033492,0.0287072970755785,0.57495266059737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,39589,0.00318160891332437,0.00570843968307156,-0.0080069328654959,0.0143701506921446,0.577298468806025
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,39589,-0.00316164381050082,0.00569990614426797,-0.014333459853266,0.00801017223226441,0.579122462412367
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,39600,-0.00206355345811162,0.00372077908680917,-0.00935628046825759,0.00522917355203435,0.579177840589743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,41758,0.0026297187023872,0.00475050945365317,-0.00668127982677302,0.0119407172315474,0.579885567426127
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,39250,-0.00272077779858392,0.00491989434851485,-0.012363770721673,0.00692221512450519,0.580264408791231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,41689,0.00550448636186725,0.00995568175139402,-0.014008649870865,0.0250176225945995,0.580342022927532
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,39308,0.00137630579199848,0.00251316224221048,-0.00354949220273405,0.00630210378673102,0.583951182253177
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,39427,0.00388996218446208,0.00711218060872881,-0.0100499118086464,0.0178298361775705,0.584428702577243
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,39427,-0.00233444701494795,0.00427760806585969,-0.0107185588240329,0.00604966479413703,0.585258295699547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,41819,-0.00661190109851516,0.0121178953315411,-0.0303629759483358,0.0171391737513054,0.585328718122252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,39427,0.00419512183063024,0.00770595235261822,-0.0109085447805015,0.0192987884417619,0.586177334826909
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,39393,-0.00211813531510652,0.00390390929207668,-0.0097697975275768,0.00553352689736377,0.587438645318934
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,41521,0.00404697879606935,0.00748626865297301,-0.0106261077637577,0.0187200653558964,0.588801664333918
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,41758,-0.00149440447665258,0.00276936068336566,-0.00692235141604928,0.00393354246274412,0.589467738033172
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,41511,-0.00508359462500811,0.0094266655174079,-0.0235598590391276,0.0133926697891114,0.589704250791379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,39427,-0.00363253062939803,0.00675708412605072,-0.0168764155164574,0.00961135425766137,0.590872229308102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,39589,0.00229545827345588,0.00427256974037163,-0.00607877841767251,0.0106696949645843,0.591102553774854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,41585,-0.00390064521165217,0.0072795948505582,-0.0181686511187462,0.0103673606954419,0.592083334436974
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,39408,-0.00723183820268298,0.0135004009115961,-0.0336926239894114,0.0192289475840455,0.592193646726603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,39334,0.00256545133006658,0.00480918054892543,-0.00686054254582726,0.0119914452059604,0.593734027172678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,41534,0.0023372944498922,0.00438951653115755,-0.00626615795117659,0.010940746850961,0.594408307534624
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,39408,0.00160837057289382,0.00302452165651541,-0.00431969187387638,0.00753643301966402,0.594891493935651
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,41878,0.00193668665567133,0.0036761563476849,-0.00526857978579107,0.00914195309713373,0.598324754526443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,41466,-0.00273953461863319,0.00523140722374831,-0.0129930927771799,0.0075140235399135,0.60051662623463
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,39259,-0.00243949763521617,0.00466103294074978,-0.0115751221990857,0.0066961269286534,0.600719791805434
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,41465,0.00408140813631061,0.00782579775366579,-0.0112571554608743,0.0194199717334956,0.602004825253517
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,39633,0.00634174605285931,0.0121646249243448,-0.0175009187988565,0.0301844109045752,0.60214953715549
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,41758,0.00656305537684252,0.0125982553555941,-0.018129525120122,0.031255635873807,0.602410687459944
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,39427,0.00311208101984914,0.00598483111054238,-0.00861818795681393,0.0148423499965122,0.603077835008019
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,39361,-0.00474946244783854,0.00913931401873214,-0.0226625179245535,0.0131635930288765,0.60330160911313
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,39250,0.00216071160253865,0.00417283662617091,-0.00601804818475634,0.0103394713898336,0.604605764904947
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,39241,-0.00200423420735981,0.00388052672469251,-0.00961006658775712,0.0056015981730375,0.605526380499327
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,39600,-0.00241375272910507,0.00467926312943383,-0.0115851084627954,0.00675760300458523,0.605976286121215
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,41746,0.00326528212927111,0.00635017796155268,-0.00918106667537213,0.0157116309339144,0.607118541053781
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,41925,0.000881195223892909,0.00171443512496058,-0.00247909762102983,0.00424148806881564,0.607270476634305
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,39334,0.00214457753685306,0.00417710997410376,-0.0060425580123903,0.0103317130860964,0.607673862274536
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,41925,-0.00137523294327375,0.00269820289576374,-0.00666371061897068,0.00391324473242317,0.610280760117487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,39598,-0.00209015050985115,0.00410139275049724,-0.0101288803008257,0.00594857928112344,0.610328150748291
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,41765,0.00414207723670902,0.00813649446811654,-0.0118054519207994,0.0200896063942174,0.6107089344698
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,39589,0.00190065823916236,0.00374040550524937,-0.00543053655112642,0.00923185302945113,0.611363755069144
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,39334,-0.00308027911739139,0.00608231257055631,-0.0150016117556818,0.00884105352089899,0.612563655202577
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,41689,-0.00404529505552561,0.00799297184389436,-0.0197115198695586,0.0116209297585073,0.612790406976678
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,39241,0.00355390168926089,0.00705462836755378,-0.0102731699111445,0.0173809732896663,0.614434281545458
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,39334,-0.00255063577799751,0.00506433840073256,-0.0124767390434333,0.0073754674874383,0.614520219474164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,41765,-0.001523533077913,0.00303149471901366,-0.00746526272717976,0.00441819657135377,0.615276243781376
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,41521,-0.00265508371667162,0.00529997582381972,-0.0130430363313583,0.00773286889801502,0.616406768430797
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,41521,0.00405222356905578,0.00809956022670191,-0.01182291447528,0.0199273616133915,0.616871193704953
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,41466,-0.00282131373812526,0.00564570632149674,-0.0138868981282589,0.00824427065200836,0.617275632613602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,41790,0.00143132605727814,0.00286977536833705,-0.00419343366466247,0.00705608577921875,0.617957549686142
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,39328,0.00327871899716315,0.006576778066322,-0.00961176601282798,0.0161692040071543,0.61812098298985
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,39328,-0.00411813764431939,0.00829006329101767,-0.020366661694714,0.0121303864060752,0.619371393740369
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,39408,-0.00577000435793064,0.0116298128731592,-0.0285644375893227,0.0170244288734614,0.619806395948422
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,39650,0.00111015512429168,0.00224656823653597,-0.00329311861931882,0.00551342886790217,0.621205849616048
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,39250,-0.00173410199119272,0.00351264791532753,-0.00861889190523468,0.00515068792284924,0.621546802687892
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,39600,-0.00286430628641708,0.00580455683922304,-0.0142412376912942,0.00851262511846008,0.621698705281373
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,39334,-0.00157461551635264,0.00320074080289964,-0.00784806749003594,0.00469883645733067,0.622762303903083
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",41466,-0.0015818914734994,0.00321878392044089,-0.00789070795756353,0.00472692501056474,0.62311217209671
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,39334,0.00284501650720432,0.00580762506542653,-0.00853792862103167,0.0142279616354403,0.624231613368963
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,39250,-0.0022281094970737,0.00455653042983786,-0.0111589091395559,0.0067026901454085,0.624857031113983
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,41466,-0.00169998906600042,0.00347679513082294,-0.00851450752241338,0.00511452939041254,0.624883376388743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,39241,0.00203035984931215,0.00415667212266636,-0.00611671751111391,0.0101774372097382,0.62523551699674
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,41646,-0.00365119063987296,0.00747611820278394,-0.0183043823173295,0.0110020010375836,0.625288532096175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,41577,0.00310653094534212,0.00637090579135022,-0.00938044440570432,0.0155935062963886,0.625832839040912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,41740,0.00291888070298945,0.00601192638865293,-0.0088644950187703,0.0147022564247492,0.627319139086117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,41840,0.00369056265976466,0.00760328023476704,-0.0112118666003787,0.018592991919908,0.627407152847304
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",39334,-0.00321244148748644,0.00664031954799422,-0.0162274678015551,0.00980258482658223,0.628553194378879
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,39600,-0.0024776836073997,0.0051273928933308,-0.0125273736783281,0.00757200646352866,0.628945717826818
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,41534,-0.00202601643943542,0.00419977009869441,-0.0102575658328765,0.00620553295400561,0.62952197834743
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,41740,0.00254941386480895,0.00529937359752594,-0.00783735838634189,0.0129361861159598,0.630468830509694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,41847,-0.00215359396584192,0.00447964875782803,-0.0109337055311849,0.006626517599501,0.630701681391384
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,39259,0.00466260126945463,0.00975996121261164,-0.0144669227072642,0.0237921252461734,0.632854008610968
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,39250,-0.00216518984101187,0.00454229172288663,-0.0110680816178697,0.00673770193584592,0.633604455324936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,41689,0.00421264724589195,0.00887755907741269,-0.0131873685458369,0.0216126630376208,0.635131602024738
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",41534,-0.00364222481022402,0.00767909839922016,-0.0186932576726955,0.0114088080522475,0.635291357967038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,41865,-0.00141226900872044,0.00298650816917921,-0.00726582502031169,0.00444128700287081,0.636304418789484
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,41765,0.00440405949556387,0.0093168098228287,-0.0138568877571804,0.0226650067483081,0.636434795307108
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,41740,-0.00215172909779282,0.00456123550333608,-0.0110917506843315,0.0067882924887459,0.637118358771308
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,39600,0.00248171542092094,0.00526598325135075,-0.00783961175172653,0.0128030425935684,0.637455181498374
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,41466,0.00426590196745708,0.0090819794216496,-0.0135347776989761,0.0220665816338903,0.638569756892327
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,41911,0.00224748160113758,0.0048541120976175,-0.00726657811019271,0.0117615413124679,0.643367846014676
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,41708,0.00426181339814614,0.00920865456462917,-0.013787149548527,0.0223107763448193,0.643511672221774
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,41706,-0.00172768516297966,0.00373801135987491,-0.00905418742833448,0.00559881710237516,0.643950119475713
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,39650,-0.00149670927798603,0.00325744734090586,-0.00788130606616152,0.00488788751018946,0.645903536805817
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",39250,0.00198236469633403,0.00432706893091289,-0.00649869040825522,0.0104634198009233,0.646867629211846
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,39259,-0.00367427928250225,0.00802065555648039,-0.0193947641732038,0.0120462056081993,0.646888417400495
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,39576,0.00177966411299346,0.0038858663739502,-0.00583663397994893,0.00939596220593584,0.646973097365598
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,41465,0.00615672302290438,0.0134537387173871,-0.0202126048631744,0.0325260509089831,0.647231965901864
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,41740,-0.00445949323544902,0.00974752506683536,-0.0235646423664463,0.0146456558955483,0.647319228243412
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,41593,-0.00167009422917926,0.00366920246954526,-0.00886173106948796,0.00552154261112945,0.648997812821853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,39334,-0.00129725501331503,0.0028590365236006,-0.0069009665995722,0.00430645657294214,0.650026208521443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,41636,-0.0033270717229856,0.00739521164220389,-0.0178216865417052,0.011167543095734,0.652793343024006
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,39633,-0.00206731752987891,0.00459693040993744,-0.0110773011333563,0.00694266607359847,0.652923381640664
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,39427,0.00265869177147383,0.00595317323626594,-0.00900952777160741,0.0143269113145551,0.655172269289147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,41805,-0.00102301750563318,0.0023032245744585,-0.00553733767157185,0.00349130266030548,0.656928764615106
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,41740,0.00305366281100981,0.00688802188709819,-0.0104468600877026,0.0165541857097223,0.657534771222208
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,39241,0.0030790890028555,0.00696455898677685,-0.0105714466112271,0.0167296246169381,0.658419857800325
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,39600,0.00159122632846941,0.00360790327228159,-0.0054802640852025,0.00866271674214133,0.659193375401439
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,39221,0.0016973911315848,0.0038532577269631,-0.00585499401326287,0.00924977627643247,0.659578132334117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,41925,-0.00328216527399595,0.00745395408305083,-0.0178919152767756,0.0113275847287837,0.659708593002912
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,39241,0.00254668661635983,0.005785971081741,-0.00879381670385253,0.0138871899365722,0.659838481121188
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,41758,-0.00168011555822659,0.00383408681158973,-0.00919492570894245,0.00583469459248928,0.661244963691806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,41865,-0.00132296228517501,0.00302508866191561,-0.00725213606252961,0.00460621149217959,0.661879098713371
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,41689,-0.00088453192618653,0.00202983714448498,-0.00486301272937709,0.00309394887700403,0.663014446672744
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,41689,-0.00246089037673025,0.00566895458768244,-0.0135720413685878,0.00865026061512733,0.664223340517968
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,41689,-0.00169629087637111,0.00391486408970509,-0.00936942449219308,0.00597684273945086,0.664807639820076
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,39600,0.00258447409532584,0.00599395941433827,-0.00916368635677717,0.0143326345474289,0.666346105077564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,39250,-0.00181375578907125,0.00420896420916485,-0.0100633256390344,0.00643581406089186,0.666530263575268
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,41689,-0.00215740979870947,0.00501727303916038,-0.0119912649554638,0.00767644535804487,0.667205272977581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",39259,-0.00377138483321596,0.00881988336644901,-0.021058356231456,0.0135155865650241,0.66895078067602
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,41705,0.00104879412456708,0.00245637435393247,-0.00376569960914055,0.00586328785827472,0.66940938886283
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,39328,-0.00165202428606154,0.00387397125130877,-0.00924500793862674,0.00594095936650366,0.669794314274103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,41758,0.00152725802299035,0.00362067857439739,-0.00556927198282853,0.00862378802880923,0.673166646859779
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,39625,-0.00323862115918124,0.00768796050079787,-0.0183070237407451,0.0118297814223826,0.673574310120875
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,39241,0.00246229097924359,0.00586040503333803,-0.00902410288609895,0.0139486848445861,0.674379151044027
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,41750,-0.00228493022570723,0.0054470162416098,-0.0129610820592624,0.00839122160784798,0.674870094287218
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,39589,0.00215224802618626,0.00513131660286059,-0.00790513251542049,0.012209628567793,0.67490726765537
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,39308,-0.0023880592883068,0.00570562870600672,-0.01357109155208,0.00879497297546637,0.675557480987607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,39259,0.00252136764832634,0.006044780622954,-0.00932640237266349,0.0143691376693162,0.676602817655112
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,41769,0.00416549124205698,0.010047254905565,-0.0155271283728505,0.0238581108569644,0.678448835348168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,41521,-0.00145708399355124,0.00351738030081443,-0.00835114938314753,0.00543698139604504,0.67869598771524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,39328,-0.00223586204200074,0.00540099915020435,-0.0128218203764013,0.00835009629239978,0.678902939956701
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,39427,-0.00156908949725346,0.00379904179917271,-0.00901521142363197,0.00587703242912505,0.679598355122147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",39250,-0.00219461257701513,0.00532886541311381,-0.0126391887867182,0.00824996363268794,0.680468751714573
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,39427,0.00300204367823844,0.00730351123078942,-0.0113128383341088,0.0173169256905857,0.681050493983296
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",41466,0.00223118115672688,0.00543393335006532,-0.00841932820940115,0.0128816905228549,0.681371605012117
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,41758,0.00232056695574675,0.00566422192534272,-0.00878130801792498,0.0134224419294185,0.682041088248237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,41534,0.00151092777570011,0.00369308306301651,-0.00572751502781224,0.00874937057921247,0.682455665029822
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,39493,0.00134514060274718,0.00335908846718025,-0.00523867279292612,0.00792895399842048,0.688834353991334
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,39625,-0.00457291174317519,0.0114259229385823,-0.0269677207027964,0.017821897216446,0.689000378781221
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,41590,0.00182803255809756,0.00456834262047101,-0.00712591897802562,0.0107819840942207,0.689050965188435
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,39250,0.00216046674725655,0.00542099838435262,-0.00846469008607459,0.0127856235805877,0.690242608937641
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,41802,-0.00192903105657254,0.00486411352430572,-0.0114626935642117,0.00760463145106667,0.691680442013012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,41534,-0.00581430359421082,0.0146781779491418,-0.0345835323745287,0.022954925186107,0.692023855835853
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,41466,-0.00232384420221194,0.00589199307772709,-0.013872150634557,0.00922446223013316,0.693287002388874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,39589,0.00166712130269129,0.00426204432361724,-0.00668648557159851,0.0100207281769811,0.69569001699893
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,39334,0.00243375132207195,0.00628817878243362,-0.00989107909149794,0.0147585817356418,0.698737257952547
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,39241,-0.00318851438658635,0.00824705939240107,-0.0193527507956925,0.0129757220225197,0.699042022511516
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,39420,0.00414097269691335,0.0107320348008968,-0.0168938155128443,0.0251757609066711,0.699614170639164
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,41465,0.00233432293221845,0.0060568112563182,-0.00953702713016522,0.0142056729946021,0.699944045417897
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,39589,-0.00245273960183441,0.00640467795456999,-0.0150059083927916,0.0101004291891228,0.70175635151798
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,39314,-0.00182640989026719,0.00477340064944408,-0.0111822751631776,0.00752945538264321,0.702007368074037
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,39241,0.00126897081416086,0.00332920319708317,-0.00525626745212215,0.00779420908044387,0.703089524987387
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,39427,-0.00123202626974478,0.00323480127915335,-0.00757223677688534,0.00510818423739578,0.703310052741699
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,39328,0.00149069109518714,0.0039213905617304,-0.00619523440580444,0.00917661659617873,0.703846429677611
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,39655,-0.00374417508732184,0.00988994144864392,-0.0231284603266639,0.0156401101520202,0.705003963087858
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,41328,-0.00339328170336111,0.00897264885832976,-0.0209796734656874,0.0141931100589652,0.705302745067559
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",39633,-0.00252070498192488,0.00673504355850379,-0.0157213903565923,0.0106799803927425,0.708212825609001
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,39408,-0.00477346338653974,0.0128101625845909,-0.0298813820523379,0.0203344552792584,0.709430421884181
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,39259,0.003012260516457,0.00809724133966009,-0.0128583325092768,0.0188828535421908,0.709892269034071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,39250,0.00400473881811862,0.0107752925868347,-0.0171148346520774,0.0251243122883146,0.710153848088375
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,39259,0.00191323410543314,0.00515828644415305,-0.00819700732510683,0.0120234755359731,0.710715680409952
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,41447,0.00190469231594392,0.00515968907899587,-0.00820829827888797,0.0120176829107758,0.712023003558091
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,39600,0.00136825393673971,0.00370974058530256,-0.00590283761045331,0.00863934548393273,0.712263486056983
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,39250,0.00176125046435867,0.00477644340869636,-0.00760057861668618,0.0111230795454035,0.712331244832316
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,41581,-0.00109172977363229,0.00296804686872787,-0.00690910163633892,0.00472564208907434,0.71300773029464
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,41877,0.00115190723284966,0.00314597076491204,-0.00501419546637794,0.00731800993207726,0.71425660287702
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,39408,-0.00139597176855065,0.00381352076309849,-0.00887047246422369,0.00607852892712239,0.714328573004443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,41414,-0.00226661903043703,0.00619199755217049,-0.0144029342326912,0.00986969617181712,0.714329190599059
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",41740,0.00322591588712462,0.00881585448311701,-0.0140531588997847,0.020504990674034,0.714429103984724
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,39250,-0.00244349123908089,0.00667990300531525,-0.0155361011294988,0.010649118651337,0.714523515574595
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,41925,0.000979936938379406,0.00268935621555888,-0.004291201244116,0.00625107512087481,0.715583014913036
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,41758,0.00465329270426761,0.0129566891331593,-0.0207418179967246,0.0300484034052598,0.719494541915504
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,39600,-0.00114976489155565,0.00321266945529477,-0.00744659702393341,0.00514706724082211,0.720436549970724
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",41466,-0.00159110238278986,0.00444812258098088,-0.0103094226415124,0.00712721787593266,0.720572197191724
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,41521,-0.000882934489138448,0.00247267953105845,-0.00572938637001301,0.00396351739173612,0.721040750511429
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,41765,-0.00147913270602362,0.00414384596300333,-0.00960107079351014,0.0066428053814629,0.72113732696292
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,39241,-0.00348359308177188,0.0097949232833157,-0.0226816427170706,0.0157144565535269,0.7221075556585
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,39334,-0.000972720237116712,0.0027588860507389,-0.00638013689656495,0.00443469642233153,0.724412377669565
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,41808,0.00101660740534786,0.00290312801802218,-0.0046735235099756,0.00670673832067133,0.726211774821811
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,39328,-0.00125810514294873,0.00364543762223291,-0.00840316288252523,0.00588695259662777,0.730012633675099
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,39600,-0.0028324559743468,0.00821927785165197,-0.0189422405635847,0.0132773286148911,0.730393202224574
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",39625,-0.00192863572178113,0.00560856202439547,-0.0129214172895963,0.00906414584603399,0.730947997231325
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,41802,-0.00400413267562376,0.0116905706694038,-0.0269176511876552,0.0189093858364077,0.731972873849731
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,41765,0.00117323483531695,0.00343237059925611,-0.00555421153922503,0.00790068120985893,0.732495778265551
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,39250,0.00116626184570932,0.00342412207947809,-0.00554501743006773,0.00787754112148637,0.733410157842146
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,39427,0.00209385533819691,0.00618298524535761,-0.010024795742704,0.0142125064190978,0.734881515455507
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,39250,-0.00122834796746188,0.00363858373022974,-0.00835997207871218,0.00590327614378842,0.735679145996673
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,41758,0.00127125267162164,0.00376592482563315,-0.00610995998661933,0.00865246532986261,0.735694753466306
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,39328,-0.00182881927677943,0.0054177961388855,-0.012447699708995,0.00879006115543616,0.735703061823102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,41614,-0.00120675340731921,0.00358256937803595,-0.00822858938826968,0.00581508257363125,0.736242793943113
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,39328,0.00150093586498635,0.00446708441142641,-0.00725454958140942,0.0102564213113821,0.736878196684381
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,41744,0.00209973166221176,0.00625033150980923,-0.0101509180970143,0.0143503814214379,0.736922042382772
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,39600,0.00354994988991872,0.010576181954875,-0.0171793667416363,0.0242792665214738,0.737137335565983
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",39250,-0.00240044147324552,0.00719722327184783,-0.0165069990860673,0.0117061161395762,0.738745889681977
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,39334,-0.00126417434104754,0.00379960079220295,-0.00871139189376532,0.00618304321167025,0.739357877465855
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,41521,-0.00395583601864069,0.0118961458284858,-0.0272722818424729,0.0193606098051915,0.739493809356806
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,41466,-0.00160860706988371,0.00484239330268805,-0.0110996979431523,0.00788248380338486,0.739749266304166
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",41689,-0.00244572150405847,0.00736476087909533,-0.0168806528270853,0.0119892098189684,0.739830917907444
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,39600,-0.00219958558857449,0.00663410666795622,-0.0152024346577687,0.0108032634806197,0.740229986402231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,41408,-0.0022442500589561,0.00677145442074225,-0.0155163007236109,0.0110278006056987,0.740326588704408
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,39241,0.00177148126982814,0.00537712943087279,-0.00876769241468253,0.0123106549543388,0.741824035437612
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,39266,-0.00120977722219275,0.00367378639020829,-0.00841039854700099,0.0059908441026155,0.741935540876453
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,39334,-0.00147407368186524,0.00447727837933521,-0.0102495393053623,0.00730139194163177,0.741985011064969
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,39259,-0.00254712310557353,0.00778367617987195,-0.0178031284181225,0.0127088822069755,0.743493484010631
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,39562,0.000948135593280402,0.00290094354190037,-0.00473771374884432,0.00663398493540513,0.743797436905581
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,39427,0.0015558212675088,0.00477354826215747,-0.00780033332631985,0.0109119758613374,0.744486994985433
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,39600,0.00335225273659092,0.0103095345827818,-0.0168544350456614,0.0235589405188432,0.745065836245157
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,39334,-0.0014312157130686,0.00442332498089314,-0.0101009326756192,0.00723850124948195,0.746276677409069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,39250,0.00161942721216534,0.00501841591618059,-0.00821666798354861,0.0114555224078793,0.746931141917826
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,41758,-0.00248953181761666,0.00774723250269156,-0.0176741075228921,0.0126950438876588,0.747954317521819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,39427,-0.0015231126036959,0.00478927042350926,-0.0109100826337741,0.00786385742638226,0.750471334405134
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,39334,-0.000999469517583593,0.00315004272365374,-0.00717355325594492,0.00517461422077773,0.751031551265265
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,39250,0.00164079301064127,0.00517276185325642,-0.00849782022174132,0.0117794062430239,0.751099101790125
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,41740,0.00112112165976947,0.00356198524833431,-0.00586036942696577,0.00810261274650472,0.752959288491485
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,39259,-0.00250194998534253,0.00796283694069855,-0.0181091103891117,0.0131052104184266,0.75337275315328
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,39625,-0.0011805456822229,0.00378590041770657,-0.00860091050092776,0.00623981913648197,0.755177957591244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,39427,0.00117605041279361,0.00378924982096286,-0.0062508792362936,0.00860298006188083,0.756289402432389
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,41765,-0.00225186079279841,0.0072637232560299,-0.016488758374617,0.0119850367890202,0.756554705019244
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,39334,0.000929691976888854,0.00303800776002907,-0.00502480323276813,0.00688418718654584,0.759595141749071
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,39334,-0.00132371253773081,0.00434655862749162,-0.0098429674476144,0.00719554237215277,0.760720399091896
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,41636,-0.00338837164132331,0.0111863491647388,-0.0253136160042114,0.0185368727215648,0.76196910054722
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,39408,0.00311764073748552,0.0103513744476738,-0.0171710531799551,0.0234063346549262,0.763282018594926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,41802,0.000790311641427867,0.00262730081838652,-0.00435919796260972,0.00593982124546545,0.763566069275675
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,39241,0.000852334556628931,0.00283363529516825,-0.00470159062190084,0.0064062597351587,0.763579058723503
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,39122,-0.00147010490944912,0.00489799812843023,-0.0110701812411724,0.00812997142227412,0.764073222834015
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,39241,0.00198190676999235,0.00664827912022422,-0.0110487203056471,0.0150125338456318,0.765626375032851
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,41866,0.00108992571149517,0.00367809672497306,-0.00611914386945203,0.00829899529244238,0.766983690115262
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,41490,0.00156176544292317,0.00529342968955002,-0.00881335674859488,0.0119368876344412,0.7679692372231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,41466,-0.00147604999185231,0.00502341697260796,-0.0113219472581639,0.00836984727445929,0.768889600900423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,39259,0.0033140131876395,0.0113110962804466,-0.0188557355220359,0.0254837618973149,0.769537182142753
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,41534,-0.00105618705539144,0.00361286439047662,-0.00813740126072562,0.00602502714994275,0.77003088505038
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,39598,0.000829405146078171,0.00284074199821007,-0.00473844917041357,0.00639725946256991,0.770316762915197
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,39598,0.00746594626615953,0.0257425298268226,-0.0429894121944128,0.0579213047267319,0.771803499328664
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,39250,-0.00213646429609161,0.00742399744115872,-0.0166874992807627,0.0124145706885795,0.773522158665685
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,41466,0.00223429234294349,0.00781263159271577,-0.0130784655787794,0.0175470502646664,0.774894518683086
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,41722,-0.000517099379684805,0.00185028679085386,-0.00414366148975838,0.00310946273038877,0.779888674228044
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,39589,0.0016963741646219,0.00609160455837445,-0.010243170769792,0.0136359190990358,0.78065115539799
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,39334,-0.00185348980264146,0.00670132973160831,-0.0149880960765938,0.0112811164713108,0.782103820463103
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,39589,-0.00129577809652071,0.00471077841516744,-0.0105289037902489,0.00793734759720748,0.783270194752423
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,39328,0.000910912484201535,0.0033471128504693,-0.00564942870271828,0.00747125367112135,0.785512905484242
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,39650,0.000430591370796338,0.00158425579379706,-0.00267454998504591,0.00353573272663859,0.78578542301841
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,39334,0.00168614298812538,0.00626228020503983,-0.0105879262137527,0.0139602121900034,0.787739526900762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,41861,-0.00125013668298951,0.00465738819169448,-0.0103786175387107,0.00787834417273168,0.788380131689281
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,41865,-0.00210534766213981,0.00785192950437157,-0.0174951294907081,0.0132844341664285,0.78860246251379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,39334,-0.000756784876926105,0.00285460505329141,-0.00635181078137726,0.00483824102752505,0.790929671329723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,39241,0.00165577791251971,0.00625897229268175,-0.0106118077811365,0.0139233636061759,0.791365353448876
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,41465,0.00152357461509809,0.00576402494599961,-0.00977391427906115,0.0128210635092573,0.791533902943553
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,41521,0.000884727671343793,0.00336057577952137,-0.00570200085651809,0.00747145619920567,0.792349227566156
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,39570,0.0014686551656294,0.00561311791083358,-0.0095330559396044,0.0124703662708632,0.793598558041171
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,39427,0.00212379569330542,0.00815258858781709,-0.0138552779388161,0.0181028693254269,0.794478682977211
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,39589,-0.00127509943962333,0.00493634542951458,-0.0109503364814719,0.00840013760222524,0.796173749241017
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,41877,-0.00164932907014856,0.00639133816539788,-0.0141763518743284,0.0108776937340313,0.796366974881377
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,41465,0.00365411430550812,0.0141798377016652,-0.0241383675897556,0.0314465962007719,0.79664419371029
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,39250,-0.00127504496784873,0.00496724219305031,-0.0110108396662273,0.00846074973052987,0.79742249542764
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,41865,-0.0017765117372735,0.00693754090185145,-0.0153740919049023,0.0118210684303553,0.797899016579012
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,39334,0.00196202505869841,0.00766466843687,-0.0130607250775668,0.0169847751949636,0.79796884535379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,41667,-0.00157995166939213,0.00618585417067071,-0.0137042258439067,0.0105443225051225,0.798407639494644
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,41925,0.000840023880488742,0.0032932062022743,-0.00561466027596889,0.00729470803694638,0.798666926333045
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,39399,0.00056877390004946,0.00224436391056957,-0.00383017936466691,0.00496772716476583,0.799946020384175
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,39565,0.00103462679639927,0.00409087730162409,-0.00698349271478395,0.0090527463075825,0.800341932654048
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,39259,-0.00314542278826293,0.0124980967674016,-0.0276416924523701,0.0213508468758443,0.801299343142143
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,41465,0.00432470997674922,0.0172086554229112,-0.0294042546521567,0.0380536746056552,0.80157833316189
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,41636,0.0015124080758228,0.00613066835080805,-0.010503701891761,0.0135285180434066,0.805147801489966
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,39328,0.00119306597145272,0.0048767934936458,-0.00836544927609306,0.0107515812189985,0.806738723195404
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,39630,0.000582164911631419,0.00239808951390775,-0.00411809053562778,0.00528242035889061,0.808194319231431
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,39328,0.000810801033770256,0.00334897064202957,-0.00575318142460769,0.0073747834921482,0.808703779602288
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,39334,-0.000630201948781813,0.00262838255699978,-0.00578183176050137,0.00452142786293775,0.810514717578489
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,39600,0.0030357682716224,0.012827607380761,-0.0221063421946691,0.0281778787379139,0.812925779389223
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,41838,-0.00159297507011465,0.00677469009814599,-0.0148713676624808,0.0116854175222515,0.814106638538884
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,41447,0.00150953566992035,0.00645424629555711,-0.0111407870693716,0.0141598584092123,0.815079876729579
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,39600,-0.00315914211257654,0.0136608777518321,-0.0299344625061675,0.0236161782810144,0.817121242356598
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,41744,0.000571937447358084,0.00250076607762143,-0.00432956406477991,0.00547343895949608,0.819101846684279
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,39230,0.00200396081996237,0.00876746739208228,-0.0151802752685189,0.0191881969084436,0.819209242971428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,39600,-0.000799349415741009,0.00350182626236303,-0.00766292888997255,0.00606423005849053,0.819443355522932
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,41498,-0.00103900088541188,0.00455792107378352,-0.00997252619002758,0.00789452441920381,0.819684839931597
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,41534,-0.00139940516841963,0.00615079219742008,-0.013454957875363,0.0106561475385237,0.820025931835151
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,41925,-0.00102789371196348,0.0045267387306911,-0.00990030162411804,0.00784451420019109,0.820371566840525
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,39633,0.000731002013735476,0.00322767140532644,-0.00559523394070434,0.00705723796817529,0.820832550872368
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",39598,0.000610747192214484,0.00270871796241233,-0.00469834001411368,0.00591983439854265,0.821614245609335
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,39193,0.000820527274309932,0.00366104956015564,-0.00635512986359513,0.00799618441221499,0.822665522504528
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,41617,-0.000777206432757362,0.00348114699590468,-0.00760025454473053,0.00604584167921581,0.823335418499862
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,39633,0.00220235996432882,0.0098851792911386,-0.0171725914463028,0.0215773113749605,0.823699857549732
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,39241,0.00123977601350647,0.00559144931725429,-0.00971946464831194,0.0121990166753249,0.824530563317562
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,41534,0.000734260226593574,0.00334396122472383,-0.00581990377386512,0.00728842422705227,0.82620331303858
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,39241,0.00180651566793237,0.00832464357129776,-0.0145097857318112,0.018122817067676,0.82820613818416
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,39600,-0.000496526771229291,0.0022979952739357,-0.00500059750814326,0.00400754396568468,0.828937552424955
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,39408,-0.00259675764878525,0.0120734153738458,-0.0262606517815231,0.0210671364839526,0.829708522436762
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,39241,-0.00118804333013834,0.00555811028705739,-0.0120819394927708,0.00970585283249415,0.830746498147861
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",39250,-0.000885423135437773,0.00415382009177927,-0.00902691051532515,0.0072560642444496,0.831207214628364
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,39427,-0.0017967451747427,0.00855208865042942,-0.0185588389295844,0.014965348580099,0.83359801862224
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,39250,0.00123645423788286,0.00589520680905005,-0.0103181511078552,0.012791059583621,0.833875468657747
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,39328,-0.00120395364817593,0.00576718330662977,-0.0125076329291703,0.0100997256328184,0.834640041084854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,39250,0.00234802052113816,0.0112790163562027,-0.0197588515370192,0.0244548925792955,0.835095527252439
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,41465,-0.000887195219456256,0.0042772419520052,-0.00927058944538645,0.00749619900647393,0.835683377691068
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",39250,-0.000846282412737499,0.0040851195280712,-0.00885311668775706,0.00716055186228206,0.83588713535487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,41465,0.000665442759313649,0.00321724066934781,-0.00564034895260806,0.00697123447123536,0.836140832783152
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,39241,-0.000805795621872791,0.00389608184440141,-0.00844211603689955,0.00683052479315397,0.836152794710346
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,39334,-0.00153063081379415,0.00741648118222375,-0.0160669339309527,0.0130056723033644,0.836496171142097
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,39250,0.00103726413864659,0.00503058084887471,-0.00882267432514784,0.010897202602441,0.836645093503607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,39408,-0.00191851908058284,0.00935520305256479,-0.0202547170636098,0.0164176789024441,0.837517322304114
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,39553,-0.000623828058142951,0.00305175523037575,-0.00660526830967942,0.00535761219339352,0.838032107997619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,39334,-0.00161414259625747,0.00790623523235715,-0.0171103636516775,0.0138820784591625,0.838231784281132
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,39328,-0.0022566073130166,0.0110867556676399,-0.0239866484215908,0.0194734337955576,0.838716205983529
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,39533,0.000662148301432791,0.00327282660171068,-0.00575259183792015,0.00707688844078573,0.839672712922945
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,41636,-0.000901959593196413,0.00451131857810222,-0.00974414400627676,0.00794022481988393,0.841536422937524
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,39420,-0.00204337711359964,0.0105937115291845,-0.0228070517108013,0.018720297483602,0.847051982729222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,41534,-0.00192386386630152,0.0100213587416436,-0.0215657269999229,0.0177179992673198,0.847763745094791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,41697,0.00118961250604232,0.00627804747058575,-0.0111153605363058,0.0134945855483904,0.84971356446278
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,39259,0.00105807482901146,0.00558800250028345,-0.00989441007154411,0.012010559729567,0.849824000481509
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,39589,-0.00191285413631096,0.0101194607499009,-0.0217469972061166,0.0179212889334947,0.850074927029936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,39633,-0.000843828515478162,0.00460424024764694,-0.00986813940086616,0.00818048236990984,0.854587937192609
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,41534,-0.000937819691896241,0.00515763732790247,-0.0110467888545851,0.00917114947079261,0.855718001260326
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,39250,-0.00118023762345826,0.00649669714079627,-0.013913764019419,0.0115532887725024,0.855847263463487
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,39241,0.00139171916763883,0.00778750769606432,-0.0138717959166472,0.0166552342519249,0.858167440838237
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,39600,0.000689199481051014,0.0039080760297456,-0.00697062953725036,0.00834902849935239,0.860020164602592
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,39589,-0.000901663936380044,0.00513934836927841,-0.0109747867401657,0.00917145886740564,0.860734598243852
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,41717,-0.0007078845143339,0.00409159493498616,-0.00872741058690678,0.00731164155823898,0.862646683457742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,39259,0.0010616144390728,0.0063018675553754,-0.011290045969463,0.0134132748476086,0.866224377058819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,39241,-0.000999292801102874,0.00596580662281448,-0.0126922737818193,0.0106936881796135,0.866977167670165
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,41534,-0.000913762029622884,0.00545914744353811,-0.0116136910189576,0.0097861669597118,0.867072246434168
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,39589,-0.00177812222734796,0.0106746169654178,-0.0227003714795669,0.0191441270248709,0.867707684975541
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,39259,0.00172244795047093,0.0103843245669373,-0.0186308282007261,0.022075724101668,0.868262400185876
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,41911,0.000845124555171394,0.00515961112232345,-0.00926771324458256,0.0109579623549253,0.86989409142406
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,41465,0.000822626391105713,0.00503516684220196,-0.00904630061961012,0.0106915534018215,0.870224812305102
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",41728,-0.00186754698589811,0.0116664091568078,-0.0247337089332414,0.0209986149614452,0.872821314722443
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,41815,-0.000675205075685372,0.00426039603923817,-0.00902558131259219,0.00767517116122145,0.87407776225466
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,39427,-0.000684186296127895,0.00438530242451758,-0.00927937904818235,0.00791100645592656,0.876021708932286
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,39600,-0.000501010082505416,0.00321670995701626,-0.00680576159825729,0.00580374143324645,0.876231102181122
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,41466,0.00122990349382655,0.00803471724748752,-0.014518142311249,0.0169779492989021,0.87834259591778
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,41465,-0.00127315540573306,0.00832731738447553,-0.0175946974793051,0.015048386667839,0.878488191517024
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,41744,0.00208899723166628,0.0137017010924119,-0.0247663369094611,0.0289443313727937,0.878824411679663
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",39241,-0.000840004186451278,0.00574258299032665,-0.0120954668474915,0.010415458474589,0.883705991139234
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,39633,-0.000954534132568177,0.00654349629726829,-0.013779786875214,0.0118707186100777,0.884022538234006
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,41521,0.00048609035694559,0.00334101049845545,-0.00606229022002709,0.00703447093391827,0.884324687476379
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,39625,-0.000460635436491594,0.00321162041762065,-0.00675541145502807,0.00583414058204488,0.885955002686926
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,39082,-0.00107323863429747,0.00753665424856364,-0.0158450809614822,0.0136986036928873,0.886764800867742
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,41788,-0.00180039737442036,0.0127042927732072,-0.0267008112099065,0.0231000164610658,0.88730676089872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,39259,0.00136347003116454,0.00987986172713321,-0.0180010589540166,0.0207279990163456,0.890239095670193
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,41466,-0.00099027292719169,0.00729074353588761,-0.0152801302575314,0.013299584403148,0.891960918549155
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,39250,-0.000733869031471072,0.00544084582908792,-0.0113979268564834,0.00993018879354124,0.892708175998669
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",39334,-0.00042133532243396,0.00314015344259342,-0.00657603606991707,0.00573336542504915,0.893265391716492
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",39600,-0.000951736281475265,0.0071972476294043,-0.0150583416351077,0.0131548690721572,0.894799931127854
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,41925,0.000743661794562376,0.00595973682328953,-0.0109374223790851,0.0124247459682098,0.900698828642251
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",39259,0.000586827157724735,0.004833974344262,-0.00888776255702877,0.0100614168724782,0.903379344273093
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,39589,-0.00100384823153395,0.0082692740265796,-0.01721162532363,0.0152039288605621,0.903380424268459
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,41465,-0.0010102761460931,0.00837598241745798,-0.0174272016843107,0.0154066493921245,0.903997206371842
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,41521,-0.000719884843120715,0.00600190853693046,-0.0124836255755044,0.011043855889263,0.904530439603073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,39334,0.000373414985530154,0.00315838295314038,-0.005817015602625,0.0065638455736853,0.905887790640249
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,41465,-0.00105105096609483,0.00897870035846401,-0.0186493036686843,0.0165472017364946,0.906813954735619
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,39259,0.000760936425947233,0.00657984953591145,-0.0121355686644392,0.0136574415163337,0.9079349042178
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,41447,0.000659587559058837,0.00573056520824953,-0.0105723202491102,0.0118914953672279,0.908367727386791
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,41534,0.000359621645814822,0.00329958607847625,-0.00610756706799862,0.00682681035962827,0.913212170576725
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,39598,-0.00103412042844239,0.0101353627254857,-0.0208994313703944,0.0188311905135097,0.918733989084618
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,41802,-0.000301907471667518,0.00315735613017227,-0.00649032548680516,0.00588651054347013,0.923823560268657
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,41765,-0.000321649359494649,0.00338236636459335,-0.00695108743409761,0.00630778871510832,0.924240058299668
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,39589,0.000265816516039148,0.00283048983242422,-0.00528194355551233,0.00581357658759063,0.92518089839063
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,39328,0.000469590321120899,0.00505919465940453,-0.00944643121131198,0.0103856118535538,0.926048943197156
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,41689,0.00080093907061754,0.00876417836646378,-0.0163768505276515,0.0179787286688865,0.9271858456119
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,39583,-0.00068205659909881,0.00749759514650756,-0.0153773430862536,0.014013229888056,0.927518048611991
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,41740,0.00080173593573231,0.00883241388092542,-0.0165097952708815,0.0181132671423461,0.92767513686936
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,41849,0.000399229045863838,0.00445037615815952,-0.00832350822412882,0.00912196631585649,0.928521560603571
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,39241,0.0006015472071251,0.00682391761210411,-0.012773331312599,0.0139764257268492,0.92975691782685
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,41466,-0.000359703340929498,0.00413569394271214,-0.00846566346864529,0.00774625678678629,0.930692475958485
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,41798,-0.000522751079742279,0.00614884503221384,-0.0125744873428814,0.0115289851833968,0.932249847570958
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,41534,0.000587283083482294,0.00693411024421078,-0.0130035729951708,0.0141781391621354,0.932505340579701
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,41424,0.000406169571654988,0.00505119975992994,-0.00949418195780769,0.0103065211011177,0.935912019363948
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,39259,0.00046449427332539,0.00585758476701487,-0.0110163718700238,0.0119453604166745,0.93679715131659
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,39589,-0.000305617210179161,0.00385616856737862,-0.00786370760224125,0.00725247318188293,0.936831948951872
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,41466,0.000333399782736796,0.00425172464954852,-0.00799998053037831,0.0086667800958519,0.937499012824069
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,39308,-0.000340576868775967,0.00436701102776802,-0.00889991848320128,0.00821876474564935,0.937838616214424
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,41740,-0.000989761008962353,0.0127690683294514,-0.026017134934687,0.0240376129167623,0.938217115023591
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,39408,0.000793347066241417,0.0102423364312598,-0.0192816323390279,0.0208683264715107,0.93826093318704
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",39598,-0.000457735835412265,0.00596865973770267,-0.0121563089213095,0.011240837250485,0.938871645557654
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,41598,0.00052853717539774,0.00690922920805431,-0.0130135520723887,0.0140706264231842,0.939024662829729
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",39308,-0.000395746573264042,0.00522496901659029,-0.010636685845781,0.00984519269925292,0.939626237091723
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,41815,-0.000225040533370911,0.00314760586923639,-0.00639434803707424,0.00594426697033241,0.943004265808498
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,39589,-0.000543262107105446,0.00765018208381242,-0.0155376189913778,0.0144510947771669,0.943388729774728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,39585,0.000616313962546337,0.00937251925162056,-0.01775382377063,0.0189864516957226,0.947572044827819
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,39241,0.000577226401595436,0.00911553524485341,-0.0172892226783172,0.0184436754815081,0.949510196751775
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,39598,-0.000266397456275814,0.00431831378426525,-0.00873029247343571,0.00819749756088408,0.950810699428393
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,41465,-0.000337892235595032,0.00552891160579849,-0.0111745589829601,0.01049877451177,0.951269609227413
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,39328,0.000444770216906654,0.00740735643727228,-0.014073648400147,0.0149631888339603,0.952121396820252
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,39241,0.000247752246698071,0.00426201059104566,-0.00810578851175142,0.00860129300514756,0.953645876137166
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,39408,0.000151044908785394,0.00262743980666693,-0.0049987371122818,0.00530082692985258,0.954157937163299
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,39334,0.000326472780615735,0.00580695453765322,-0.0110551581131846,0.011708103674416,0.955166799867607
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,39328,0.000380939621039211,0.00688098215434171,-0.0131057854014705,0.013867664643549,0.955851715037813
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,39328,0.000209218768480139,0.00387854309250072,-0.00739272569282127,0.00781116322978155,0.956981886238707
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,41689,8.36428335917823e-05,0.00160579322751073,-0.00306371189232925,0.00323099755951281,0.958459232538227
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,41786,0.000317745845417124,0.00610481899074543,-0.0116476993764439,0.0122831910672782,0.958490944551564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,39625,-0.000214058473773167,0.00426180239593957,-0.00856719116981473,0.00813907422226839,0.959942232763469
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,39241,-0.000179836156830096,0.00358460196381702,-0.00720565600591146,0.00684598369225127,0.959988598464327
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,39241,-0.000223973097283327,0.00448315947970398,-0.00901096567750313,0.00856301948293648,0.960156188106564
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",39427,-0.00036778264542689,0.00740162488961534,-0.0148749674290729,0.0141394021382192,0.960370782958017
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,41758,-0.000320896653195618,0.0065574578654287,-0.0131735140694359,0.0125317207630446,0.960970933321834
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,39328,-0.000290816771900448,0.00640826069754807,-0.0128510077390947,0.0122693741952938,0.963804035362194
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,39328,0.000319858081348017,0.00717812414887285,-0.0137492652504428,0.0143889814131388,0.964458759157824
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,41758,-0.000169613094360449,0.00393882598051167,-0.00788971201616331,0.00755048582744242,0.965652891695905
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,41865,0.000348600290939527,0.00832079631577898,-0.0159601604879873,0.0166573610698663,0.966582982152073
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,39589,-0.000158830847467701,0.00410055509280635,-0.00819591882936815,0.00787825713443275,0.969103179676231
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,41507,-0.000205362133046968,0.00570279666282239,-0.0113828435921789,0.0109721193260849,0.971274323427402
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,41758,0.000117227386962194,0.00341522747284204,-0.00657661845980821,0.0068110732337326,0.972618579274517
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,39655,0.000133099123460113,0.00394754745448492,-0.00760409388733034,0.00787029213425056,0.973103498833728
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,39250,-0.000305110823047584,0.00983510454674308,-0.019581915734664,0.0189716940885688,0.97525207243372
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,39427,-0.000283909247304587,0.00934577007101769,-0.0186016185864993,0.0180338000918901,0.975765856241694
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,39600,-0.000317022540795577,0.0106984193831648,-0.0212859245317986,0.0206518794502074,0.976360561622923
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,39427,6.37564895378995e-05,0.00248185752594697,-0.00480068426131815,0.00492819724039395,0.979505854555095
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",39250,-0.000111065640680909,0.00432719599830774,-0.00859236979736409,0.00837023851600227,0.979523518231888
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,39250,0.000117733277304775,0.00508098329137871,-0.0098409939737975,0.010076460528407,0.981514020448222
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,41595,-9.6159088226568e-05,0.00434560573810106,-0.00861354633490464,0.0084212281584515,0.982346278202928
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,39250,9.22432191449868e-05,0.00418367508004233,-0.00810775993773798,0.00829224637602796,0.982409783700174
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,39259,-0.000153362652763784,0.00713697207259232,-0.0141418279150447,0.0138351026095172,0.982856398419287
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,39427,-9.13318025159533e-05,0.00428098039178376,-0.00848205337041213,0.00829938976538022,0.982979360373603
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,39630,8.51776612827189e-05,0.00407880472591761,-0.0079092796015158,0.00807963492408123,0.983339368920394
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,39328,-8.00993877064328e-05,0.00428451085911449,-0.00847774067157083,0.00831754189615797,0.985084679518874
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,39600,0.000152868910971345,0.00832109206983846,-0.016156471545912,0.0164622093678547,0.985343016310737
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,39250,-9.12224147057692e-05,0.00507218456733612,-0.0100327041666846,0.00985025933727303,0.985651286358953
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,41802,0.000151008013618958,0.00846805493255138,-0.0164463796541817,0.0167483956814197,0.985772612949203
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,41521,0.000147250062317879,0.00837077807030531,-0.0162594749554805,0.0165539750801163,0.985965436218706
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,41779,5.26594442692433e-05,0.00328839873931102,-0.00639260208478035,0.00649792097331884,0.987223701236428
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,41466,9.25243173009764e-05,0.00592691125982135,-0.0115242217519489,0.0117092703865508,0.987545065541994
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,39250,-8.33373328138113e-05,0.00593990313229427,-0.0117255474721106,0.011558872806483,0.988806243588693
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,39250,-4.45226177538271e-05,0.00351652751333113,-0.00693691654388285,0.00684787130837519,0.989898521718147
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],41534,-5.86534533639873e-05,0.0057297198545934,-0.0112889043683671,0.0111715974616391,0.991832591447491
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,39259,-6.16384547108452e-05,0.00635419668813972,-0.0125158639634647,0.012392587054043,0.992260477766684
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,39633,-2.38344991734376e-05,0.00287989670809201,-0.00566843204703378,0.00562076304868691,0.993396801061863
NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,39241,2.59795331618999e-05,0.00671621264051637,-0.0131377972422502,0.013189756308574,0.996913717473652
